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Executive summary 
 
Background  
Human Immunodeficiency Virus (HIV) is a blood borne virus that attacks the 
body’s immune system by reducing the number of CD4 blood cells, making 
individuals more susceptible to infection and disease. HIV infection is 
associated with a wide range of symptoms, varying from symptoms of primary 
infection (e.g. rash and fever), to serious diseases associated with a 
suppressed immune system (e.g. hepatitis) (Adler, Edwards, Miller, Sethi, & 
Williams, 2012). Acquired Immunodeficiency Syndrome (AIDS) is the most 
advanced stage of HIV infection, when the CD4 count drops to a very low 
level, which makes individuals more likely to develop opportunistic illnesses. 
People with AIDS survive for about three years without treatment (CDC, 
2016).  
 
HIV can be transmitted through unprotected sexual contact, from mother to 
child transmission (either through pregnancy, birth or breastfeeding), or 
through sharing of equipment used for intravenous drug use (WHO, 2017). In 
the 1990’s antiretroviral therapy (ART) was introduced and changed the 
clinical picture of HIV from being a fatal to a chronic illness. ART cannot cure 
HIV but it prevents it from replicating itself and it has been shown to reduce 
transmission of HIV by 96% (Hull, Wu, & Montaner, 2012). In 2016, 96% of 
people receiving a HIV diagnoses in the United Kingdom (UK) were on ART. 
For the first time, the death rates among people living with HIV was 
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comparable to the rest of the population in the UK (Public Health England, 
2017a). However, HIV remains a major public health concern with 1.8 million 
new diagnoses in 2016 worldwide and around a million deaths a year (WHO, 
2017).  
 
Between 2000 and 2016, new HIV infections rates fell by 39% and HIV-
related deaths fell by 33% due to the availability of ART (WHO, 2017). 
Despite this success, levels of HIV acquisition vary notably across countries 
and sub-groups in the population (UNAIDS, 2013). In the UK, there were 4 
363 new HIV infections in 2016. Fifty-four percent of these were reported 
among men who have sex with men, and 19% and 22% of diagnoses were 
among heterosexual men and women respectively (Public Health England, 
2017a). HIV also continues to disproportionately affect individuals of black 
African ethnicity (Public Health England, 2017b).  
 
HIV can be a demanding illness to live with and often represents a burden for 
people living with the illness (Remien et al., 2006). Stressors include ART 
adherence and potential side-effects, symptoms associated with illness 
progression, as well as adjustment and acceptance of living with a serious 
illness (Moskowitz & Wrubel, 2005). Other stressors include HIV disclosure, 
managing safe sex, as well as managing on-going relationships with HIV 
services. The ability to adjust and cope with the stressors associated with a 
HIV diagnosis is vital as poor adjustment can have detrimental effects on the 
individual’s mental health and the progression of HIV (e.g. Bottonari, Roberts, 
Ciesla, & Hewitt, 2005; Remor et al., 2007). According to Moss-Morris’ model 
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of adjustment, personality traits are key processes in how individuals adjust to 
a chronic illness (Moss-Morris, 2013). As personality-related difficulties may 
increase one’s risk of contracting HIV (e.g. Hutton & Treisman, 2008), it can 
be hypothesised that there is a high prevalence of personality disorders (PDs) 
in individuals living with HIV.  
 
PD is a way of understanding individuals whose personality seriously impacts 
on either their own lives or those of others in an unhelpful way. According to 
the Diagnostic and Statistical Manual of Mental Disorders (DSM), PDs are 
defined as “an enduring pattern of inner experience and behavior that 
deviates markedly from the expectation of the individual’s culture”. The 
pattern must be pervasive, inflexible, have an onset in adolescence or early 
adulthood and cause significant distress or impairment (DSM-5; American 
Psychiatric Association, 2013). The current classification in DSM-5 includes 
ten categories of PD, which can be divided into three clusters. Cluster A 
(described as ‘odd and eccentric‘) includes paranoid, schizoid and schizotypal 
PD; Cluster B (‘dramatic and erratic’) includes antisocial, borderline, histrionic 
and narcissistic PD; and Cluster C (‘anxious and fearful’) includes avoidant, 
dependent and obsessive-compulsive PD (American Psychiatric Association, 
2013).  
 
Research has suggested that Cluster B disorders are most common PDs in 
individuals with HIV (Hutton & Treisman, 2008; Singh & Ochitill, 2006). Cluster 
B PDs are often characterised by behaviour associated with an increased risk 
of HIV acquisition, such as impulsive sexual behaviour, more sexual partners 
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and substance use (Durvasula & Regan, 2015). After infection, personality-
related difficulties have been associated with reduced treatment adherence 
(Golding & Perkins, 1996) and poorer post-HIV diagnosis outcomes, such as 
poor physical health, mental health difficulties and poor support systems 
(Gerhardstein, Griffin, & Hormes, 2011). However, very few studies haves 
explored the impact of personality-related difficulties in those living with HIV. 
Understanding the relationship between personality-related difficulties and 
HIV is crucial to the development of theoretical frameworks, tailored 
interventions and guidelines, to be able to better support this population.  
 
Systematic review 
The literature above highlights that a better understanding of the relationship 
between PD and HIV is crucial to be able to develop targeted treatments. The 
prevalence of PD in HIV populations, however, remains unclear. In addition, 
there do not appear to be any reviews which have examined the associations 
of PD in individuals living with HIV. Understanding prevalence rates and 
associations of the two disorders is crucial to guiding the development of 
specific treatment guidelines as well as theoretical frameworks. Therefore, the 
current systematic review synthesised the literature exploring the prevalence 
and associations of PD and HIV. Studies were included if they reported 
prevalence rates and/or associations of PD in HIV. Thirty-four studies met the 
review’s inclusion criteria. The review described and evaluated the reviewed 
studies, synthesised the data, and explored the relationship between the two 
disorders.  
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Across studies, there were significantly higher rates of PDs in HIV-positive 
individuals compared to HIV-negative populations, across inpatient settings, 
psychiatric emergency departments, substance use settings and community 
samples. In addition, there were a large variety of associations explored in the 
34 studies. The associations were grouped into five categories: socio-
demographic variables, substance use, mental health, high-risk sexual 
behaviours, and health-related factors. Variables where three or more studies 
indicated a relationship with HIV and PD included: gender, substance use, 
axis I disorders, quality of life and ART adherence. The review indicated that 
there was a higher prevalence of PD in HIV-positive males and substance 
users. Furthermore, PDs in people living with HIV were related to higher rates 
of Axis I disorders, decreased quality of life and reduced ART adherence. The 
review demonstrated that the relationship between HIV and PD may be 
influenced by several factors, which will be important to take into 
consideration when supporting this population. Future research could 
examine these factors to gain a clearer understanding of how the associated 
variables may impact on life with HIV and PD.  
 
Empirical article  
The elevated risk of contracting HIV when living with PD has already been 
established, but the effect of PD when living with HIV is less researched. 
Despite the common comorbidity, and the potentially severe consequences 
and outcomes, there is very limited literature on personality-related difficulties 
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and wellbeing in HIV. To my knowledge, there have been no first-hand 
accounts of what it is like to live with HIV in individuals with personality-related 
difficulties. Understanding the impact of personality-related difficulties in 
people living with HIV is important to better support this population, as we will 
better understand the challenges they are faced with. The empirical article 
explored the impact of personality-related difficulties in people living with HIV. 
The participants were recruited from two HIV clinics.  Nine adults presenting 
with personality-related difficulties met the criteria for Cluster B PD on a 
screening measure. They took part in semi-structured interviews about their 
life with HIV. The data was analysed using the qualitative method of 
Grounded Theory.  
 
Eight theoretical codes were identified and a theoretical model indicating the 
diagrammatic representation of the relationship between the codes was 
generated. Findings suggest that the individuals present with difficulties 
experiences and deficits in the following areas prior to the HIV diagnosis: 
traumatic experiences prior to HIV; mentalizing deficit (self and others); 
difficulties identifying and regulating current emotions; and dysfunctional 
relationships. The model then suggests that these areas lead to; difficulties 
managing sex; dissatisfaction over the support they have received; negative 
feelings towards HIV and self before and after diagnosis; fear and shame 
impacting on life with HIV. Clinically, the current study suggests that there is a 
significant impact of personality-related difficulties when living with HIV. It is 
surprising that there is no specific guidance for people living with comorbid 
HIV and personality-related difficulties. The current study has identified many 
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barriers for treatment, which may indicates that individuals with personality-
related difficulties and HIV may need different support and treatment 
compared to individuals living with either HIV or PD traits. 
 
Integration, impact and dissemination  
Integration  
The literature within the review highlighted the problem, that is, there is a high 
prevalence of personality-related difficulties in people living with HIV and the 
traits have a significant impact on the individuals’ lives. The literature provided 
a clear rationale for the systematic review and empirical article which both 
focused on the HIV and personality-related difficulties. Specifically, the 
systematic review explored the relationship between HIV and personality-
related difficulties, in terms of prevalence and associated variables, whereas 
the empirical article focus on the impact of personality-related difficulties when 
living with HIV.  
 
The review highlighted that there was a high prevalence rate of PD in HIV, as 
well as multiple associations of the two disorders.  The review findings were 
relevant to the empirical project as they informed areas to be further explored 
(e.g. symptoms of mental health, substance use and support). Therefore, it 
felt necessary to include questions on substance use, mood, socio-
demographic variables and physical health in the empirical study. 
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Impact 
HIV can be a demanding illness and often represents a burden for people 
living with the illness (Remien et al., 2006). The ability to adjust and cope with 
the stressors associated with a HIV diagnosis is vital as poor adjustment can 
have detrimental effects on the individual’s mental health and the progression 
of HIV (e.g. Bottonari, Roberts, Ciesla, & Hewitt, 2005; Remor et al., 2007). 
Dysfunctional personality traits are thought to have a negative effect on 
adjustment to chronic conditions (Moss-Morris, 2013). The current review and 
empirical relationship investigate the relationship between personality-related 
difficulties and HIV. This research contributes knowledge regarding the 
prevalence and associations of PD in HIV, but also indicates areas affected 
by the diagnosis where individuals may need extra support. The potential 
beneficiaries of this work are: a) individuals with personality-related difficulties 
and HIV b) friends and family of these individuals c) HIV clinicians d) clinical 
psychologists and other mental health staff e) GP and A&E staff f) support 
organisations and peer groups g) policy makers h) researchers. 
 
Dissemination  
It is planned that the current research will be made more broadly available by 
publishing results in a journal article in an academic journal (e.g. AIDS & 
Behaviour and Clinical Psychology Review). Alongside this, the empirical 
abstract will also be submitted to the 2019 AIDS Impact conference. By 
disseminating the research findings in this way, researchers and clinicians 
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working in the field of HIV and mental health could become aware of the 
study’s findings. 
 
It is planned that I will disseminate the key findings written in lay language to 
the service users participating in the research. Disseminating findings with 
participants would allow feedback on what elements of the study could 
potentially be most useful to other service users. Once this has taken place, 
the feedback will be incorporated and findings will be disseminated at the 
participating services as well as relevant service user forums. To facilitate 
dissemination to clinicians it is planned that I will attend team meetings to 
present key findings. Feedback from team members will be important as the 
impact of the study will be maximised if the clinicians find the summarised 
information useful and feel able to incorporate it during consultations.  
 17 
 
A systematic review of the rates and associations of 
personality disorders in people living with HIV 
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Abstract 
 
Introduction:  Personality difficulties may increase one’s risk of HIV and lead 
to poorer outcomes following an HIV-positive diagnosis. Despite this, the 
relationship between PDs and HIV is not understood. Understanding 
prevalence rates and associations related with the two disorders is crucial to 
guiding the development of specific treatment guidelines as well as theoretical 
frameworks. Therefore, the current systematic review synthesised the 
literature exploring prevalence and associations of PD and HIV. Method: 
Studies were included if they reported prevalence rates and/or associated 
variables of PD in HIV. Thirty-one studies met the review’s inclusion criteria. 
The review described and evaluated the reviewed studies, synthesised the 
data, and explored the relationship between the two disorders. Results: 
Across studies, there were significantly higher rates of PDs in HIV-positive 
individuals compared to HIV-negative individuals, across inpatient settings, 
psychiatric emergency departments, substance use settings and community 
samples. In addition, there were a large variety of associated variables 
explored in the 34 studies. The associated variables were grouped into five 
categories: socio-demographic variables, substance use, mental health, high-
risk sexual behaviours, and health-related factors. Variables where three or 
more studies indicated a relationship with HIV and PD included: gender, 
substance use, axis I disorders, quality of life and ART adherence. 
Discussion: The review demonstrated that there is a higher prevalence rate 
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of PD in people living with HIV compared to the HIV-negative population. The 
relationship between HIV and PD may be influenced by several factors, which 
will be important to take into consideration when supporting this population. 
Future research could examine these factors to gain a clearer understanding 
of how these associated variables may impact on life with HIV and PD.  
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Introduction  
 
HIV: General Overview   
As defined in greater detail in the Executive Summary (p. 8) HIV is a blood 
borne virus that attacks the body’s immune system by reducing the number of 
CD4 blood cells, making individuals more susceptible to infection and 
disease. Acquired Immunodeficiency Syndrome (AIDS) is the most advanced 
stage of HIV infection, when the CD4 count drops to a very low level, making 
individuals more likely to develop opportunistic illnesses. People with AIDS 
survive for about three years without treatment (CDC, 2016). In the 1990’s 
antiretroviral therapy (ART) was introduced and changed the clinical picture of 
HIV from being a fatal to a chronic illness. ART cannot cure HIV but it 
prevents it from replicating itself and it has been shown to reduce 
transmission of HIV by 96% (Hull, Wu, & Montaner, 2012).  
 
HIV remains a major public health concern with 1.8 million new diagnoses in 
2016 worldwide. HIV can be transmitted through unprotected sexual contact, 
from mother to child transmission (either through pregnancy, birth or 
breastfeeding), or through sharing of equipment used for intravenous drug 
use (WHO, 2017). There are 36.7 million people in the world living with HIV, 
suggesting a prevalence of 0.8% adults aged 15-49 years old worldwide 
(WHO, 2017). In 2017, the United Kingdom (UK) had an estimated 102 000 
people living with HIV, suggesting a prevalence of 0.16% adults in the UK 
(Public Health England, 2017b).  
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HIV can be a demanding illness to live with and often represents a burden for 
people living with the illness (Remien et al., 2006). Stressors include 
adherence to medication, side-effects of treatment, symptoms associated with 
illness progression, a fear of death, financial difficulties, adjustment and 
acceptance of living with a serious illness, as well as being faced by HIV 
stigma (Moskowitz & Wrubel, 2005). Other stressors include HIV disclosure, 
negotiating safer sexual relationships, as well as managing on-going 
relationships with HIV services. The ability to adjust and cope with the 
stressors associated with a HIV diagnosis is vital as poor adjustment can 
have detrimental effects on the individual’s mental health and the progression 
of HIV (e.g. Bottonari, Roberts, Ciesla, & Hewitt, 2005; Remor et al., 2007). 
 
HIV and Mental Health  
In a recent population study in Sweden, Bauer-Staeb and colleagues (2017) 
found that prevalence of blood-borne viruses (e.g. HIV) was elevated in 
people with severe mental illness. The odds of HIV infection were nearly three 
times higher in people with severe mental illness than in the general 
population. The authors also found that having a history of substance misuse 
increased the odds of HIV infection in those with and without severe mental 
health difficulties (Bauer-Staeb et al., 2017). It has been proposed that the link 
between HIV and psychiatric disorders is bi-directional and influenced by 
many factors, for example HIV stigma and discrimination, family support and 
educational level. Other factors such as medication side effects, treatment 
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adherence, concurrent substance use and the course of HIV infection have 
also been found to influence the relationship (Chandra, Desai, & Ranjan, 
2005).  
 
Depression, anxiety disorders and substance use are more common in people 
with HIV than in the general population. Individuals with HIV are two to seven 
times more likely to meet diagnostic criteria for depression than individuals in 
the general population, and they present with lifetime rates as high as 40-50% 
for substance use (Owe-Larsson, Sall, Salamon, & Allgulander, 2009). In 
2009 the New York State Department of Health AIDS Institute estimated that 
13% to 23% of individuals living with HIV had comorbid mental health and 
substance use diagnoses (New York State Department of Health AIDS 
Institute, 2009).  
 
Personality Disorders: General Overview  
As defined in greater detail in the Executive Summary (p. 10) personality 
disorders (PDs) are  “an enduring pattern of inner experience and behavior 
that deviates markedly from the expectation of the individual’s culture”. The 
pattern must be pervasive, inflexible, have an onset in adolescence or early 
adulthood and cause significant distress or impairment (DSM-5; American 
Psychiatric Association, 2013). The current classification in DSM-5 includes 
ten categories of PDs, which can be divided into three clusters. Cluster A 
(described as ‘odd and eccentric‘) includes paranoid, schizoid and schizotypal 
PDs; Cluster B (‘dramatic and erratic’) includes antisocial, borderline, 
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histrionic and narcissistic PDs; and Cluster C (‘anxious and fearful’) includes 
avoidant, dependent and obsessive-compulsive PDs (American Psychiatric 
Association, 2013).  
 
It is has been long known that there is a poor diagnostic reliability of PDs and 
poor temporal stability (Zimmerman, 1994) and, as such, the prevalence of 
PD in the general population ranges from 4-15% depending on studies. A 
recent meta-analysis presented a prevalence rate of 12.16% in the general 
population (Volkert, Gablonski, & Rabung, 2018). PDs are associated with 
high mortality (Skodol, 2016) and comorbidity (Moran et al., 2016). There is 
also a high level of comorbidity with other mental health disorders; 85% of 
patients with Borderline PD have at least one Axis I disorder of the DSM-5 
and 74% have another PD (Grant et al., 2008). Furthermore, PDs are also 
associated with higher levels of alcohol and substance use, lower levels of 
education (Moran et al., 2016) and an increased risk for self-harm and suicide 
(Linehan et al., 2015) compared to people without PD. In addition to this, 
individuals with PD have been found to make less contact with psychiatric 
services, compared to individuals with other conditions such as schizophrenia 
and depression (Andrews, Issakidis, & Carter, 2001), as well as presenting 
with a low level of treatment adherence for psychological therapies (Martino, 
Menchetti, Pozzi, & Berardi, 2012). 
  
 24 
Personality Disorders and Adjustment  
Personality traits and early life experiences are key processes contributing to 
how individuals adapt to a chronic illness (Moss-Morris, 2013). Brunault and 
colleagues found that psychological characteristics (e.g. PD) accounted for 
more of the variance of the individuals’ quality of life (as reported on a 
questionnaire) compared to biological or physiological variables (e.g. 
treatment types and severity of illness) in individuals diagnosed with non-
metastatic breast cancer (Brunault et al., 2016). This suggests that individuals 
with personality related-difficulties may find the emotional challenges of their 
physical illness even more daunting, and the physical symptoms or treatment 
adherence even more problematic, than someone without mental health 
difficulties. Furthermore, PDs are often accompanied by an Axis I diagnosis 
(e.g. depression or anxiety) further complicating the likelihood of positive 
coping with a physical illness and treatment adherence (Tyrer, Reed, & 
Crawford, 2015) 
 
HIV and Personality Disorders: Impact  
PD difficulties, and particularly Cluster B PDs, are often characterised by 
behaviours associated with an increased risk of HIV acquisition, such as 
impulsive sexual behaviour, more sexual partners and substance use 
(Durvasula & Regan, 2015). In a sample of men involved in the criminal 
justice system, Borderline PD traits were strongly associated with HIV risk 
behaviours. The PD symptoms most associated with an increased risk of 
contracting HIV were abandonment worry and mood swings. Higher 
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Borderline PD scores (as measured on a questionnaire) were associated with 
sexual risk behaviours, including multiple partners and sex with non-
monogamous partners (Scheidell et al., 2016).  
 
Personality-related difficulties may also lead to poorer outcomes following 
diagnosis (e.g. Hutton & Treisman, 2008; Scheidell et al., 2016). In a review 
study, it was argued that individuals with HIV and PD difficulties often present 
with challenges in terms of engagement with care, medication adherence, 
difficulty with interpersonal skills and struggle with how to appropriately 
express their health care needs (Willinger, 2010). In another review, the 
authors argued that individuals with PD are often characterised by their 
dysfunctional interpersonal skills and poor impulse control, which frequently 
leads to disrupted HIV treatments. In addition to this, individuals often present 
with poor physical health, mental health difficulties, poor support systems and 
health-related quality of life (Gerhardstein, Griffin, & Hormes, 2011).  
 
Personality Disorders in HIV: Rates and Associations 
PDs have been suggested to be risk factors for HIV (e.g. Scheidell et al., 
2016) which indicates that the prevalence rate will be higher in individuals 
living with HIV compared to the population. The relationship between PDs and 
HIV, however, is not understood. It is therefore important to further explore 
study populations, sampling methods, diagnostic tools and other 
discrepancies to further understand the relationship between HIV and PD. 
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This will help us to understand the relationship between HIV and PD further to 
develop specific interventions and care. 
 
In addition, there do not appear to be any reviews which have examined the 
associations of PD in individuals living with HIV. For example, it has been 
hypothesised that substance use may mediate the relationship between PD 
and HIV risk behaviours (Gerhardstein et al., 2011). The rates of substance 
use among individuals living with HIV are consistently higher than in the 
general population. Half of participants enrolled in a large national study in the 
US looking at HIV-positive individuals currently in care, reported illicit drug use 
during the previous year (Bing et al., 2001). In addition, a recent review 
highlighted that 45-86% of individuals with borderline PD also met criteria for 
lifetime substance use disorder (Trull et al., 2018). The relationship between 
PD and HIV appears to be influenced by many factors, and one of these may 
be substance use disorder. It will be important to further explore associated 
variables of PD in living with HIV to gain a better understanding of this 
common comorbidity. There are currently no specific guidelines for people 
living with comorbid HIV and PD so increasing the awareness and 
understanding of the relationships between the two disorders could assist in 
the development of specific guidance, interventions and care.  
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Aims and Objectives of the Current Review  
The current systematic review will synthesise the literature exploring the 
prevalence and associations of personality disorders in HIV, to answer the 
following research question:  
 
 What are the rates and associated variables of personality disorders in 
samples of people living with HIV?  
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Method 
 
Study Eligibility  
The following inclusion criteria was used:  
 Observational or experimental studies.  
 Individuals with an HIV-positive diagnosis and a diagnosis of a 
personality disorders or scores on a personality disorder questionnaire/ 
self-report measure suggestive of a personality disorder diagnosis. All 
diagnostic systems and classifications of personality disorders (e.g. 
DSM-III, DSM-IV and DSM 5) were included.  
 Quantitative or mixed methods studies where the rate of personality 
disorders in HIV are presented or can be calculated from available 
quantitative data.  
 
Sources of Information  
Studies in peer-reviewed journals were retrieved from Pubmed, PsychINFO 
and Web of Science. Only studies published in English were included. All 
settings and locations were included and there was no date exclusion.  
 
Search Strategy  
Searches were conducted using combinations of the following search terms:  
 “HIV” or “AIDS” or “AIDS Viruses” or “Human immunodeficiency 
disease” and  
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 “Personality disorder” or “personality difficulties” or “axis 2” or 
“interpersonal difficulties” or “personality dysfunction” or “personality-
related difficulties”.  
The terms were searched for as key words in titles and abstracts. In addition, 
the reference lists and citing articles of the included studies were searched.  
 
Data Collection  
The data collection process followed the practice guidelines of PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
(Moher, Liberati, Tetzlaff, Altman, & Group, 2009) (see Figure 1 and Appendix 
L).  
 
The researcher carried out searches for the identification of studies using the 
pre-specified search criteria in three databases (27th September 2018). The 
researcher removed any duplicate articles. Two reviewers (the researcher and 
an undergraduate psychology student) independently screened the remaining 
titles and abstracts for eligibility. Articles considered relevant by either 
reviewer were retrieved in full text. The two reviewers independently assessed 
eligibility of retrieved articles. Exclusions were recorded in an Excel 
spreadsheet, with reasons given. The inter-rater agreement between the two 
reviewers was Kappa = .57, indicating a moderate level of agreement 
between the reviewers (McHugh, 2012). A third reviewer (the academic 
supervisor) resolved any disagreements.
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Data Abstraction  
For each included study the following details were extracted:  
 Study information: Authors, year of publication, location, study design, 
sampling strategy, response rate and sample characteristics (including 
sample size, gender, age and ethnicity). 
 Assessment tools: Measures of PDs and associated variables.  
 Prevalence and associations: Reported or calculated prevalence of PD 
in the HIV sample. Associations between PDs, HIV and associated 
variables. 
 
Quality assessment  
The methodological quality of the studies was evaluated using a bespoke 
assessment tool (Table 1). A bespoke tool was developed as this is a mixed 
prevalence and association review and due to this some of questions of 
others tools not being suitable for the current study. The developed tool was 
based upon the Mixed Methods Assessment quality assessment tool (Pluye et 
al., 2011) and Joanna Briggs Checklist for prevalence studies (The Joanna 
Briggs Institute, 2017). The quality assessment tool was used to ascertain the 
risk of bias for included studies. The developed tool assessed dimensions of 
internal validity (e.g. detection bias and confounding) and external validity 
(e.g. sample representativeness and response rate). Two reviewers (the 
researcher and an undergraduate psychology student) assessed all included 
papers independently. A third reviewer (the academic supervisor) resolved 
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any disagreements. The biases highlighted by the assessment tool were 
considered in the subsequent interpretation of the data. 
 
Data synthesis  
There was too much heterogeneity in the variables examined to combine the 
study results for statistical analysis, such as a meta-analysis. Therefore, the 
current study described and evaluated the included studies, synthesised the 
data and examined and compared the relationship of factors/variables 
included to answer the key objectives of the review. 
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Table 1: Quality Assessment Tool for Quantitative Studies  
 
External 
validity 
Sampling Is the sampling clear 
and representative to 
address the research 
question? 
 
Consider:  
 Whether the sample is suitable to assess personality disorder traits in a HIV-positive 
sample e.g. used random sampling or sampled everyone from population and NOT 
used convenient sampling (e.g. only people who turn up at clinic)  
 Have the study used inclusion and exclusion criteria? 
 Both needed for yes  
 Response rate  Was the response rate 
adequate, and if not, 
was the low response 
rate managed 
appropriately? 
 
Consider:  
 Whether the study has a low response rate (<70%). The authors should in this case 
clearly discuss the response rate and any reasons for non-response and compare 
persons in the study to those not in the study, particularly with regards to their socio-
demographic characteristics.  
 Yes if the response rate is higher than 70% OR if the authors have assessed and not 
found any non-significant differences between responders and non-responders  
Internal 
validity 
Detection 
validity:  
PDs 
Were reliable and valid 
measurements used in 
the identification of 
personality 
disorder/personality 
disorder difficulties? 
Consider:  
 Whether either a diagnostic interview was used or a questionnaires which had either a) 
been used in previous studies or b) developed for the study and had reliability of ≥0.7 
(e.g. internal consistency or inter-rater reliability).  
 Yes if authors used diagnostic interview or questionnaire (which had been used in 
previous studies or had a reliability of ≥0.7). 
 Detection 
Validity: 
Associated 
variables 
If associated variables 
are measured, were the 
majority of the measures 
used reliable and valid? 
Consider: 
 Whether either objective measures or self-report measures were used. Have the 
measures either been a) used in a previous study or b) they were developed for the 
study and had reliability of 0.7 (e.g. internal consistency or inter-rater reliability). 
 Yes if authors used diagnostic interview or questionnaire (which had been used in 
previous studies or had a reliability of 0.7) for a majority of the associated variables.  
 Control of 
confounding 
variables 
Did the study control for 
potential confounders? 
 
Consider:  
 Whether the authors conducted multivariate analysis, i.e. an adjusted analysis where 
the authors have not just reported t-test and correlations but instead used for example 
partial correlations, multiple regression, adjusted odds ratio etc.  
 Yes if multivariate analysis is completed  
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Results 
 
Of 1847 citations identified through the initial search, 31 articles met inclusion 
criteria for the review. An additional 3 studies were included from reference 
lists and citations leaving a total of 34 studies included in the review (see 
Figure 1). 
 
Overall Study Characteristics 
Study characteristics are described in Table 2. All reports of multiple 
publications were included. Overall, the 34 studies relate to 33 datasets; two 
studies used data from one data set. All 34 articles were published between 
February 1990 and December 2017. Twenty-seven studies were conducted in 
the United States, two in Spain, one in the United Kingdom, one in the 
Netherlands, one in Romania and one in Italy. The location of one study was 
unclear.  
 
Most studies were either cross-sectional (n=20), longitudinal (n=6) or 
retrospective (n=5) in design, however, there was also 1 prospective cohort 
study and 1 randomised controlled trial. Across all studies, sample sizes 
ranged from 1 to 22 606 (median: 93, inter-quartile range: 57-142) and overall 
39 279 HIV positive participants were included. Across the thirty-three data 
sets, five studies looked at female only samples, five studies looked at male 
only and the remaining twenty-three studies had a mixed sample.  
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Across all studies, four studies recruited participants from inpatient 
admissions, two from psychiatric emergency departments, two from forensic 
institutions, and eight from substance use outpatient services. Participants 
from the remaining sixteen studies were recruited from community settings 
(such as HIV primary care and mental health outpatient services).  Sixteen of 
the studies only included HIV-positive participants and seventeen studies 
included both HIV-positive and negative participants. 
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Assessment of Personality Disorders   
There was a great variability in how PDs were assessed. Seven studies listed 
that they based their diagnoses on the Diagnostic and Statistical Manual 
(DSM) but did not specify how the participants were assessed. One study 
stated that participants were diagnosed in hospital but did not state any 
further details. Six studies listed that they used the Structured Clinical 
Interview for DSM-IV Axis II Personality disorders (SCID-II; (First, Gibbon, 
Spitzer, Williams, & Smith Benjamin, 1997) and two studies used the SCID-II 
combined with International Personality Disorders Examination (IPDE; 
Loranger, 1997). Three studies used the Millon Clinical Multiaxial Inventory 
(MCMI-III; Millon, 1997), two used The Computer-Assisted SCID-II (CASII; 
First, Gibbon, Spitzer, Williams, & Smith Benjamin, 1997).  
 
Four studies used the Diagnostic Interview Schedule (Robins et al., 2000) 
where one of these used a computerised version of the schedule. Two studies 
used different versions of the Personality Diagnostic Questionnaire-4 (PDQ-R 
and PDQ-4; Hyler et al., 1988). Two studies used the Psychiatric Research 
Interview for Substance and Mental Disorders (PRISM; Hasin et al., 1996) or 
the Spanish version of the PRISM (Torrens, Serrano, Astals, Pérez-
Domínguez, & Martín-Santos, 2004). The remaining four studies used the 
Alcohol Research Center Intake Interview (Schuckit, Irwin, Howard, & Smith, 
1988), Alcohol Use Disorder and Associated Disabilities Interview Schedule 
(AUDADIS-IV; Grant et al., 2003), Personality Factors Questionnaire based 
on the DSM-III-R (Brown, unpublished  manuscript, 1987), or a structured 
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personality inventory from the Karolinska Psychodynamic Profile (KAPP; 
(Weinryb, Rössel, & Åsberg, 1991)). One study did not state any information 
in regards to how PD symptoms were assessed.  
 
Data Synthesis: Prevalence 
To ensure brevity, when no specific disorder is mentioned in the result or 
discussion sections, it indicates any PD.  
 
Inpatient settings  
Bansil and colleagues found a prevalence rate of 8.2% (1994) and 4.7% 
(2004) in a large sample of hospitalised HIV-positive women (Bansil, 
Jamieson, Posner, & Kourtis, 2009). Travin and colleagues explored 
prevalence and characteristics of 11 violent patients in an AIDS service. No 
participants met criteria for a PD (Travin, Lee, & Bluestone, 1990). 
 
Psychiatric emergency departments  
Two studies explored prevalence rates of PD in HIV-positive patients treated 
in psychiatric emergency departments. One study found a prevalence rate of 
8.6% for PD and 4.7% for Borderline PD, both significantly higher than for 
HIV-negative patients (Bennett, Joesch, Mazur, & Roy-Byrne, 2009). 
However, another study did not find a significant difference between groups. 
Ellis et al. found that 13% met criteria for PD in the HIV-positive group, 
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compared to 11% in the HIV-negative control group (Ellis, Collis, & King, 
1994).  
 
Forensic settings  
Two studies explored psychiatric disorders in incarcerated men and women in 
the US and Spain. Out of 81 HIV-positive female inmates in the US, 8.6% met 
criteria for Borderline PD and 18.5% met criteria for Antisocial PD on the 
SCID-II (Lewis, 2005). In inmates co-infected with Hepatitis C and HIV across 
25 Spanish prisons, 75.9% received a PD diagnosis (Marco et al., 2015). 
 
Substance use settings  
Across studies, HIV-positive substance users were more likely than HIV-
negative substance users to have a PD (Brooner, Greenfield, Schmidt, & 
Bigelow, 1993; Gilchrist, Blazquez, & Torrens, 2011; McGurk, Miller, & 
Eggerth, 1994; Palmer, Salcedo, Miller, Winiarski, & Arno, 2003; Turrina et al., 
2001), whilst controlling for confounding variables. However, one study found 
that there was no significant difference in the prevalence of PD in HIV-positive 
methamphetamines users compared to HIV-negative non-substance users 
(Moore et al., 2012). 
 
In terms of prevalence rates, Turrina and colleagues found a PD prevalence 
rate of 36% in intravenous drug users (Turrina et al., 2001). The prevalence 
rates varied from 37% to 47% for Borderline PD in different studies (Gilchrist 
et al., 2011; Palmer et al., 2003), whereas the prevalence rates of Antisocial 
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PD across studies had a greater variation, ranging from 13% to 64% (Brooner 
et al., 1993; Gilchrist et al., 2011; Moore et al., 2012; Palmer et al., 2003).  
 
A few of the studies also explored the rates of HIV in participants with PD. 
Two studies found that individuals with PD were more likely to be HIV-positive 
compared to those without PD (Brooner et al., 1993; Gilchrist et al., 2011), 
however, one study found a low prevalence rate of HIV in participants 
diagnosed with Borderline PD (Chen, Brown, Lo, & Linehan, 2007). 
 
Community samples 
Nineteen studies recruited participants from community samples, including 
military personnel, primary care HIV clinics, and participants receiving 
psychological or psychiatric outpatient treatment. 
 
Female only samples 
James et al. explored psychiatric disorders in HIV-positive pregnant women 
and found that 40% met criteria for a PD diagnosis (James, Rubin, & Willis, 
1991).  
 
Male only samples 
There was a great variation in prevalence rates of PDs in male only samples. 
The prevalence ranged from 17% to 61% across four studies (Johnson, 
Williams, Rabkin, Goetz, & Remien, 1995; Johnson, Rabkin, Williams, 
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Remien, & Gorman, 2000; Kooiman & Spinhoven, 1996; Lopes et al., 2012). 
One study found that there was a significantly higher prevalence of PD in HIV-
positive (33%) compared to HIV-negative (15%) men (Perkins et al., 1993). 
They found there was a significantly higher prevalence of PDs in HIV-positive 
individuals compared to HIV-negative after controlling for age and ethnicity, 
although when controlling for education, the finding was reduced to a trend 
(Perkins et al., 1993). Another study found that HIV-positive men were 
significantly more likely than HIV-negative men to have a PD, however the 
difference was not significant when adjusting for socio-demographic variables 
(Lopes et al., 2012). Two studies did not find a significant difference between 
HIV-positive and HIV-negative men (Johnson et al., 1995b; Johnson et al., 
2000).  
 
Mixed gender samples 
Fourteen studies recruited mixed gender samples. The prevalence rates of 
PD varied from 12.6-33% across samples (Beatie, Mackenzie, & Chou, 2015; 
Bottonari & Stepleman, 2009; Jacobsberg, Frances, & Perry, 1995; Modrigan, 
Draganescu, Condratovici, Pavel, & Condratovici, 2017; Pace et al., 1990).  
 
In terms of specific disorders, 2.5-65% of HIV-positive participants met criteria 
for Antisocial PD (Bauer & Shanley, 2006; Fellows, Spahr, Byrd, Mindt, & 
Morgello, 2015; Haller & Miles, 2003; Modrigan et al., 2017; Newville & Haller, 
2012; Shacham, Önen, Donovan, Rosenburg, & Overton, 2016), whereas 5-
30% of participants met criteria for a Borderline PD diagnosis across studies 
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(Fellows et al., 2015; Haller & Miles, 2003; Newville & Haller, 2012). In two 
different articles, Hansen et al (2007, 2009) found that a total of 28.4% of the 
study sample met criteria for Antisocial PD or Borderline PD (Hansen et al., 
2009; Hansen, Vaughan, Cavanaugh, Connell, & Sikkema, 2007).  
 
Data Synthesis: Associated variables 
There were a large variety of associations explored in the 34 studies. The 
associated variables explored can be grouped into five categories: socio-
demographic variables, substance use, mental health, high-risk sexual 
behaviours, and health-related factors.   
 
Socio-demographic variables 
Five studies explored socio-demographic variables (Bennett et al., 2009; 
Brooner et al., 1993; Fellows et al., 2015; Lopes et al., 2012; Modrigan et al., 
2017). In terms of gender, there were significantly more males than females 
meeting criteria for PD across studies (Fellows et al., 2015; Lopes et al., 
2012; Modrigan et al., 2017). One study found that individuals with Antisocial 
PD were more likely to be an ethnic minority (Brooner et al., 1993) 
 
Substance use  
Across studies, substance users were more likely to have a PD compared to 
non-substance users (Bansil et al., 2009; Haller & Miles, 2003; James et al., 
1991; Marquine et al., 2014), although one study did not find a significant 
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different between groups (Moore et al., 2012). In addition, three studies found 
that individuals with PD and substance use were more likely to be HIV-
positive than those not using substances (Beyer, Taylor, Gersing, & Krishnan, 
2007; Brooner et al., 1993; Chen et al., 2007) 
 
Mental health  
Sixteen studies explored associations related to mental health, including 
suicidal ideation, axis I disorders, quality of life, defence and attachment 
styles.  
 
Suicidal ideation 
Two studies found an increase in suicidal ideation and suicide attempts in 
individuals with a PD diagnosis compared to individuals without PD (Bansil et 
al., 2009; Haller & Miles, 2003). In one study, Narcissistic PD was negatively 
associating with suicidal ideation, suggesting that this was a protective factor 
compared to other PDs (Haller & Miles, 2003).  
 
Axis I disorders 
Three studies found higher rates of Axis I disorders (two of these specified 
depression) in individuals with PD and HIV, compared to HIV-positive and 
HIV-negative individuals without PD (Bauer & Shanley, 2006; Johnson et al., 
1995; Turrina et al., 2001). Two studies found that individuals meeting criteria 
for PTSD were more likely than those without PTSD to meet criteria for 
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Antisocial PD and/or Borderline PD (Fellows et al., 2015; Lewis, 2005). One 
study found that when participants with a current Axis I disorder were 
eliminated from the analysis, Borderline PD continued to be more frequent 
among HIV-positive than HIV-negative individuals (Jacobsberg et al., 1995). 
 
Quality of life  
Three studies found that PDs was related to decreased health-related quality 
of life (Haller & Miles, 2003; Hansen et al., 2009, 2007). Interestingly, one 
study found that family/friends quality of life was negatively correlated with 
Narcissistic PD and positively correlated with Borderline PD (Haller & Miles, 
2003). 
 
Defence and attachment styles  
One study explored found that individuals with a PD scored higher for 
primitive and neurotic defence styles compared to individuals without PD. In 
addition, individuals with a PD had significantly lower scores on a measure of 
dependent attachment style than patients without a PD (Kooiman & 
Spinhoven, 1996). 
 
High-risk sexual behaviour   
Two studies explored high-risk sexual behaviours as associated variables. 
One study found that individuals with Borderline PD were more likely to report 
having multiple sex partners, and twice as likely to report irregular condom 
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use compared to individuals without Borderline PD traits, even after 
controlling for substance dependence (Newville & Haller, 2012). Marquine and 
colleagues found that Antisocial PD was found to be a univariable predictor of 
impulsivity/disinhibition, compared to individuals without PD, in a sample of 
HIV-positive participants with and without methamphetamine dependency 
(Marquine et al., 2014). 
 
Health-related factors  
Eleven studies explored correlated relating to health, such as ART, HIV 
symptoms, awareness of HIV status, functioning and impairment.  
 
Antiretroviral medication  
Across studies, PDs was associated with non-adherence (Modrigan et al., 
2017; Moore et al., 2012; Palmer et al., 2003), although one study found that 
HIV-positive individuals with a PD were less likely to be non-adherent to 
medication compared to those without a PD (Bansil et al., 2009). 
 
Symptoms 
PD was associated with increased HIV symptoms in one study (Hansen et al., 
2007), however, another study did not find an association between PD 
symptoms and CD4 levels (Johnson et al., 1997). 
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Awareness of HIV status  
One study found an increased rate of PD in HIV-positive individuals not aware 
of their seropositive HIV status prior to the study (Jacobsberg et al., 1995), 
whereas another study found that individuals with and without a PD did not 
differ significantly with regard to the time they had known they were HIV-
positive (Kooiman & Spinhoven, 1996).  
 
Functioning and impairment 
One study found that the HIV-positive individuals with PD reported higher 
levels of psychiatric symptoms and poorer functioning compared to those 
without PD (Johnson et al., 1995). 
 
Hepatitis C 
One study found that participants with HIV and Hepatitis C were significantly 
more likely to receive a Cluster B or Obsessive-compulsive PD diagnosis 
compared to participants with Hepatitis C only (Marco et al., 2015). 
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Table 2.  Summary of studies  
Reference Location 
and context 
 
 
Design, sampling and 
sample 
 
 
 
Measurement 
of PDs 
 
 
Measurement of associated variables 
 
Prevalence, associated variables and associations 
between HIV and PDs 
 
 
Bansil et 
al., 2009 
United States 
 
HIV women 
hospitalized 
with psychiatric 
diagnoses 
 
 
 
 
Retrospective study. 
Systematic sampling. 
  
Data from a nationwide 
inpatient care database  
 
1994: N=13 037  
Age (years); 15-34 (44%), 
35-44 (42%), 45+ (14%) 
 
2004: N=22 606 
Age (years); 15-24 (3%), 
25-34 (18%), 35-44 (40%), 
45+ (40%) 
 
 
100% female.  
 
Response rate not 
reported. 
Diagnosed in 
hospital. No 
further 
information.  
 Hospitalisation  
 Alcohol/substance use 
 Non-adherence with medical 
treatment  
 Suicide attempt/self-inflicted self-
injury 
 Age 
 Year hospitalized 
 
Information collected in hospital.  
 
Multivariate analysis: yes.  
 
Prevalence:  
 Prevalence of PD in inpatient women with HIV: 
8.2% (1994) and 4.7% (2004). Significant 
difference p<0.001 when controlling for 
associated variables.  
 
Associated variables: 
 HIV+ individuals with a PD < without a PD 
non-adherent to ART AOR: 1.05 p>.05 (95% 
CI: 0.78-1.41) and more likely to disclose 
previous suicide attempt/self-inflicted injury 
AOR: 3.56 (95% CI: 2.27-5.59)  
 Alcohol/substance users were more likely to 
have a PD. AOR: 4.36 (95% CI: 3.68-5.16)   
 
Bauer & 
Shanley, 
2006) 
United States 
 
Impact of 
Antisocial PD 
on the effects 
of HIV and ART 
on Event-
Related brain 
potentials.  
 
Cross-sectional study.  
Systematic sampling.  
 
91 HIV+ 68 HIV- formed 3 
groups: 
1. HIV- 
2. HIV+ and complying 
with ART  
3. HIV+ and not 
complying with ART 
 
Mean age=38-44;  
42% female; 28% 
Caucasian 
 
Response rate not 
Measrue 5*  Age 
 Treatment status  
 Alcohol or drug use measured by the 
Addiction Severity Index, Michigan 
Alcoholism Screening Test and Drug 
Abuse Screening Test.  
 Depression measured by the Beck 
Depression Inventory (BDI-II)  
 Brain function measured through 
EEG  
Multivariate analysis: yes. 
 
Prevalence:  
 43% ASPD in HIV+ (24% HIV-; p<.05) when 
controlling for socio-demographic factors.   
 
Associated variables: 
 Neither HIV/treatment status nor the 
interaction of HIV/treatment status with ASPD 
were related to differences in alcohol or drug 
use. The only significant findings were related 
to ASPD.  
 No significant effects of ASPD on HIV disease 
severity  
 Higher rate of depression in the HIV+ group 
not receiving treatment > HIV- control group 
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reported.  (p<.05) 
 Participants with ASPD exhibited a significant 
decrement in frontal P300 amplitude in 
comparison to those ASPD-negative  (p<.05) 
Beatie, 
Mackenzie, 
& Chou, 
2015 
United States  
 
Prevalence of 
psychiatric and 
medical 
comorbidities in 
middle-aged 
and older 
adults  
Cross-sectional study. 
Stratified sampling.  
 
N=15 456 (46 were HIV+)  
 
Age (years): 50-59 (45%); 
60-69 (32%); 70+ (23%). 
64% Males; 43% White.  
 
87% response rate. 
Measure 12*  Sex 
 Marital status  
 Ethnicity 
 Personal and household income  
 Insurance 
 Sexual orientation  
 Hypertension  
 Diabetes  
 Arthritis  
Multivariate analysis: yes.  
 
Prevalence: 
 22% PD in HIV+ (p>.05; compared to HIV-). 
 
 
Bennett et 
al., 2009 
United States.  
 
HIV+ treated in 
psychiatric 
emergency 
departments.  
 
.  
Cross-sectional study.  
Stratified sampling. 
 
N=553 HIV positive (1178 
visits)  
 
Mean age= 39 years; 84% 
Males; 61% Caucasian.  
 
94% response rate.  
Measure 1*   Presenting to emergency services 
 Gender  
 Age  
 Race 
 
 
Multivariate analysis: yes.  
 
Prevalence:  
 8.6% PD in HIV+ (p>.05; compared to HIV-).  
 4.7% BPD in HIV (p>.05; compared to HIV-).  
 
Associated variables: 
 HIV+ were more likely to have a BPD 
diagnosis AOR: 2.1 (95% CI: 1.3-3.2) p<0.01, 
when controlling for gender, age and race 
Beyer, 
Taylor, 
Gersing, & 
Krishnan, 
2007 
 
United States. 
 
Prevalence of 
HIV in a 
psychiatric 
outpatient 
population.  
Retrospective study.  
All patients included.  
 
N=11 284 (130 were 
HIV+). 
 
Mean age=41 years; 54% 
Males; 19% Caucasian.  
 
Response rate not 
reported.  
Measure 1*  Substance use  Multivariate analysis: no. 
 
Prevalence:  
 3.1% of HIV in PD (p<.001; compared to 
national average) 
 9.5% of HIV in PD + substance misuse 
(p<.001; compared to psychiatric population) 
Bottonari & 
Stepleman, 
2009 
United States.  
 
Factors 
associated with 
Psychotherapy 
Longevity 
 
 
Retrospective study. 
  
N=82 
 
Mean age=42 years; 33% 
female. 
 
Reported good response 
rate 
Measure 1*  N/A Multivariate analysis: no.  
 
Prevalence:  
 12.6% PD  
 
Other relevant findings:  
 PD > non-PD to complete 6 sessions of 
therapy (p<0.05) 
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Brooner et 
al., 1993 
United States.  
 
ASPD and HIV 
infection 
among 
intravenous 
drug users  
 
 
Longitudinal study.  
Convenience sampling.  
 
N=272 (33 HIV+)  
 
Mean age= 36 years 
72% Male; 60% Black  
 
Response rate not 
reported.  
Measure 9*  Gender 
 Ethnicity 
 Current and Shorter lifetime duration 
methadone treatment 
 
Multivariate analysis: yes. 
 
Prevalence of PD:  
 64% ASPD 
 
Prevalence and associations of HIV:  
 ASPD group > non-ASPD had HIV  (18 vs. 
8% p<.05), when controlling for ethnicity, 
gender and current methadone treatment. 
 Individuals in the ASPD group were more 
likely to be an ethnic minority, not currently 
and shorter lifetime duration of methadone 
treatment  
Chen et 
al., 2007 
United States.  
 
Rates of STDs 
in women with 
BPD and 
substance use. 
 
  
Cross-sectional study. 
Random sampling. 
 
N=184 (1 HIV+)  
 
Mean age=31 years; 
100% Female; 83% 
Caucasian 
 
80% response rate  
Measures 2, 3*  STDs was assessed using a medical 
history interview 
 Substance use was assessed using 
measure 2* 
Multivariate analysis: yes.  
 
Prevalence:  
 HIV in BPD: 1% (no statistical test)   
 HIV in BPD and substance use: 0% 
 
Ellis et al., 
1994 
United 
Kingdom. 
 
Psychiatric 
illness and 
treatment in 
referrals to 
psychiatric 
liaison service  
 
Retrospective study.  
All patients referred to 
service.  
 
N=140 (70 HIV+ and age 
and sex-matched controls) 
 
Mean age=33 years 
60% Male  
 
Response rate not 
presented.  
Measure 1* N/A Multivariate analysis: no.  
 
Prevalence:  
 PD in HIV+ group 13% (vs. 11% control group; 
p>.05). 
 73% of the PDs diagnosed met the criteria for 
BPD in the HIV+ group (vs. 42% control group; 
p>.05). 
 
Fellows et 
al., 2015 
United States.  
 
Association 
between 
trauma 
exposure, 
PTSD and 
suicide 
attempts in 
people with 
Prospective cohort study. 
Sampling strategy not 
reported.  
 
N=316 (across 3 groups) 
 
Mean age=44-46 years 
and 23-56% female  
 
Response rate not 
Measure 8*  Trauma exposure 
 PTSD (measure 8*) 
 Gender  
 
 
 
Multivariate analysis: yes 
 
Prevalence:  
 8.5% ASPD in control group  
 7.5% ASPD in trauma exposure but no PTSD 
(p>.05) 
 20% ASPD in trauma exposure and PTSD 
(OR 2.69, 95% CI 1.13-6.42, p<.05).  
 5% BPD control group 
 9% BPD in trauma exposure but no PTSD 
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HIV.  
 
  
reported.  (p>.05) 
18% BPD in trauma exposure and PTSD (OR 
3.73, 95% CI 1.39-10.04, p<.01). 
 
Associated variables: 
 See above 
 Males with PTSD > females with PTSD to 
meet criteria for BPD (OR=13.53, 95% CI 
[1.08–169.10], p<.05) 
Gilchrist et 
al., 2011  
Spain 
 
Psychiatric, 
behavioural 
and social risk 
factors  
among drug 
users 
 
 
Cross-sectional study. 
Convenience sample. 
 
N=118 (32 HIV positive) 
 
Mean age=39 years; 
100% female 
 
71% response rate 
Measure 8* 
(Spanish) 
 Unprotected sex  
 Depression  
 Drug use  
 Ever injected with used syringe  
 Ever been in prison 
 Ever sex traded  
 Ever homeless  
 Ever had an HIV+ partner 
 Substance use disorders, major 
depressive disorder  
Multivariate analysis: yes.  
 
Prevalence of PD:  
 46.9% BPD in HIV+  
 46.9% ASPD in HIV+  
 
Prevalence and associations of HIV: 
 Participants with ASPD (OR 5.44; 95% CI 
2.16-13.71) more likely to be HIV+ compared 
to non-PD when controlling for all the 
associated variables. The difference was not 
significant for BPD when controlling for the 
associated variables.  
 
Haller & 
Miles, 
2003 
United States 
 
Suicidal 
ideation among 
HIV+ 
psychiatric 
patients  
 
 
Longitudinal study.  
Convenience sampling.  
 
N=190 
 
68% Male; Mean age= 37 
years; African American 
68%; White 29%; Other 
3% 
 
54% response rate  
Measure 4*  Suicidal ideation assessed by a 
structured interview  
 Drug dependence assessed with 
University of Michigan Composite 
International Diagnostic Interview 
(UM-CIDI) 
 Quality of life assessed with HIV 
Patient-Assessed Report of Status 
and Experience (HIV-PARSE). 
Multivariate analysis: yes.  
 
Prevalence:  
 Depressive (40%), dependent (36%), passive–
aggressive (35%), avoidant (31%), self-
defeating (31%), borderline (BPD; 27%), 
antisocial (ASPD; 21%), and paranoid (21%) 
PD.  
 
Associated variables: 
 Drug dependence (but not alcohol 
dependence) was significantly associated with 
ASPD (p<.001) and BPD (p<.05) in people 
living with HIV. 69% of ASPD and 55% of BPD 
were also drug dependent. 
 BPD (p<.01) and Avoidant PD (p<.05) were 
positively associated with suicidal ideation, 
whereas Narcissistic PD (p<.05) was 
negatively associated.  
 Overall Quality of Life was significantly 
correlated with BPD (p<0.05). Family/friends 
quality of life was negatively correlated with 
Narcissistic PD (p>0.05) and positively 
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correlated with BPD (p>0.05) in people living 
with HIV.  
Hansen et 
al., 2007  
United States. 
 
BPD and ASPD 
indications on 
HIV and health-
related quality 
of life (HRQoL) 
in AIDS-
bereaved 
adults. 
 
 
RCT study.  
 
N=268 
 
Age not reported. 65% 
Male; 54% African-
American; 9% Hispanic, 
10% other  
 
83% Response rate  
Measure 5*  Grief severity measured using the 
Grief Reaction Index (GRI) (Lennon, 
Martin, & Dean, 1990)  
 Social support measured using 
Interpersonal Support Evaluation List 
(ISEL; Cohen, Mermelstein, 
Kamarck, & Hoberman, 1985).  
 Years since HIV diagnosis 
Multivariate analysis: yes.  
 
Prevalence:  
 28.4% ASPD or BPD 
 
Associated variables included in the structural equation 
modelling:  
 PD indications were related to increased HIV 
symptoms and decreased HRQoL above and 
beyond the influences of social support and 
grief severity.  
 PD indications were related to HIV-symptoms 
and decreased HRQoL indirectly through 
decreased social support and increased grief 
severity. 
Hansen et 
al., 2009 
United States. 
 
PD Indication, 
Social Support 
and Grief on 
Alcohol and 
Cocaine Use 
among HIV+ 
coping with 
AIDS-related 
Bereavement 
 
 
RCT study (same sample 
as above). 
 
N=268 
 
Age not reported. 65% 
Male; 73% ethnic 
minorities.  
 
83% response rate  
Measure 5*  Grief severity and social support see 
above 
 Substance abuse scale (Sikkema et 
al., 2003).  
Multivariate analysis: yes.  
 
Prevalence:  
 28.4% ASPD or BPD  
 
Associated variables: 
 ASPD and BPD had a direct effect on cocaine 
use. No direct effect of PD on alcohol use.  
 PD indirect effects on both alcohol use and 
cocaine use (p<.05), with this relationship 
mediated by social support, but not grief. 
Participants with PD less likely to experience 
social support but more likely to use alcohol 
and cocaine.  
 PD indication linked to increases in grief 
severity; and ASPD and BPD indications had 
indirect effects on grief through reduced 
perception of social support (p<.05). 
Jacobsber
g et al., 
1995 
United States. 
 
Axis II 
diagnoses 
among 
volunteers for 
HIV testing and 
counselling  
Longitudinal study.  
Recruitment procedures 
specified elsewhere.  
 
N=260 volunteers (81 
HIV+) 
 
Mean age= 33 years 
Measures 2,3*  Knowledge of HIV status 
 Current Axis I disorder (2*) 
Multivariate analysis: no.  
 
Prevalence:  
 33% PD (vs. 20% of HIV-). Only significantly 
different for Cluster B PD and BPD. 
 11% Cluster A; 21% Cluster B; 16% Cluster C 
PD 
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82% Male 
 
Response rate not 
reported.  
Associated variables: 
 Rate of PD was higher in the group who were 
not aware of their HIV status (p<.05)  
 When Axis I disorder were eliminated BPD in 
HIV+ > HIV- (p<.05)  
James et 
al., 1991 
United States.  
 
Substance use 
and psychiatric 
findings in 
pregnant 
patients 
 
 
Cross-sectional study. 
Convenience sampling.  
 
N=55; 85% Black; 100% 
female; Mean age=24 
years 
 
Good response rate.  
 
Measure 1*   Substance use 
 
Multivariate analysis: no.  
 
Prevalence:  
 40% PD 
 
Associated variables: 
 84% PD in substance users (vs. 17% non-
substance users; p<0.001). There was a 
higher rate of ASPD (p<0.001); BPD (p>.05); 
mixed BPD and ASPD (p<0.01) in substance 
users compared to non-users.  
Johnson et 
al., 1995 
United States. 
 
Axis I 
Psychiatric 
Symptoms 
Associated with 
HIV and PD 
 
 
 
Longitudinal study.  
Sampling strategy not 
reported.  
 
N=162 homosexual men 
(110 HIV+) 
 
100% male. Other 
demographics not 
reported.  
 
Response rate not 
reported.  
Measure 2*   Depression as measured on the 
Hamilton Depression Rating Scale 
 Anxiety measured on the Hamilton 
Anxiety Rating Scale 
 Psychiatric symptoms measured on 
the Brief Symptom Inventory  
 Functioning measured on the Global 
Assessment of Functioning Scale 
(DSM-III-R) 
 Measure 2*  
Multivariate analysis: yes.  
 
Prevalence:  
 19% PD in both HIV+ and HIV- (p>.05) 
 
Associated variables: 
 Axis I disorder in PD and HIV+ > no PD or HIV 
(33% vs. 5%; OR: 10.0 p<.05) 
 Psychiatric symptoms and poorer functioning 
in PD and HIV+ with PD > without PD.  
 Current depression, anxiety and poorer 
functioning in PD and HIV+ > all participants 
without PD.  
Johnson et 
al., 1997 
United States.  
 
Stability and 
Change in PD 
Symptomatolog
y   
 
 
Longitudinal study.  
Convenience sampling. 
 
N=80 HIV+ homosexual 
men 
 
100% Male; Mean age=38 
years; 87% Caucasian 
 
67% response rate (non-
responders and 
responders, p>.05) 
 
Measure 2*  CD4 levels  
 HIV Symptom levels  
 Psychological distress was 
measured by pooled scores on the 
Beck Hopelessness Scale (BHS; 
Beck, Weissman, Lester, & Trexler, 
1974), the Brief Symptom Inventory 
(BSI; Derogatis & Melisaralos, 1983), 
the Global Assessment of 
Functioning Scale (GAP; American 
Psychiatric 
Association, 1987), the Structured 
Interview Guide (SIGH-AD) for the 
Hamilton Anxiety (HARS) and 
Depression (HDRS) Rating scales 
(Williams, 1988) 
Multivariate analysis: yes.  
 
Prevalence:  
 Stability of PD symptom levels ranged from 
low-moderately high.  
 Change in PD symptom levels not associated 
with HIV status or change in CD4/HIV 
symptom levels.  
 
Associated variables: 
 Change in psychological distress predicted 
change in PD symptomatology accounting for 
9% of residual change in SCID-II interview 
symptom totals (p<.02) and 13% of residual 
change in total SCID-II questionnaire scores 
(p<.0001).  
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Johnson et 
al., 2000 
United States.  
 
Interpersonal 
difficulties 
associated with 
PD and Axis I 
disorders 
 
 
 
Longitudinal study.  
Convenience sample.  
 
N=140: 95 HIV+ and 45 
HIV- men.  
 
Mean age=39 years  
88% Caucasian; 100% 
men 
 
79% response rate (>.05)  
Measure 2*   Axis I disorders (Measure 2*) Multivariate analysis: yes. 
 
Prevalence:  
 17% PD in HIV+ (p>.05 HIV-) 
 
Associated variables: 
 HIV+ and PD (46%) > HIV+ and no-PD (21%) 
met criteria for an Axis I disorder (<.01).  
Kooiman & 
Spinhoven, 
1996 
Netherlands.  
 
Psychoanalytic
al aspects of 
PD in people 
with HIV 
 
 
Cross-sectional study. 
Convenience sampling.  
 
N=41 homosexual men  
 
Mean age=40 years (PD) 
and 42 years (no PD); 
100% men 
 
98% response rate.  
Measure 7* 
 
 Time since diagnosis  
 CD4 count  
 Pychopathology was measured on 
the Hospital Anxiety and Depression 
Scale (HADS; Zigmond & Snaith, 
1983).  
 Defense styles were measured on 
the Defense Style Questionnaire 36 
(DSQ-36; Andrews, Pollock, & 
Stewart, 1989).  
 Attachment style was measured on 
the Adult Attachment Scale (AAS; 
Collins & Read, 1990).   
 Perceived Parental Care was 
measured on Parental Bonding 
Instrument (PBI; Parker, Tupling & 
Brown, 1979).  
 
Multivariate analysis: yes.  
 
Prevalence:  
 61% PD 
 
Associated variables: 
 PD or no PD no difference on knowing the 
diagnosis, CD4 count or HIV classification 
(p>.05) 
 PD > non-PD higher scores on the HADS 
(p<.01),  anxiety subscale (p<.01)   
 PD > non-PD higher primitive (p<.01) and 
neurotic (p<.05) defense styles, and remained 
significant after partialling out the effect of 
anxiety and depression.  
 PD < non-PD dependent attachment style 
(p<.05).  
 Negative correlation between dependent 
attachment and the total score for the PDQ-R 
(p<.001) and Clusters A (p<.001) and C (r=-
0.46, p<.001), after correcting for anxiety and 
depression 
 Perceived parenting style was not correlated 
with PDQ-R scores.  
 
Lewis, 
2005 
United States  
 
PTSD in 
Incarcerated 
HIV+ Women  
 
 
Cross-sectional study. All 
HIV+ inmates were 
approached.  
 
N=81 
 
Mean age=38 years; 
100% women; 52% Black, 
30% white, 16% Hispanics 
and 2.5% Native American  
Measure 2*  PTSD  measured on the Post-
traumatic Stress Scale for DSM-IV 
(CAPS).  
 Axis I (2*) 
 Past suicide attempts 
 Outpatient psychiatric treatment  
Multivariate analysis: yes.  
 
Prevalence:  
 8.6% BPD 
 18.5% ASPD.  
 
Associated variables: 
 ASPD in lifetime PTSD > without lifetime 
PTSD (p<.01). There was a trend for BPD 
group to have lifetime PTSD.  
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90% Response rate 
 PD + Axis I disorder in lifetime PTSD > without 
PTSD (p<.02).  
 Past suicide attempts were associated with 
Antisocial PD (p<.02). Outpatient psychiatric 
treatment was not significantly associated with 
BPD or ASPD. 
 
Lopes et 
al., 2012 
 
United States.  
 
Prevalence of 
psychiatric 
disorders  
 
 
Cross-sectional study. 
Stratified sampling.  
 
N=34 653 (110 were 
HIV+).  
 
HIV+ men: 55% white; 
79% US-born, aged 18-44 
(52%); 45-64 (43%), 65+ 
(5%) 
 
HIV+ women: 70% non-
white; 77% US-born, aged 
18-44 (69%), 45-64 (20%), 
65+ (11%)  
 
70% response rate.  
Not known.   Gender 
 Socio-demographic variables: 
ethnicity, education, individual 
income, family income, employment 
status, marital status, urbanity, 
region, sexual orientation and STD 
 
Multivariate analysis: yes.  
 
Prevalence:  
 In 70 HIV+ men (compared to HIV- men), 43% 
received a PD diagnosis (OR 2.50, 95% CI: 
1.34-4.67); 16% Schizotypal (OR 4.42, 95% 
CI: 1.99-9.82), 14% Schizoid (OR 5.06, 95% 
CI: 1.65-15.54), 15% Paranoid (OR 4.51, 95% 
CI: 1.53-13.26), 19% Borderline (OR 4.01, 
95% CI 1.96-8.20), 15% Narcissistic (OR 2.15, 
95% CI 1.00-4.61), 2% Histrionic (OR 0.88, 
95% CI 0.17-4.59), 4% Antisocial (OR 0.64, 
95% CI 0.14-2.99), 7% Obsessive-compulsive 
(OR 0.90, 95% CI 0.34-2.34), 12% Avoidant 
(OR 7.49, 95% CI 2.18-25.75) and 1% 
Dependant (OR 2.11, 95% CI 0.26-17.23).  
 
Associated variables: 
 PD in HIV+ men > HIV-. p>0.5 when adjusting 
for socio-demographic associated variables.  
 There were no significant difference in the 
prevalence of psychiatric disorders between 
HIV+ and – women in adjusted or unadjusted 
models.  
Marco et 
al., 2015 
Spain  
 
Prevalence of 
PDs and their 
associated 
factors in 
prison inmates  
 
 
Epidemiological, cross-
sectional, multicenter 
study carried out in 25 
Spanish prisons. 
 
 
N=193 (58 HIV+)  
 
Mean age= 40 years; 93% 
men 
 
74% response rate  
Measure 7* 
 
 Hepatitis C Multivariate analysis: yes. 
 
Prevalence of PD: 
 75.9% PD in individuals with Hepatitis C and 
HIV 
 
Prevalence of HIV in PD:  
 Patients with cluster B PD were more likely to 
be HIV-infected (OR 2.20, 95% CI 1.10-4.39). 
 
Associated variables: 
 No significant difference between HIV and 
Hepatitis C co-infection or Hepatitis C only. 
 In participants with Hepatitis C, HIV+ inmates 
were significantly more likely to receive a 
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Cluster B diagnosis (69 vs. 49.6%, p <.01) and 
obsessive-compulsive PD (29.3 vs. 14.8%, p 
>.02) compared to HIV-.  
 
Marquine 
et al., 2014 
United States. 
 
‘Frontal 
systems’ 
behaviour in 
comorbid HIV 
and 
methamphetam
ine 
dependency 
(MA) 
Cross-sectional study.  
Random sampling.  
 
N=135 (64 HIV+) 
 
Mean age=38-41 years 
(across the groups); 89% 
male.  
 
 
Good response rate 
Measure 6* 
 
 Gender  
 Substance use and 
methamphetamine dependency 
assessed on the Composite 
International Diagnostic Interview 
(CIDI; Kessler & Ustun, 2004).  
 Lifetime mood disorder was also 
obtained by the CIDI. 
 
Multivariate analysis: yes.  
 
Prevalence:  
 Not reported.  
 
Associated variables: 
 ASPD in MA > not MA, regardless of HIV 
serostatus (p<.05).  
 
McGurk et 
al., 1994  
United States 
 
HIV, substance 
dependency 
and psychiatric 
diagnosis 
 
 
Cross-sectional study. 
Systematic sampling.  
 
N= 46 (23 HIV+ and age- 
and gender matched 
controls) 
 
Mean age=31 years for 
both groups; 93% Male.  
 
Response rate not 
reported.  
Measure 1*  N/A  Multivariate analysis: no  
 
Prevalence:  
 Prevalence not reported but HIV+ were 
significantly more likely to have a PD 
diagnosis (p<.002). 
 
 
Modrigan 
et al., 2017 
Romania 
 
Personality 
Patterns in 
Young Adults 
with 
Nosocomial 
HIV  
 
 
Cross-sectional study. 
Convenience sampling.  
 
N=123 
 
Mean age=27 years; 48% 
male  
 
Good response rate.  
Measure 4*  Gender  
 Treatment adherence was assessed 
using a questionnaire developed by 
the Department for monitoring 
HIV/AIDS from the Institute of 
Infectious Diseases. Good 
adherence when 95% ART, 80% 
non-adherent.  
Multivariate analysis: no.  
 
Prevalence:  
 28.5% had PD 
 Obsessive-compulsive (9.75%), avoidant 
(7.3%), Histrionic (7.3%), Narcissistic (4.9%), 
Depressive (2.4%), Antisocial (2.45%) and 
Schizoid (0.8%).  
 48.5% met criteria for 1 PD, 51.5% met criteria 
for 1+ 
 
Associated variables: 
 PD in males > females (37% vs. 20%, p<.05).  
 Multiple disorders men > women (22% vs. 
7.9%, p<.05).  
 Reduced adherence to ART in PD vs. non-PD 
(p>0.01).  
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Moore et 
al., 2012 
Location 
unknown.  
 
Impact of 
methamphetam
ine on ART 
adherence  
 
 
Cross-sectional study.  
 
125 HIV+ individuals in 3 
conditions: either no, 
current or life time history 
of methamphetamine 
dependence/use 
 
Mean age=40-45 years; 
86-100% Male; 64-75% 
Caucasian  
 
Response rate not 
reported.  
Measure 6* 
 
 
 Methamphetamine dependence 
assessed by DSM-IV criteria using 
the Composite International 
Diagnostic Interview (CIDI; Wittchen, 
1993). Good inter-rater reliability.  
 ART adherence assessed with the 
AIDS Clinical Trials Group (ACTG; 
Chesney et al., 2000) 
 Attention Deficit Hyperactivity 
Disorder (ADHD) assessed using the 
ADHD Module (L) of measure 6*  
Multivariate analysis: yes.  
 
Prevalence:  
 Prevalence of ASPD ranged from 9-16%; no 
methamphetamine dependence/use (9%), 
current dependence/use (13%), lifetime history 
of dependence/use (16%). (p>.05)  
 
Associated variables: 
 See above. 
 Comorbid ASPD, ADHD and lifetime MDD 
diagnosis each predicted reported ART non-
adherence.  
 ASPD did not uniquely predict ART non-
adherence after accounting for the other 
predictors in the model (p>.05).  
 
Newville & 
Haller, 
2012 
United States.  
 
Axis II 
pathology and 
risk behaviours 
in people with 
HIV.  
 
 
 
Cross-sectional study.  
Convenience sampling  
 
N=179 
 
Mean age=36 years; 75% 
Male; African American 
63% 
 
Response rate not 
reported.  
 
Measure 4*  Drug- and sex- risk behaviours 
measured on the CMHS HIV Risk 
Questionnaire.  
 Substance dependence assessed 
by the University of Michigan 
Composite International Diagnostic 
Interview (UM-CIDI; Kessler at al., 
1994).  
Multivariate analysis: yes.  
 
Prevalence:  
 Depressive (47%), Passive-Aggressive (43%), 
Avoidant (38%), Dependent (37%), Self-
defeating (33%), Borderline (30%), Schizoid 
(30%), Antisocial (26%), Paranoid (23%), 
Narcissistic (20%), Schizotypal (16%), 
Aggressive-Sadistic (11%), Histrionic (6%) and 
Compulsive (5%).  
 
Associated variables: 
 Antisocial traits and PD was associated with 
both drug- and sex-risk behaviours, including 
lifetime (p>.01) and recent IDU (p>.001), 
recent sharing of injection equipment (p>.001) 
and multiple sexual partners (p>.01). Not 
significant after controlling for substance 
dependence.  
 BPD > non-PD to report multiple sex partners 
(OR=2.65 95% CI 1.41-4.97, p<.01) and 
irregular condom use (OR= 2.44, 95% CI 1.11-
5.36, p<0.05), even after controlling for 
substance dependence.  
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Pace et al., 
1990  
United States 
 
Prevalence of 
psychiatric 
disorders in 
HIV+ Air Force 
personnel  
 
 
Cross-sectional study.  
Random sampling.  
 
N=95  
 
Age range=20-55; 90% 
Male 
 
99% response rate.  
Measure 10*  N/A Multivariate analysis: no.  
 
Prevalence:  
 30.5% met criteria for at least one PD and 
8.4% met the criteria for more than one PD.  
 6.3% ASPD 6.3% avoidant, 4.2% obsessive-
compulsive, 3.2% passive-aggressive, 3.2% 
BPD, 2.1% histrionic, 2.1% schizoid, 1.1% 
paranoid, 1.1% schizotypal.  
Palmer et 
al., 2003 
United States  
 
Psychiatric and 
social barriers 
to ART 
adherence in 
individuals with 
HIV, opioid 
dependence 
and a 
psychiatric 
disorder.   
 
 
Cross-sectional study.  
Stratified sampling. 
 
N=107 
 
Mean age=43; 47% Males; 
63% Hispanics,  
27% African American, 
7% Caucasian,  
3% other of mixed 
ethnicity  
 
71% response rate.  
Measure 2*  Medication adherence instrument 
adapted from the Adult AIDS Clinical 
Trials Group. Non-adherence was < 
95% adherence  
Multivariate analysis: no.  
 
Prevalence:  
 37% met criteria for BPD   
 56% met criteria for ASPD 
 
Associated variables: 
 BPD was significantly associated with non-
adherence to HIV medication  (p<.05). 
Adherence in BPD < non-BPD (39% vs. 65%). 
 BPD was associated with skipping HIV 
medication during the past weekend (p<.05).  
 
Perkins et 
al., 1993 
 
 
United States.  
 
PD on coping, 
social support 
and mood   
 
 
Cross-sectional design. 
Convenience sampling. 
 
N=111 (58 HIV+ and 53 
HIV-) 
 
Mean age=29-31 years; 
100% men.   
 
53% response rate. 
Authors explored 
differences on age, gender 
and ethnicity.  
Measure 2*  Age 
 Ethnicity 
 Depression measured on the 
Hamilton Rating Scale for 
Depression 
 Anxiety measured on the Hamilton 
Rating Scale for Anxiety 
 Anger and tension measured on the 
Profile of Mood State (POMS) 
 Hopelessness measured on the 
Beck Hopelessness Scale 
 Denial and helplessness measured 
on COPE (Carver, Scheir and 
Weintraub, 1989).  
Multivariate analysis: yes.  
 
Prevalence:  
 PD in HIV+ > HIV- (33% vs. 15%, p<.05) after 
controlling for age and ethnicity. When 
controlling for education, the finding was 
reduced to a trend (p=.11).  
 
Associated variables: 
 No difference in the overall proportion of Axis I 
disorders in HIV+ and HIV- participants. No 
relationship between current major depression 
and PD (>.05).  
 In the HIV+ sample, PD > non-PD greater 
mood disturbance (including depression, 
anxiety, anger, tension and hopelessness) and 
greater use of denial and helplessness when 
coping with the threat of AIDS as well as 
greater social conflict.  
Shacham, 
Önen, 
Donovan, 
Rosenburg
United States.  
 
Psychiatric 
diagnoses in an  
Cross-sectional design.  
All patients seen in 
service.  
 
Measure 6*  Socio-demographic variables  
 Biomedical variables (e.g. viral load, 
overall health)  
Multivariate analysis: yes. 
 
Prevalence:  
 65% met criteria for Antisocial PD.  
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, & 
Overton, 
2016 
HIV+ outpatient 
population  
N= 201.  
 
Mean age= 43 years; 69% 
Males; 72% African 
American. 
 
Response rate not 
reported.  
 
Associated variables:  
 None significant (further details not reported in 
the article) 
 
Travin et 
al., 1990 
United States.  
 
Prevalence and 
characteristics 
of violent 
patients  
 
 
Retrospective study.  
Systematic sampling.  
 
N=11 (seen by AIDS 
service)  
 
Age ranges: 26-35 (73%), 
35-45 (27%).  
81% male.  
 
Response rate not 
reported.  
Measure 1* N/A Multivariate analysis: no.  
 
Prevalence:  
 0% met criteria for a PD diagnosis.  
 
 
Turrina et 
al., 2001 
Italy  
 
Depressive 
disorders and 
personality 
variables in 
intravenous 
drug-users. 
 
  
Cross-sectional study.  
Random sampling. 
 
3 groups: 1) HIV+ inpatient 
2) HIV+ outpatient  3) HIV- 
outpatient 
 
N=178 (127 HIV+ but only 
50 for personality 
assessment) 
 
Mean age=32.1 years; 
67% Males; 56% pre-AIDS 
or AIDS 
 
87% response rate  
Measure 11* 
 
    
 Drug use  
 Depression measured on the 
Hospital Anxiety and Depression 
Scale (HADS; Zigmond & Snaith, 
1983). Good reliability.  
Multivariate analysis: no.  
 
Prevalence:  
 36% PD  
 
Associated variables: 
 HIV+ with a PD had a higher rate of 
depression (67% vs. 44%, p>.05) 
 
ASPD= Antisocial PD; BPD = Borderline PD; ART=Antiretroviral treatment; 1= Diagnosis according to DSM; 2= SCID-II; 3= IPDE; 4= MCMI-III; 5= CASII; 6= Diagnostic Interview 
Schedule; 7= PDQ; 8= PRISM; 9= Alcohol Research Center Intake Interview; 10= Personality Factors Questionnaire; 11= KAPP; 12= AUDADIS-IV.  
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Methodological quality 
External validity  
Twenty-one of the 34 studies reported a clear and suitable sampling strategy 
to address the research question (see Table 3). Nineteen studies reported a 
good response rate, that is, at least 70% of those eligible to participate were 
recruited. Only 13 studies met both criteria for external validity.  
 
Internal validity  
Thirty-two out of the 34 studies used reliable and valid measurements in the 
identification of PD/PD difficulties (see Table 3). Out of the 29 studies 
exploring associated variables, all but five used reliable and valid measures 
for the majority of associations. No discrepancy was indicated between self-
reported measures and ‘gold standard’ structured clinical interviews when 
exploring the prevalence rates of PD in HIV in the current review. Out of all 
studies, 23 carried out multivariate analysis to control for potential 
confounding variables. In total, only 20 of the 34 studies provided evidence of 
meeting all criteria for internal validity.   
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Table 3: Methodological quality ratings for quantitative studies  
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Discussion  
 
This review explored the rates and associations of PDs in people with HIV. 
Across studies, there were significantly higher rates of PDs in HIV-positive 
individuals compared to HIV-negative populations, across inpatient settings, 
psychiatric emergency departments, substance use settings and community 
samples. In addition, there were a large variety of associations explored in the 
34 studies. The associated variables were grouped into five categories: socio-
demographic variables, substance use, mental health, high-risk sexual 
behaviours, and health-related factors. 
 
Prevalence of Personality Disorders in People with HIV  
Nine studies found significantly higher rates of PDs in HIV-positive individuals 
compared to HIV-negative populations, across inpatient settings, psychiatric 
emergency departments, substance use settings and community samples. 
Five studies found that the prevalence of PD in HIV-positive individuals was 
significantly higher than individuals who were HIV-negative when controlling 
for socio-demographic variables. This suggests that there is strong evidence 
that prevalence rates of PDs are higher in HIV-positive individuals compared 
to their HIV-negative counterparts. Research has established that people with 
PD are at higher risk of contracting HIV, suggesting that the rates of PD in 
people living with HIV will also be higher. There are no clear evidence that 
interpersonal difficulties and identity problems improve significantly or reliably 
with treatment. Individuals may lose a standardised diagnosis of PD following 
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treatment but their identity difficulties often remain impaired (e.g.  Bateman & 
Fonagy, 2008; Zanarini, Frankenburg, Reich, & Fitzmaurice, 2012). PDs are 
thought to be lifelong disorders (Bateman, Gunderson, & Mulder, 2015) and 
therefore impacting individuals before and after their HIV diagnosis. However, 
it is also important to note that research has shown that negative life events 
and life stressors (such as a HIV diagnosis) might increase the chance of a 
later PD diagnosis (e.g. Pagano et al., 2004; Skodol et al., 2005). 
 
Interestingly three studies did not find a significant difference between HIV-
positive and HIV-negative groups, when exploring differences in one 
psychiatric liaison team as well as in two male community samples. It is likely 
that the lack of difference in Ellis et al.’s study is due to not controlling for 
confounding variables. The sample was referred to a psychiatric liaison 
service from HIV services or general wards, suggesting that there was a high 
level of mental health disorders in the sample that should have been 
controlled for. In addition, it appears that there was a lack of statistical power 
in the sample, as the study was not able to detect a significant difference 
between a prevalence rate of 42% and 73% of Borderline PD in the two 
groups. There is very limited information reported about the two male 
samples, leaving the lack of significant findings unclear (Johnson, Rabkin, 
Williams, Remien, & Gorman, 2000; Johnson, Williams, Rabkin, Goetz, & 
Remien, 1995).  
 
This review highlighted higher levels of PDs in HIV-positive forensic 
populations. The higher prevalence rates are in line with the findings of 
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previous research (e.g. Scheidell et al., 2016, 2017). Scheidell and colleagues 
found high levels of Antisocial and Borderline PD, which were strongly 
associated with HIV-risk behaviour, in incarcerated HIV-negative men. It is 
therefore difficult to ascertain whether the high levels of PDs is due to being 
HIV-positive or vice versa, as high levels of PDs are often also found in 
forensic settings regardless of HIV status (e.g. Culhane, Hildebrand, Mullings, 
& Klemm, 2016). This would need to be explored further in future research. 
 
This review also found a high prevalence of PDs in substance use settings. 
Five studies found that HIV-positive substance users were more likely than 
HIV-negative substance users to have a PD, whilst controlling for 
confounders. However, one study found that there was no significant 
difference in the prevalence of PD in HIV-positive methamphetamines users 
compared to HIV-positive non-substance users. This is surprising as previous 
research have highlighted that the co-morbidity of substance use and mental 
health disorders such as PD, is high in the HIV-positive population (Willinger, 
2010). In fact, another study in the review found that female inpatient 
substance users were four times more likely to have a PD compared to non-
substance users (Bansil et al., 2009). It is worth noting that Moore and 
colleagues explored the impact of methamphetamine (i.e. a stimulant and 
often classified as a ‘party drug’) on Antisocial PD prevalence rates (Moore et 
al., 2012), whereas the other studies explored the effect of intravenous drugs. 
The findings may also be due to the PD diagnosis, as previous studies have 
found high levels of methamphetamine in Borderline PD samples (Dimeff, 
Rizvi, Brown, & Linehan, 2000). Therefore, it can be hypothesised that there 
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is an increased prevalence rate of PD in substance users, however it may 
dependent on substance type or PD diagnoses.  
 
Associations of Personality Disorders in People with HIV 
There were a large variety of associations explored in the 34 studies. The 
associated variables were grouped into five categories: socio-demographic 
variables, substance use, mental health, high-risk sexual behaviours, and 
health-related factors. Variables examined by several studies where three or 
more indicated a relationship with HIV and PD included: gender, substance 
use, axis I disorders, quality of life and ART adherence. 
 
Given the large amount of research into the psychological impact of receiving 
a HIV-positive diagnosis in individuals without PD, it was not surprising that 
the results of this review suggest that life with PD and HIV may also contribute 
to other mental health difficulties. Sixteen studies explored associations 
related to mental health, such as suicidal ideation, Axis I disorders and quality 
of life. Two studies found an increase in suicidal ideation and suicide attempts 
in individuals with a PD diagnosis compared to individuals without PD. 
Interestingly, Narcissistic PD was negatively associating with suicidal ideation 
suggesting that this might be a protective factor. This is in line with previous 
studies which has shown that individuals with Narcissistic PD were two times 
less likely to make a suicide attempt compared with non-Narcissistic 
individuals with and without PDs (Coleman et al., 2017). 
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Four studies found higher rates of Axis I disorders (three of these specified 
depression) in individuals with PD and HIV, compared to HIV-positive and 
HIV-negative individuals without PD. Two studies also found that individuals 
meeting criteria for PTSD were more likely than those without PTSD to meet 
criteria for Antisocial PD and/or Borderline PD (Fellows et al., 2015; Lewis, 
2005).This is in line with the PD literature, suggesting that PDs are often 
accompanied by an Axis I diagnosis (Tyrer et al., 2015). For individuals living 
with HIV, an Axis I disorder (as well as PD) may further complicate the 
likelihood of adjusting to the HIV diagnosis as well as adhering to treatment. 
 
Perhaps not surprisingly, the review also indicated that PDs were related to 
decreased health-related quality of life and poorer functioning in three studies. 
Two studies also explored the link between PD and HIV symptoms. One study 
did not find an association between PD symptoms and CD4 levels, whereas 
Hansen and colleagues found that PDs were associated with increased HIV 
symptoms (Hansen et al., 2007). It can be hypothesised that the higher level 
of HIV symptoms could be due to lower levels of ART adherence. Another 
potential reason could be that patients presenting with mental health concerns 
get diagnosed with HIV at a later stage compared to individuals without 
mental health difficulties (e.g. Bohnert & Latkin, 2009; Evangeli, Pady, & 
Wroe, 2016); however, this would need to be explored further.  
 
Two other studies did not find an association between Antisocial PD and 
disease severity, however quality of life was positively correlated with 
Borderline PD (on a self-report measure). The higher levels of quality of life 
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results are surprising as previous studies have found that Borderline PD is 
linked with decreased levels of quality of life (e.g. Cramer, Torgersen, & 
Kringlen, 2006; IsHak et al., 2013). The same study found that family/friends 
quality of life was positively correlated with Borderline PD (Haller & Miles, 
2003). It is worth nothing the difference in how the authors assessed quality of 
life. In Haller and Miles study, quality of life was assessed by asking 
participants how their current quality of life was in six different areas on a 5-
point Likert scale, whereas Hansen and colleagues assessed quality of life on 
a 55-item questionnaire (Hansen et al., 2007). It can therefore be 
hypothesised that there is a decreased in quality of life in individuals living 
with comorbid HIV and PD, but it is dependent on the quality of life measure 
used.  
 
Across studies PDs were generally associated with lower rates of adherence 
to ART, however one study found that HIV-positive women with a PD were 
less likely to be non-adherent to medication compared to those without PD 
(Bansil et al., 2009). Similarly, one study found that individuals with a PD 
diagnosis were more likely to complete six sessions of therapy compared to 
non-PD patients (Bottonari & Stepleman, 2009). This is interesting as 
previous studies have listed that PD clients often finds it difficult to engage in 
both psychological and pharmacological treatment and have a high level of 
drop out (e.g. Stoffers-Winterling et al., 2012). The surprising results could be 
due to lack of control of confounding variables (e.g. socio-demographic 
variables, types of therapy or other mental health disorders) (e.g. in Bottonari 
& Stepleman, 2009) and poor detection validity (e.g. in Bansil et al., 2009) as 
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PDs overall in the current review were associated with lower rates of 
treatment adherence. However it may be worth noting that other studies have 
argued that PD clients have more severe presentations, often with an 
increased levels of impairment, which may suggest that they are motivated to 
remain in care due to their desire to reduce their distress (Norén et al., 2007). 
It will be therefore be important for further studies to explore this relationship 
further.  
 
As suspected, the findings of the review suggest that the socio-demographic 
variables in HIV-positive individuals (e.g. age, ethnicity, gender, employment 
status, marital status and sexual orientation) may impact on their mental 
health. The results in this review is similar to previous findings suggesting that 
socio-demographic variables (e.g. being male and an ethnic minority) are 
associated with higher levels of PDs (Eaton & Greene, 2018), increased HIV-
risk (Lessard, Lebouché, Engler, & Thomas, 2016), poorer HIV test-seeking 
(Mirandola et al., 2016) and an increased level of HIV infection (Gelaw, 
Magalhães, Assefa, & Williams, 2019).  
 
Strengths and Limitations of the Review 
A limitation of the review was the fact that the review was not unable to 
conduct a meta-analysis due to the large variability in populations (gender, 
settings etc.) and how PDs and associated variables were assessed. As 
previously noted, there is a poor diagnostic reliability of PDs and poor 
temporal stability (Zimmerman, 1994). In the current review 18 studies based 
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their diagnosis on DSM criteria. It is important to note the discrepancy even 
between the different DSM classification systems (e.g. deletion of passive-
aggressive PD; American Psychiatric Association, 2013) and also within 
disorders (Oldham, 2015). For example, there are 256 ways that someone 
can meet criteria for Borderline PD; two patients could receive the diagnosis 
but share only one diagnostic criterion. This suggests that there may be a lot 
of heterogeneity in the included studies and samples.  
 
Despite poor reliability and stability, it is important to note that the diagnostic 
system (e.g. DSM) is helpful in terms of standardising disorders as well as 
providing opportunities for treatment and research. In terms of the current 
review, DSM diagnostic criteria have been useful in highlighting areas 
individuals need to struggle with to receive a PD diagnosis. For example, to 
get a diagnosis of PD the individual will need to present with a problematic 
impact either for the individual themselves and/or their system. Continuum 
based assessments (e.g. self-report measures) on the other hand is helpful in 
highlighting individuals who may not meet full criteria for a diagnosis but still 
presents with PD traits. However, self-report measures are more sensitive to 
whether the individuals are able to assess themselves accurately, be honest 
about their difficulties and whether they understand and interpret the question 
correctly. It would be beneficial for future studies to assess whether there is a 
difference in PD prevalence depending on PD measures in HIV populations. 
However, in the current review no discrepancy was indicated between self-
reported measures and ‘gold standard’ structured clinical interviews when 
exploring the prevalence rates of PD in HIV in the current review.  
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A limitation in the search strategy used is that key terms were only searched 
for in the titles and abstracts. The search strategy used was felt to be efficient 
given the lack of recourses available, whereas a more comprehensive search 
strategy may have found additional articles. No date cut off was used, which 
can be both a strength and limitation of the current review. It means that all 
suitable studies were included, however, a third of the included articles were 
published more than two decades ago. This is important to note as many 
studies were published before ART changed the clinical picture of HIV from 
fatal illness to a chronic condition, which most likely will have had an impact of 
the individuals’ mental health. In addition, there has also been a change in 
how mental health disorders and other cultural variables (such as 
homosexuality) are thought about and perceived.  
 
Another strength of the review process was that two independent reviewers 
assessed eligible for all studies and a third reviewer (the academic 
supervisor) resolved the disagreements. Similar strategies were used to 
appraise the quality of the studies included. This increased the reliability of 
decision making throughout the review process. 
 
Strengths and Limitations of the Included Studies 
A limitation of the included studies was that all studies were conducted in 
high-income countries. Sixty-six per cent of people living with HIV are 
currently from Sub-Saharan Africa (Avert, 2017) but none of the studies 
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included in this review recruited from this population. This is very surprising 
and leads to a difficulty in generalising the findings from the current review. 
The impact of mental health on life with HIV and vice versa has previously 
been confirmed in Western societies (e.g. Treisman & Angelino, 2004), 
however research has identified the lack of understanding of prevalence and 
impact of mental health in Sub-Saharan populations (Parcesepe et al., 2018). 
The current review has highlighted that there is a high prevalence of PD in 
people with HIV in specific groups in Western societies (i.e. concentrated 
epidemics) and that it often is associated with impairment and other mental 
health difficulties. Studies in low income countries have indicated that there is 
no consistent variation in PD rates around the world (Tyrer et al., 2010). It is 
therefore important to further examine the prevalence and associations of PD 
also in African HIV-positive populations, where the there is a more 
generalised epidemic, and where the majority of HIV-positive individuals live.  
 
The quality appraisal highlighted that the studies in the review had high levels 
of internal and external validity. Twenty out of 34 studies met all the criteria for 
internal validity, suggesting that the majority of studies included in the review 
had good detection validity and controlled for confounding variables. In terms 
of internal validity, 13 out of 34 met all the criteria, suggesting that it limits 
conclusions that can be drawn from the study. Only nine studies met all 
criteria for both external and internal validity, suggesting that the quality of 
studies could be improved.  
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Clinical and Research Implications 
In terms of implications for future practice, the review has highlighted that 
there appears to be a large amount of consistency across the findings of the 
included studies. As hypothesised, multiple studies found that there is a 
higher prevalence rate of PD, and in particular Antisocial and Borderline PD, 
in people living with HIV compared to HIV-negative populations. The 
prevalence rate of PD has been estimated to be around 14% in the general 
population (Torgersen, Kringlen, & Cramer, 2001). In addition, the studies 
also highlighted the additional severity and impairment individuals with 
comorbid HIV and PD often face, such as additional mental health difficulties, 
poor health-related quality of life and medication adherence, which will need 
to be addressed, for example in therapy.  
 
Theories of adjustment may be helpful when thinking about mental health and 
wellbeing in individuals with PD and HIV. Moss-Morris’ model of adjusting to 
chronic condition (2013), proposes that background factors (e.g. personality 
traits and early life experiences) together with socio-demographic factors 
influence how people respond and adapt to stressors around their illnesses 
(Moss-Morris, 2013). It can therefore be hypothesized that individuals with PD 
have not adjusted well to the HIV diagnosis and may therefore experiencing 
other mental health difficulties as a result. In fact, adjustment has been found 
to be difficult in individuals with comorbid PD and other chronic health 
conditions, such as diabetes and cancer (Hay & Passik, 2000). Brunault and 
colleagues also found that psychological characteristics (e.g. PD) were 
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strongly associated with quality of life in individuals diagnosed with non-
metastatic breast cancer (Brunault et al., 2016).This suggests that individuals 
with PD find the emotional and other challenges of their physical illness even 
more daunting and the physical symptoms or treatment adherence even more 
problematic than someone without mental health difficulties. It will therefore 
be important to consider adjustment and wellbeing when thinking about 
treatment and support for people living with comorbid HIV and PD.  
 
The findings suggest that prevention and treatments targeting PD and HIV will 
need to consider socio-demographic variables. For example, British HIV 
Association (BHIVA) indicated that HIV-positive individuals from Black and 
Minority Ethnicity (BME) backgrounds are less likely to be offered, engage in 
and remain in psychological talking therapies (BHIVA, 2011). Similar results 
were also found in the current review when looking at rates of HIV and 
methadone treatment in people from BME backgrounds. It is therefore vital 
that clinicians discuss any potential difficulties and discuss support options 
with people from this population, as well as offer culturally sensitive 
treatments (e.g. language, cultural sensitivity). It would also be important to 
further explore the relationship between PD and HIV in this population to be 
able to further develop effective treatments.  
 
Research has also found a high rate of substance use in individuals at risk of 
HIV (Shuper et al., 2018), and in HIV-positive individuals (Bing et al., 2001). 
This is also an area important to keep in mind when thinking about treatment 
for individuals with comorbid PD and HIV, as research has highlighted 
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reduced treatment adherence for psychological therapies for both individuals 
with PD (Stoffers-Winterling et al., 2012) and substance use disorders 
(Andersson, Steinsbekk, Walderhaug, Otterholt, & Nordfjærn, 2018). It will 
therefore be important for future studies to consider the impact of comorbid 
substance use and PD diagnoses in individuals also living with HIV.  
 
Psychological support is defined as ‘any form of support which is aimed at 
helping people living with HIV to enhance their mental health and their 
cognitive, emotional and behavioural wellbeing’ (BHIVA, 2011). Research has 
indicated that the most effective treatment for individuals with co-occuring 
physical and mental health disorders is the so called ‘intra-agency model’ in 
which all disorders are treated together within a single treatment setting 
(Hendrickson, Schmal, & Ekleberry, 2004). Perhaps not surprisingly, this is 
not the norm for HIV and PD. HIV services do often not feel equipped to work 
with individuals presenting with PD difficulties (e.g. Willinger, 2010), as the 
individuals often require support from specialist PD services.  
 
The National Institute for Health and Care Excellence (NICE) guidelines for 
treatment of Borderline PD, suggest that rather than outpatient therapy is 
being offered in isolation (which is the norm in HIV psychology services), it 
should be provided within a structured programme where the individuals with 
Borderline PD has other inputs and access to support between sessions 
(NICE, 2009). The British HIV Associations (BHIVA) standards of care 
(BHIVA, 2018), on the other hand, suggests that the mental health 
professional working with the individual should provide evidence-based care 
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for the mental health problem identified, have up-to-date HIV-specific 
knowledge and an established communication channel with HIV services. In 
practice, however, this is often not the case. Further research is necessary to 
explore ways in how to support individuals with this common comorbidity 
better.  
 
Conclusions 
 
In conclusion, the systematic review found that there were significantly higher 
rates of PDs in HIV-positive individuals compared to HIV-negative 
populations, across inpatient settings, psychiatric emergency departments, 
substance use settings and community samples. In addition, there were a 
large variety of associated variables explored in the 34 studies. The review 
demonstrated that the relationship between HIV and PD may be influenced by 
several factors, which will be important to take into consideration when 
supporting this population. Future research could examine these factors to 
gain a clearer understanding of how the associated variables may impact on 
life with HIV and PD.  
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Developing a Model of Living with HIV in Individuals 
with Personality-related Difficulties 
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Abstract 
 
Introduction:  HIV can be a demanding illness to live with and often 
represents a burden for people living with the condition. Personality traits and 
early life experiences are key processes contributing to how individuals adapt 
to a chronic illness. Despite the common comorbidity, and the potentially 
severe consequences and outcomes, there is very limited literature on 
personality-related difficulties and wellbeing in HIV. Understanding the impact 
of personality-related difficulties in people living with HIV is important to better 
support this population, as we will better understand the challenges they are 
faced with. The empirical article explored the impact of personality-related 
difficulties in people living with HIV. Method: Nine individuals (two female, 24-
60 years) were recruited via HIV-services across London. The participants 
met criteria for Borderline or Narcissistic PD on a screening measure. They 
took part in semi-structured interviews about their life with HIV. The data was 
analysed using the qualitative method of Grounded Theory. Results: Eight 
theoretical codes were identified: 1) traumatic experiences prior to HIV; 2) 
difficulties mentalizing self and others; 3) difficulties identifying and regulating 
current emotions; 4) dysfunctional relationships; 5) difficulties managing sex; 
6) dissatisfaction over the support they have received 7) negative feelings 
towards HIV and self before and after diagnosis; 8) fear and shame impacting 
on life with HIV. A theoretical model indicating the diagrammatic 
representation of the relationship between the codes was generated. 
Discussion: The current study has identified many barriers for treatment, 
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which may indicates that individuals with personality-related difficulties and 
HIV may need different support and treatment compared to individuals living 
with either HIV or PD traits. 
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Introduction 
 
As defined in greater detail in the Executive Summary (p. 8) HIV is a blood 
borne virus that attacks the body’s immune system by reducing the number of 
CD4 blood cells, making individuals more susceptible to infection and 
disease. In the 1990’s antiretroviral therapy (ART) was introduced, changing 
the clinical picture of HIV from being a fatal to a chronic illness.  
 
HIV is a demanding illness to live with and represents a burden for people 
living with the condition (Remien et al., 2006). Research has listed HIV 
stressors such as adherence to medication, side-effects of treatment, 
symptoms associated with illness progression, a fear of death, financial 
difficulties, adjustment and acceptance of living with a serious illness, as well 
as being faced by HIV stigma (i.e. an identifying mark or characteristic that 
can be associated with shame) (Moskowitz & Wrubel, 2005). Other stressors 
include HIV disclosure, negotiating safer sexual relationships, and managing 
on-going relationships with HIV services.  
 
Personality disorders (PDs; see further details in executive summary p. 10) 
have been found to impair individuals’ ability to cope and adjust to living with a 
chronic condition (Hay & Passik, 2000). The Diagnostic and Statistical Manual 
of Mental Disorders (DSM) defines PD as “an enduring pattern of inner 
experience and behavior that deviates markedly from the expectation of the 
individual’s culture”. The pattern must be pervasive, inflexible, have an onset 
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in adolescence or early adulthood and cause significant distress or 
impairment (DSM-5; American Psychiatric Association, 2013). Due to the high 
level of distress often displayed by people with PD, it can be hypothesized 
that the difficulties encountered by people living with HIV may be enhanced in 
people living with comorbid HIV and PD.  
 
Theories of adjustment and coping 
The ability to cope and adjust to living with HIV is vital for a person’s wellbeing 
and health progression. Coping styles refers to an individual’s coping 
strategies, which have been related to distress and quality of life following 
diagnosis of a chronic illness (Johnson & Endler, 2002). Adjustment is more 
difficult to define. Stanton and colleagues suggested it is the ability to 
preserve functional status and present with low negative affect (Stanton, 
Revenson, & Tennen, 2007). The Transactional Stress and Coping model 
(Lazarus & Folkman, 1984) proposed that adjustment to a chronic illness is 
influenced by the individual’s appraisal of the illness, coping strategies used 
and the individual’s appraisal of the efficacy of the coping strategies used as 
well as their appraisal of their ability to manage the stressors. 
Moss-Morris suggested it may be restrictive to only consider the absence of 
distress, and instead adjustment may be better defined as managing negative 
emotions and not being overwhelmed by them. She highlighted that 
adaptation is an on-going process (Moss-Morris, 2013). In her model of 
adjusting to chronic condition (2013), she proposes that background factors 
(e.g. personality traits and early life experiences) together with social and 
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environment factors (e.g. availability of social support and health care) 
influence how people respond and adapt to stressors around their illnesses. 
Illness-specific factors (e.g. symptoms, degree of disability, prognosis, side 
effect of treatment) determine the nature of the stressors or critical events that 
may disrupt emotional equilibrium and quality of life. The model suggests that 
good adjustment occurs when individuals are able to use cognitive and 
behavioural factors to maintain equilibrium. Moss-Morris defines good 
psychological, physical and social adjustment as less distress and 
interference with life roles and relationships, good illness management and 
high positive affect (Moss-Morris, 2013).  
HIV and mental health 
As effective treatments for HIV became available and the view of the illness 
shifted from being a fatal to chronic illness, more people are coping with the 
chronic and complex course of the disease, as well as the many stressors 
associated with living with HIV (Miners et al., 2001). People living with HIV are 
often subjected to discrimination, stigma and social isolation (Whetten, Reif, 
Whetten, & Murphy-McMillan, 2008). The ability to adjust and cope with the 
stressors associated with a HIV diagnosis is vital as poor adjustment can 
have detrimental effects on the individual’s mental health and the progression 
of HIV (e.g. Bottonari, Roberts, Ciesla, & Hewitt, 2005; Remor et al., 2007). 
HIV has been found to both cause and exacerbate psychiatric disorders 
(Treisman & Angelino, 2004) 
 
Depression, anxiety disorders and substance use are more common in HIV 
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patients than in the general population (Owe-Larsson, Sall, Salamon, & 
Allgulander, 2009). Research has found that 50% of those living with HIV 
have a mood or anxiety disorder, and 25% have a current substance use or 
dependence disorder (Bing et al., 2001), with lifetime rates as high as 40-50% 
for substance use (Owe-Larsson et al., 2009). It has been proposed that the 
link between HIV and psychiatric disorders is bi-directional and influenced by 
many factors, for example stigma and discrimination, family support, 
educational level, medication side effects, treatment adherence, concurrent 
substance use and course of HIV infection (Chandra, Desai, & Ranjan, 2005).  
 
In a recent population study in Sweden, Bauer-Staeb and colleagues (2017) 
found that prevalence of blood-borne viruses (e.g. HIV) was elevated in 
people with severe mental illness. The odds of HIV infection were nearly three 
times higher in people with severe mental illness than in the general 
population. The authors also found that having a history of substance misuse 
increased the odds of HIV infection in those with and without severe mental 
health difficulties (Bauer-Staeb et al., 2017). For people living with severe 
mental health difficulties, an HIV diagnosis has been found to contribute to 
increased mental health-stigma (Walkup, Cramer, & Yeras, 2004) and have a 
negative effect on their quality of life (Cournos, McKinnon, & Sullivan, 2005).  
 
Earnshaw and Chaudoir (2009) defines stigma as being a devalued attribute 
in society, which affects the way people react to the knowledge that they  
possess the valued attribute (i.e. HIV infected) or not (i.e. not infected). 
According to their HIV stigma framework, people without HIV might present 
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with stigma mechanisms such as prejudice, stereotyping and discrimination in 
response to people living with HIV. HIV stigma can lead people who live with 
the virus to face social exclusion and has been identified as a considerable 
barrier to HIV prevention and treatment efforts. For individuals living with HIV, 
Earnshaw and Chaudoir proposed that there are three different mechanisms 
of stigma; enacted (i.e. experienced discrimination), anticipated (i.e. 
expectation of this happening in the future) and internalized (i.e. negative 
beliefs and feelings associated with HIV about themselves). Stigma in HIV 
has been identified as a considerable barrier to HIV prevention and treatment 
efforts (Earnshaw & Chaudoir, 2009). 
 
The presence of mental health disorders in HIV (and vice versa) has been 
established but the effect of mental health difficulties on individuals living with 
HIV is less researched. This is important as people with severe mental illness 
have an increased mortality rate of two to three times the general population 
and a reduced life expectancy of up to 20 years (Laursen, 2011). 
Approximately 60% of the increase in mortality has been attributed to poor 
physical health (Laursen, 2011). In addition, individuals with severe mental 
illness receive less assessment and treatment for physical health difficulties 
than the general population (Crawford et al., 2014). In HIV, one study linked 
the presence of mental health disorders to lower rates of virologic suppression 
than those without mental health disorders, due to reduced antiretroviral 
therapy (ART) adherence (Yehia et al., 2015). 
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Personality disorder and Physical Health 
Personality traits and early life experiences are key processes contributing to 
how individuals adapt to a chronic illness (Moss-Morris, 2013). A recent meta-
analysis suggested that there are numerous negative health outcomes 
associated with PD traits and diagnoses (Dixon-Gordon, Whalen, Layden, & 
Chapman, 2015). Brunault and colleagues found that psychological 
characteristics (e.g. PD) were more strongly associated with quality of life 
than biological or physiological variables related to the severity of the cancer 
or its treatment, in individuals diagnosed with non-metastatic breast cancer 
(Brunault et al., 2016). This suggests that individuals with personality related-
difficulties may find the emotional challenges of their physical illness even 
more daunting and the physical symptoms or treatment adherence even more 
problematic than someone without mental health difficulties.  
 
Gerhardstein and colleagues highlighted the many terms used in the 
Diagnostic and Statistical Manual (DSM) to describe the diagnostic criteria for 
PD indicating complications not only for the individuals themselves but also 
for HIV treatment. For example by hindering relationship with health care 
professionals by being suspicious, unforgiving, detached, reckless, solitary, 
deceitful, irresponsible, angry, self-important, rigid, unstable among others 
(Gerhardstein, Griffin, & Hormes, 2011). Furthermore, PDs are often 
accompanied by an Axis I diagnosis (e.g. depression or anxiety) further 
complicating the likelihood of positive coping and treatment adherence in 
people with physical illnesses (Tyrer, Reed, & Crawford, 2015). In addition to 
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this, research has found that Borderline PD is associated with poorer physical 
health than a healthy population (El-Gabalawy, Katz, & Sareen, 2010). 
 
Previous studies have found adjustment difficult in individuals with comorbid 
PD and other chronic health conditions, such as diabetes and cancer (Hay & 
Passik, 2000). However, unlike other chronic conditions, many challenges in 
HIV are relational  (due to the high level of stigma and it being a transmittable 
disease) which may be particularly difficult for individuals with significant 
personality-related difficulties (e.g. HIV disclosure, negotiating safer sexual 
relationships, managing on-going relationships with HIV services).  
 
HIV and Personality Disorders  
High levels of psychological distress are common among people living with 
HIV (Owe-Larsson et al., 2009). The prevalence of PD in the general 
population has been estimated to be around 14% (Torgersen, Kringlen, & 
Cramer, 2001). The prevalence of PD has previously been suggested to be 
somewhere between 19-36% in people living with HIV, with Antisocial and 
Borderline PD being the most common (as seen in the systematic review 
chapter) (Hutton & Treisman, 2008; Singh & Ochitill, 2006). Gerhardstein et 
al. (2011) highlighted four areas that are commonly affected in people living 
with comorbid HIV and PD; mental health, compromised physical health, poor 
health-related quality of life and poor support systems.  
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PD difficulties are often characterised by behaviours associated with an 
increased risk of HIV acquisition, such as impulsive sexual behaviour, more 
sexual partners and substance use (Durvasula & Regan, 2015). In a sample 
of men involved in the criminal justice system, Borderline PD traits were 
strongly associated with an increased HIV risk. The PD symptoms most 
associated with an increased risk of contracting HIV were abandonment 
worry, mood swings and shifts in opinion. Higher Borderline PD scores on a 
questionnaire were found to be associated with sexual risk behaviours, 
including multiple partners and sex with non-monogamous partners (Scheidell 
et al., 2016).  
 
Personality-related difficulties may also lead to poorer outcomes following 
diagnosis (e.g. Hutton & Treisman, 2008; Scheidell et al., 2016). It has been 
argued that individuals with HIV and PD traits present with challenges with 
treatment adherence, engagement with care, difficulty with interpersonal skills 
and expression of needs (Willinger, 2010), but this has not been examined 
empirically. In Romania, researchers found that a third of the patients with 
nosocomial HIV (i.e. patients infected in hospital) presented with PD traits, 
most commonly dependence, avoidance and compulsiveness. The individuals 
with comorbid HIV and PD traits had significantly lower medication adherence 
which had implications for disease progression (Modrigan, Draganescu, 
Condratovici, Pavel, & Condratovici, 2017).  
 
Despite severe consequences and poor outcomes, there is very limited 
literature on personality difficulties and wellbeing in HIV. In the United States, 
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Hansen and colleagues (2009) found that Borderline and Antisocial PD 
(assessed using a computer assisted structured clinical interview) was 
negatively associated with HIV symptoms and health-related quality of life 
(measured using questionnaires) in HIV positive adults who recently had been 
bereaved. In addition to this, the authors found that individuals with PD 
presented with higher grief severity and difficult relationships, which in turn 
also was associated with HIV symptoms and quality of life (Hansen et al., 
2009). Similarly, Perkins and colleagues, also in United States, found that 
individuals with comorbid HIV and PD showed significantly higher rates of 
depression and anxiety, hopelessness, as well as greater use of denial and 
helplessness when coping with the threat of AIDS compared to individuals not 
meeting criteria for a PD (Perkins et al., 1993).  
 
Individuals with personality-related difficulties often present with challenges in 
terms of engagement with care, medication adherence, difficulty with 
interpersonal skills and struggle with how to appropriately express their needs 
(Willinger, 2010). These individuals are often described by their dysfunctional 
interpersonal skills, poor impulse control and lack of flexibility, which often 
leads to disrupted and self-defeating experiences (Gerhardstein et al., 2011). 
In Hansen and colleagues’ (2009) study, social support was related to 
decreased HIV symptoms and increased quality of life, suggesting that social 
support is an important factor for individuals’ wellbeing. This is interesting as 
researchers and clinicians often describe clients with comorbid HIV, PD and 
substance use as the most challenging clients to support and treat (e.g. 
Willinger, 2010).  
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Rationale for the Current Study 
Mental health difficulties in HIV are a recognised problem and research can 
help in its understanding, treatment and prevention. The elevated risk of 
contracting HIV when living with PD has already been established, but the 
effect of mental health difficulties when living with HIV is less researched. 
Despite the common comorbidity, severe consequences and poor outcomes, 
there is very limited literature on personality-related difficulties and wellbeing 
in HIV. To my knowledge, there have been no first-hand accounts of what it is 
like to live with HIV in individuals with personality-related difficulties. Exploring 
the self-reported experiences qualitatively will enable us to better support 
individuals living with this common comorbidity, as we will better understand 
the challenges they are faced with.  
 
The current study aims, therefore, to build on some of the findings in previous 
research, suggesting that PDs have a negative impact on living with HIV. Due 
to the severe nature of PD, and their tendency to be under-diagnosed 
(Morgan & Zimmerman, 2015), the present study aims to investigate the 
impact of personality-related difficulties (i.e. individuals showing traits of PD) 
on individuals living with HIV.  
 
Research Aims and Question 
The aim of the current study is to develop a model describing the social and 
psychological processes associated with living with HIV in a sample of adults 
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with personality-related difficulties. The study aims to explore the impact of 
personality-related difficulties in people living with HIV.  
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Method 
Design  
A cross-sectional qualitative design was used. Participants took part in semi-
structured interviews. The data was analysed using Grounded Theory 
(Charmaz, 2006).  
 
Participants  
Participants were recruited from specialist HIV-services at two inner London 
NHS trusts, consisting of multidisciplinary teams (consultant physicians, nurse 
practitioners and sexual health advisors) running 8-10 HIV consultant clinics a 
week. Their caseloads were estimated to be around 1000 patients. 
Demographic and clinical information is presented in Table 4. All participants 
reported taking ART.  
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    Table 4: Participant Demographic Information 
 
 
 
 
 
 
Pt No Age  Gender  Employment 
status 
Sexuality Relationship 
Status 
Ethnicity Time since 
diagnosis  
CD4 count 
(cells/uL) at 
diagnosis  
CD4 count 
(cells/uL) at 
interview 
Viral load 
(copies m/L) at 
interview 
P1 26 Male Employed Homosexual Single White 2 years 311 428 <20 
P2 55 Male Unemployed Homosexual Single White 34 years  255 558 <20 
P3 24 Male Unemployed Bisexual Single Mixed 9 months Missing Missing Missing 
P4 43 Male Unemployed   Heterosexual Married  Black 18 years  703 825 <20 
P5 34 Male Employed  Homosexual Single  White  8 years 488 1165 <20 
P6 60 Female Unemployed Heterosexual  Single Black 22 years 359 673 <20 
P7 47 Male Unemployed Homosexual Single White 19 years 412 407 <20 
P8 52 Male Unemployed Homosexual Single White 25 years 290 628 <20 
P9 45 Female Employed Heterosexual  Single White 3 years  567 894 <20 
 90 
Inclusion and exclusion criteria 
Inclusion criteria   
 18 years and over  
 Received a HIV-positive diagnosis more than 6 months ago, to allow for 
adjustment to diagnosis.  
 Scoring above clinical cut-off on a screening measure (International 
Personality Disorder Examination, IPDE; Loranger, 1997) 
 Good spoken English, to ensure they could fully engage in an interview.  
 Comorbid conditions were not assessed and therefore not ruled out.  
 
Exclusion criteria  
 Evidence of significant risk of harm to self or others. This was defined as 
no episode of life threatening or deliberate self-harm which required 
medical attention within the last one month, no recent suicide attempt 
within the last 3-months, and no current expression of suicidal intent or 
plans. Risk was assessed by clinicians at the relevant service. 
 
Data collection  
Interviews 
Data was collected through semi-structured interviews. The interviews were 
conducted face-to-face in HIV clinics and were audio recorded. The interview 
schedule was developed by the researcher and then reviewed by academic and 
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field supervisors, as well as experts working in the field of personality disorders. 
Questions were formed around the experience of longstanding relational and 
emotional issues in the context of living with HIV (Appendix A). A mock interview 
with the academic supervisor was conducted. It provided opportunity to receive 
feedback and practice using the interview schedule. 
 
Service User Development 
Service user feedback was collected on the interview schedule. Feedback was 
sought from two service users (one male with an HIV diagnosis and one female 
diagnosed with Borderline PD) on the language used, areas of questions and 
content of the interview. The service users made suggestions around the order of 
questions and language used. They also felt more attention could be paid to 
positive experiences with services and relationships. The interview schedule was 
adapted based on this.  
Measures           
Potential participants were asked to complete a screening measure to assess 
their eligibility to take part in the study. Participants were administered the 
International Personality Disorder Examination (IPDE; Loranger, 1997). The IPDE 
has been reported to have good reliability and validity in a variety of PD samples 
(Carcone, Tokarz, & Ruocco, 2015). Participants who met the clinical threshold 
for Cluster B PDs were invited to take part in the study (Table 5).  
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After being accepted in to the study, participants completed a demographics 
questionnaire to provide additional contextual information (Appendix B). They 
also completed the Hospital Anxiety and Depression Scale (HADS, Zigmond & 
Snaith, 1983) (Appendix C). The HADS has been identified as a useful screening 
tool for depression in people living with HIV (Savard, Laberge, Gauthier, Ivers, & 
Bergeron, 1998). Information about the participants’ viral load and CD4 count at 
the time of diagnosis and recruitment, as well as medication at the time of 
recruitment, were obtained by a database from their medical team (Table 4). 
Participants self-reported questionnaire scores and current alcohol and drug use 
are presented in Table 5.   
Grounded theory  
Grounded theory methods are particularly suitable for studying personal 
experiences and emotions, as well as interpersonal relations (Charmaz, 2006). 
Grounded theory is often used to develop explanatory theories of basic social 
processes and behaviours (Starks & Brown Trinidad, 2007). This is particularly 
applicable for the study as it aims to explore the personal experiences of the 
individuals interviewed, by exploring the impact of personality-related difficulties 
on living with HIV.  
 
Charmaz (2006) grounded theory approach was preferred over others (e.g. 
Glaser or Straus & Corbin) due to its epistemology and approach. Charmaz 
(2006) states that we construct our world and the approach places an emphasis 
on the researcher to bring interpretations to the data. This suggests that the 
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researchers perspective will have an impact on the actions and decisions taken 
throughout the study. Glaser on the other hand suggests that the coding and 
theory emerge from the data. I felt that the study would benefit from the 
constructivist epistemology and approach and that it was in line with my own 
values as a researcher.  
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Table 5: Self-reported Questionnaire scores and Demographic information  
Pt 
no. 
IPDE Cluster B1 HADS Self-reported 
substance use 
 Antisocial Borderline Histrionic Narcissistic Anxiety 
Score2 
Depression 
Score3 
Weekly 
alcohol 
use 
Monthly  
drug use 
P1 2 6 5 7 5 2 18 units Crystal meth, 
GHB 
P2 4 5 1 6 8 7 0 units N/A 
P3 3 6 2 2 14 7 0 units Cannabis 
P4 1 6 3 4 18 6 0-3 units Cannabis 
P5 0 5 3 6 6 6 0-3 units Cannabis 
P6 0 5 2 0 11 9 0-3 units N/A 
P7 2 6 1 3 16 10 27 units Ketamine 
P8 0 6 5 4 13 9 62 units N/A 
P9 0 5 2 6 13 7 6 units N/A 
1= Clinical threshold > 3; 2=  0-7 normal anxiety, 8-10 mild anxiety, 11-21 moderate anxiety; 3= 0-7 normal depression, 8-10 mild depression, 11-21 moderate depression,  
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Theoretical sampling and Theoretical saturation 
Grounded theory relies on theoretical sampling, which is defined as a process 
of on-going data collection where previous analysis influences the decisions 
about subsequent data to be collected. Data collection should continue until 
theoretical saturation is met, when the complete range of constructs that 
make up the theory is fully represented by the data (Starks & Brown Trinidad, 
2007). There is little guidance on the sample size needed for saturation to 
occur (Charmaz, 2014). Due to limitations with recruitment, theoretical 
sampling was not possible and all available participants were recruited. 
However, due to specific inclusion criteria and research aims the study was 
more likely to reach data saturation with a relatively small sample.  
 
Reflexivity  
Charmaz acknowledged that the researcher is a “a part of the world we study, 
the data we collect, and the analyses we produce” (Charmaz, 2014, p.17). 
Reflexivity allows the researcher to acknowledge their perspective, privileges 
and interactions will influence their actions and decisions throughout the study 
(Charmaz, 2014). As the researcher for this study, I reflected on the 
experiences I brought to the study. I am female, Swedish, bisexual and born 
with a hand deformity. I think this have helped me understand some of the 
issues facing those living with HIV such as stigma/discrimination, concerns 
around disclosure and adjustment of living with a condition. To encourage 
reflection on these issues and my position as the researcher, I kept a 
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reflective diary and regularly discussed relevant observations with my 
supervisors.   
 
Procedure 
The researcher together with the academic supervisor attended several 
meetings at the research sites for the set-up of the study and preparation for 
the research to commence. Multiple discussions were held with clinicians 
about how to approach and talk to potential participants about the study. All 
individuals were identified through HIV clinics via targeted sampling by 
clinicians. Clinicians at the services identified individuals who they thought 
met the inclusion criteria and would be suitable for the study. All potential 
participants were provided with detailed information about the study by their 
clinicians. If participants were interested in taking part in the study and the 
researcher was available on site, they were taken to a separate room in the 
clinic to discuss the research further. If the researcher was not available on 
site, the potential participant was provided with contact details of the 
researcher or gave consent for their contact details to be shared with the 
researcher. 
 
During the first meeting the researcher gained informed consent by going 
through the Participant Information Sheet (Appendix E) and Consent Form 
(Appendix F). The documents listed information about withdrawal from the 
study, boundaries of confidentiality, how the data would be stored and that the 
interview would be stopped immediately should they become upset or wish to 
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terminate the interview. The participant and researcher both signed the 
consent form. Once consent had been obtained the screening measure was 
completed to assess eligibility. All participants met the clinical threshold for 
the study. Participants were invited to complete the interview immediately or 
at a later day should they wish to.  
Prior to starting the interview, participants completed the HADS and a 
demographic questionnaire (Appendix B). The interviews were semi-
structured to provide structure and themes to the interview, but to be able to 
respond to participants’ individual stories during the conversations. Summary 
statements and reflections were used throughout the interview to clarify the 
information given and to provide room for elaboration.  
Interviews took place between 26th November 2018 and 13th March 2019. 
Nine interviews took place face-to-face in private rooms within the HIV clinics. 
Interviews lasted between 58 and 88 minutes (mean of 80 minutes). At the 
end of the interview, participants were given the opportunity to debrief and 
reflect on the experience. None of the participants left the conversations 
demonstrating any clear distress.  
Payment  
Participants were reimbursed for out of pocket expenses they incurred to 
participate in the study. Travel expenses (up to £12) were reimbursed if they 
were travelling to the clinic especially to participate in the research and not to 
attend a clinic appointment. Participants were also paid a £10 voucher for 
participation in the study.  
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Analysis  
Transcription  
The audio-recorded semi-structured interviews were transcribed verbatim 
after being anonymised onto a computer for coding.  
 
Coding   
Grounded Theory coding consists of three stages: initial coding, focused 
coding and theoretical coding (Charmaz, 2014):  
 Stage 1: Initial coding. Initial coding is when data from the transcript is 
studied closely and named. The aim of initial coding is to remain open 
to the possible theoretical directions of the data whilst making sense of 
the content and staying close to what was said in the interview. The 
academic supervisor gave detailed feedback on the transcript of one 
interview and verified the codes of two transcripts.  
 Stage 2: Focused coding. Focused coding is the synthesizing of initial 
codes and provides a direction for analysis. It involves attending to how 
initial codes account for the data and the constant comparison and 
refinement of codes, concepts and categories (Charmaz, 2014). The 
focused codes were discussed and verified with the academic 
supervisor. Codes were modified and developed as a result of the 
feedback and discussion.  
 Stage 3: Theoretical coding and diagramming. Theoretical coding and 
diagramming involves exploring and specifying possible relationships 
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between focused codes. The researcher reviewed memos to link and 
synthesise the focused codes into theoretical codes. The final stage 
allowed application of an emerging theoretical model to the data 
(Charmaz, 2014). The interactions between the theoretical codes were 
discussed with the academic supervisor. The academic supervisor 
provided feedback on the theoretical model.  
 
Writing memos  
Memos were written throughout the coding process to record thoughts and 
hypotheses emerging from the data (Birks & Mills, 2011). Memos encouraged 
a critical reflexive stance by facilitating acknowledgment of own assumptions 
and how they may have influenced actions and decisions throughout the 
study 
Ethical approval 
Full ethical approval was gained from an NHS Research Ethics Committee 
(REC) and Royal Holloway University of London REC. Ethical approval was 
received in August 2018 (Appendix I). R&D approvals from the two NHS  
saFoundation trusts were obtained in September.  
Ethical considerations  
During the interview, participants were asked personal questions about 
sensitive topics. If an individual became upset or disclosed risk to themselves 
or others during the interview, usual clinic safeguarding procedures were 
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followed. Interviews were conducted at the relevant service and the clinical 
team was available to offer support to participants if needed. In an attempt to 
minimise distress and allow time to adjust to living with HIV, participants were 
not contacted if they had received their HIV diagnosis in the last 6 months. In 
addition, the participant information sheet identified and listed some of the 
areas that the interview was likely to cover. At the end of every interview, 
there was time for the participant to debrief and reflect on the experience. 
Participants were informed of the limits of confidentiality.  
 
Quality assurance  
The research followed Elliot and colleagues’ proposed guidelines on good 
practice and quality in qualitative research (Elliott, Fischer, & Rennie, 1999).  
 Owning one’s perspective. The researcher reflected on their own 
contribution to the research process by for example writing memos and 
reflections following interviews and coding.  
 Situating the sample. Demographic and descriptive data of the 
participants have been reported in Table 4 and 5.  
 Grounding in examples. The themes in the analysis have been based 
on examples from the interviews. Quotes have been used throughout 
the results section.  
 Providing credibility checks. The interview guide, transcript, themes 
and model developed have been discussed with internal and external 
supervisors to improve the quality of the research. 
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 Coherence. Coherence was aimed for by naming the theoretical codes 
appropriately, giving a clear summary of the analysis and by providing 
both a diagram and narrative description of the model developed.   
 Accomplishing general vs. specific research tasks. The data and 
conclusions drawn from the study have been described as a 
description of the participants’ experiences, which cannot be 
generalised to everyone. 
 Resonating with readers. Resonance was determined by preserving 
the language of participants in the coding and themes to support the 
validity of the theoretical model. The summary of the analysis has been 
written to provide a clear sense to the reader to hopefully expand their 
understanding of personality-related difficulties and HIV.  
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Results  
 
The analysis of the data identified eight theoretical codes that form the 
proposed theoretical model. The theoretical codes consist of 19 focused 
codes. Each focused code contains specific properties (initial codes) that 
were produced when coding the transcripts. Participant quotes have been 
used to illustrate codes, and demonstrate how the codes are grounded in the 
data. Any identifiable participant information has been removed to ensure 
confidentiality, and the participants in the study are referred to by their 
designated participant number (P1 to P9). A theoretical model indicating the 
diagrammatic representation of the relationships between the theoretical 
codes is outlined and discussed.  
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Table 8: Theoretical codes, focused codes, initial codes 
Theoretical codes Focused Codes Properties of the codes (initial codes) 
Traumatic experiences prior 
to HIV  
Difficult experiences prior to HIV  Reflecting on maltreatment and difficulties during childhood 
 Reflecting on being a victim of physical assault 
 Reflecting on difficulties coming out as gay prior to HIV 
 Reflecting on mental health prior to HIV  
Feelings towards HIV and 
self before and after 
diagnosis 
Thoughts about HIV prior to diagnosis Reflecting on having negative thoughts about HIV prior to 
diagnosis 
 Reflecting on not knowing much about HIV prior to diagnosis 
Thoughts about HIV at time of diagnosis Reflecting on lack of worries around HIV when diagnosed 
 Reflecting on taking the HIV diagnosis as an indicator of being 
bad  
 Reflecting on uncertainty around how contracted HIV 
 Reflecting on trying to find out how they contracted HIV 
 Reflecting on level of responsibility for the diagnosis 
 Feeling angry with others following diagnosis 
Adjustment to HIV  Reflecting on difficulties with adjustment 
 Reflecting on the process of adjustment 
 Feeling negative emotions or shame  
Fear and shame impacting 
on life with HIV’ 
Impact of HIV on aspects of life Reflecting on the negative impact of HIV on relationships 
 Reflecting on the impact of HIV on mental health 
 Reflecting on impact on work 
 Reflecting on feeling concerned about the future 
Worrying about disclosure Reflecting on deciding not to tell people about HIV 
 Reflecting on HIV not being the business of others  
 Worrying about stigma from others 
 Reflecting over having to support others following disclosure  
Difficulties managing sex 
following HIV diagnosis  
Managing safe sex Managing disclosure about HIV to sexual partners 
 Reflecting on managing safe sex  
 Reflecting on worrying about infecting others 
 Reflecting on worries about getting other sexually transmitted 
diseases 
Sexual activity  Reflecting on change in sexual activity 
Difficulties identifying and 
regulating current emotions  
Difficulties with emotions Reflection on finding emotions difficult 
 Reflection on management of difficult emotions 
 Displaying negative emotions in the session 
 Reflecting on difficulties with anger  
Mental health difficulties Describing symptoms of low mood and high levels of anxiety  
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 Reflecting on isolating self 
 Externalising blame for mental health difficulties 
 Reflecting on management of mental health 
 Reflecting on the impact of HIV on mental health 
Risk to self Reflecting on having attempted suicide  
 Reflecting on suicidal ideation  
Difficulties mentalizing self 
and others  
Self-reflection  Describing a negative view of self  
 Describing a positive view of self  
 Displaying traits of narcissism  
 Displaying difficulties understanding self 
Difficulties mentalizing others Finding it difficult to know how others would describe them  
 Displaying an inconsistent sense of how others see them  
 Reflecting on not feeling understood by others 
 Displaying difficulties in understanding others 
Dysfunctional relationships Difficulties with romantic relationships  Reflecting on having a fear of relationships 
 Reflecting on choosing the wrong partners 
 Reflecting on not having been treated well in romantic 
relationships 
 Reflecting on not having ended negative relationships 
 Reflecting on dating others with HIV  
Interpersonal difficulties Reflecting on having high expectations of others 
 Reflecting on difficult interactions with others  
 Reflecting on not trusting others 
 Reflecting on change in relationships 
 Reflecting on having isolated self 
 Reflecting on worrying about interactions with others  
Dissatisfaction over the 
support received  
Perceived support from significant others Reflecting on support they haven’t received 
 Reflecting on not having asked for support  
Support for HIV  Reflecting on not finding services supportive 
 Reflecting on what support they would have wanted for HIV 
Support for mental health  Reflecting on times they have not felt supported around their 
mental health 
 Reflecting on what support they would have wanted for mental 
health 
Reflecting on medication Reflecting on ART adherence 
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Traumatic experiences prior to HIV  
Difficult experiences prior to HIV 
There appeared to be strong evidence for difficult interpersonal experiences 
prior to the HIV diagnosis. Five participants reflected on being maltreated or 
having difficulties during their childhood; where four of the five participants (all 
male) reflected on having been physically assaulted by family members or 
partners.  
 
I grew up like an animal. Even though my father cared for us yeah, but 
the way he raised us, there was no… we wasn’t seeing our family […] it 
was just kids raising each other… and… things happened there as well 
[abuse] (P4)  
 
It was observed that the majority of the participants identifying as homosexual 
discussed difficulties disclosing their sexuality prior to HIV. Three of the 
participants reflected on HIV disclosure being affected by the negative 
experiences around coming out as gay.  
 
When they knew I was gay […] that didn’t go down very well for neither 
of them [parents]. Umm… so I think… this disclosure was tainted by 
that (P7) 
 
1
 An ellipsis [...] denotes that a section of the extract has been removed to promote the clarity of the 
quote. Words placed between square brackets have been added by the researcher so that the extract 
can be easily understood.  
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There appeared to be strong evidence that the participants presented with 
mental health difficulties prior to the HIV diagnosis. The majority of patients 
disclosed having suffered from high levels of anxiety or low mood. One 
participant spoke about having attempted to commit suicide prior to the HIV 
diagnosis.  
 
[…] when I was younger, I’d tried twice to take an overdose. At two 
separate occasions. Once I was taken, stomach pumped and whatever 
(P8)  
 
Feelings towards HIV and self before and after diagnosis 
Thoughts about HIV prior to diagnosis 
The majority of the participants spoke about having had negative thoughts 
about HIV prior to diagnosis. Three participants reflected on having ‘stigma’ 
about HIV or that HIV would be their worst nightmare prior to diagnosis. 
 
Before I was HIV positive I just used to think every HIV person is a 
freak. They like going around having sex… and they don’t care about 
anybody else and they will transmit it to anybody else. (P3) 
 
Three participants reported not knowing much about HIV prior to diagnosis. 
They reflected on having thoughts of HIV being a death-sentence.   
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The funny things is that I was obsessed about HIV but I never actually 
got myself that informed to the point of knowing it was not a death-
sentence anymore (P9) 
 
Thoughts about HIV at time of diagnosis 
Almost all participants discussed the thoughts they were having about HIV at 
time of diagnosis. Although the majority of the participants were aware of how 
they contracted HIV (either through consensual unprotected sex or having 
been victim of sexual assault), three participants (diagnosed in the 1980/90s) 
displayed uncertainty around how they contracted HIV. Two participants who 
were diagnosed in hospital when they were very unwell described trying to 
find out how they contracted HIV.  
 
I still don’t know, like… I used to wake up in the hospital… or being 
awake until 4 o’clock in the morning thinking, thinking, thinking, and 
then wake up and ‘oh I don’t know how I got it’ (P7) 
 
The majority of the participants reported a negative reaction and difficulties 
coming to terms with the diagnosis. Interestingly, two male participants 
reported lack of worries around HIV at the time of diagnosis and also reported 
a low level of responsibility for having contracted HIV. On the contrary, three 
participants (two female and one male), who described having a high level of 
HIV-stigma prior to the diagnosis, reflected on taking the HIV diagnosis as an 
indicator of being bad.  
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That’s why I’m saying I just feel like a failure, completely. It’s made me 
feel in so many ways… so many ways in my life (P6) 
 
Adjustment to HIV 
The majority of the participants discussed the process of adjustment or 
reported difficulties with adjustment to the HIV diagnosis. Two participants 
reported finding it difficult to come to terms with HIV and described having 
moments when it is still difficult to live with HIV. Five participants discussed 
the process of adjustment. They reflected feeling like they had to ‘get on with 
it’ (P8) or to ‘deal with it’ (P2) 
 
I kind of processed it more mechanical […] I said just give me the 
medicine immediately so we can work this out, and just solve the 
problem, in a way… and that’s just how I dealt with it (P1) 
 
There appeared to be strong evidence for negative emotions and shame 
towards HIV and self. All participants but two described a high level of shame 
or reflected on feeling negative emotions towards HIV or self. Two middle-
aged gay men described  feeling like HIV has ruined them. 
 
I feel like damaged goods because of it [HIV] (P7) 
 
I’ve got this invasion on my personal being, by this disgusting virus […] 
what else is responsible for destroying you, or by its very presence 
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being inside your body, having absolutely negative impact for me […] 
this sinister virus, you know. (P2)  
 
Fear and shame impacting on life with HIV 
Impact of HIV on aspects of life 
There appeared to be strong evidence for a perceived negative impact of HIV 
on different aspects of the participants’ lives. The majority of the participants 
reflected on the negative impact on relationships. 
 
I couldn’t go and ask a woman out. I couldn’t… it was just difficult... 
(P4) 
 
Interestingly, two of the participants discussed a positive impact of HIV on 
mental health as it had made them work on their low mood and anxiety. 
However, many of the participants spoke about feeling concerned about the 
future. Nearly half of the participants had noticed an impact on work, where 
four of the participants have not been able to work due to having been very 
unwell at the time of diagnosis and reported difficult emotions coming to terms 
with this.   
 
I had a work capability assessment and I’ve been signed off work since 
2000 […] I’m not saying I was ever perfect but this, if people strive for 
100% this knocked a good 30% off. You know… and… so you only 
ever going to be 70% off what your ideal could be (P7) 
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Worrying about disclosure 
There appeared to be strong evidence for disclosure being a difficult area for 
the participants. Three participants described having decided to not tell people 
about HIV due to high levels of worry. For the majority of participants there 
appeared to be a lot of worries about how others would perceive them 
following disclosure. Five participants spoke about worrying about stigma from 
others.  
 
[…] because you see every time you say ‘oh I’m HIV’, people think ‘ah, 
prostitutes’ (P4) 
 
A few participants spoke about the difference disclosing HIV to other health 
conditions and the two female participants spoke about having to support 
others following HIV disclosure. 
 
You need to be here for the person you are telling. Which is crazy 
because you are the one who needs to be supported, but you need to 
support the other people. [...] I guess if you have other diseases like 
cancer […] you can tell people, you get sympathy or support […] In our 
case, most of the time you don’t, you have to rely on yourself. (P9) 
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Managing sex following HIV diagnosis 
Managing safe sex  
There was a difference in the ways the participants managed disclosure to 
sexual partners following diagnosis. Only one participant reported not 
disclosing HIV whereas the majority reported always telling their sexual 
partners. There appeared to be strong evidence for worries around managing 
safe sex with four participants reflecting on it during the interview.  
 
[…]  we only did blow jobs and kisses sort of thing, we never had… any 
kind of risky sex. (P8) 
 
There appeared to be a high level of worry about infecting others, where 
almost half of the sample reflected on having such worries despite being 
undetectable (i.e. when the virus exists in such small quantities that it can’t be 
detected by standard blood tests and HIV is therefore untransmittable) .  
 
There is always going to be that worry […] you took the tablets in the 
morning, but you didn’t have enough food with it, or it didn’t stay in your 
system long enough, you know… there is a million different things that 
you can start worry yourself about… when it comes to the bio-
availability of the drugs in your system. (P5) 
 
The two female participants also worried about getting other sexual 
transmitted diseases. 
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It’s like an obsessions… that somebody will give me something worse 
[…] there are so many sexually transmitted diseases… (P6) 
 
Sexual activity  
There was evidence for a change in sexual activity following diagnosis. The 
majority of the sample reflected on having noticed a decrease in sexual 
activity, both in terms of intercourse and masturbation. 
 
You feel dirty. You just feel put off sex (P4) 
 
I had a physical shock, I couldn’t feel anything, it’s still a bit hard now, 
but for nearly 2 years I couldn’t even touch myself […] I got to a point 
when I couldn’t even put my fingers down there without crying. (P9)  
 
Difficulties identifying and regulating current emotions 
Difficulties with emotions 
There appeared to be strong evidence for a difficulty identifying and regulating 
emotions, with all participants reflecting on this during the interview. In 
addition, four participants displayed high levels of negative emotions in the 
session. A majority of the sample reflected on finding emotions difficult in 
general and nearly half described using negative coping strategies to manage 
their emotions. 
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I ummm am a bit dead on the inside […] they [emotions] basically keep 
being stuck in my head, most of the time. (P1) 
 
[…] the way I survive is just to block it […] ‘don’t think about it!’ (P6) 
 
There was evidence of anger, with more than half of the sample reflected on 
having difficulties with anger. 
 
I do have anger problems. And I do shout sometimes. (P2) 
 
Mental health difficulties 
There was very strong evidence for mental health difficulties in the sample. 
Seven participants described symptoms of low mood or high levels of anxiety. 
 
When I saw the picture of the statue, it kind of explained how you feel. 
You are there but you are empty… and you can see straight through, to 
the background (P8) 
 
The majority of the sample reflected on how they cope with their mental health 
difficulties in the interviews. There was a strong evidence for negative 
management strategies that may have exacerbated some of their symptoms. 
For example, a third of the sample reflected on having isolated themselves, 
whereas another third (all male) reported taking illicit drugs as a management 
strategy for their mental health difficulties. 
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I became a prostitute because I needed in a weird, perverse kind of 
way […] I got self-esteem from people paying me for sex […] you are 
on the hamster wheel of sex, drugs, partying and going out (P7)  
 
Risk to self 
There appeared to be a moderate level of risk to self at the time of the 
interviews, with two middle aged male participants reporting having attempted 
suicide, which they spoke about in a matter of fact manner. In addition, more 
than half the sample disclosed current or past suicidal ideation, where the 
following quotes relate to suicidal ideation after the HIV diagnosis.  
 
I went to the fuel station and I actually bought paraffin and then I came 
in the house and I poured it on myself. Then I light up the light and then 
my wife came. (P4) 
 
I got suicidal. I… got to the point where I was making notes and writing 
letters ‘you had to put the code…’ [to provide information to others after 
their death] and ‘I had a good run’… (P7)  
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Difficulties mentalizing self and others 
Self-reflection 
The interviews showed that more than half of the participants described a 
negative view of self.  
 
This useless woman who […] is 60… and it is going to be worse from 
now because I’ve not achieved anything on this planet. (P6)  
 
On the contrary, four male participants described themselves in a positive 
way. Out of these, three participants displayed traits of narcissism in the way 
they described themselves. 
 
I consider myself to be a wise soul. And there is… wise souls are 
often… I suppose they, at some sense they are perceived as a bit on 
an enigma and at other time… umm… a loner. And I can tell you 
now… loners are people that have transcended to some degree. (P2)  
 
It was evident from the interviews that near half of the sample displayed 
difficulties understanding self and would often tell conflicting information 
during the interview.  
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I was a very emotional despondent individual when I was younger. 
Umm… very reactionary, very defensive... I took a very carefree 
attitude towards life. (P2) 
 
Difficulties mentalizing others  
The majority of the participants displayed difficulties mentalizing others during 
the interview. There appeared to be evidence that five of the participants 
found it difficult to know how others would describe them.  
 
I don’t know that’s kind of like what does other people think of me is not 
something I ask people, like ‘what do you think of me?’ (P5) 
 
Three participants displayed an inconsistent sense of how others would 
describe them and often giving opposite descriptors. A third of the sample 
reflected on not feeling understood by others and this was often linked to 
negative emotions such as feeling alone with their difficulties.  
 
[…] no really truly, they have no clue. (P4)  
 
Dysfunctional relationships  
Difficulties with romantic relationships 
There appeared to be strong evidence for difficulties with romantic 
relationships with all but three participants reflected on having a fear of 
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relationships. The majority of the participants reported avoiding relationship 
with others.  
 
I need to accept the fact that I have HIV and live well with it… instead 
of rushing into a relationship because I desperately need someone 
validating me again (P9) 
 
Nearly half the sample reflected on relationship patterns in the past, with three 
middle aged participants reported not having been treated well in romantic 
relationships, and two reflected on not having ended negative relationships 
and choosing wrong partners. 
 
I always end up with this misogynist guy because the guy was very 
abusive […] there was no respect towards me (P9) 
 
There appeared to be mixed views of dating others with HIV, with two people 
saying they would not date others with HIV and one indicating that he only 
dates others with HIV due to a high level of concern about onward 
transmission.  
 
My romantic relationships have always been with people who were 
positive […] because I would never want to live with myself giving it to 
somebody else. (P7) 
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Interpersonal difficulties 
There appeared to be strong evidence for interpersonal difficulties throughout 
the sample. Six participants reflected on difficult interactions with others. 
 
I know when he [friend] is lying […] but he doesn’t like it when I catch 
him out on it […] It’s all because he is not ready, you know, he has got 
his own boundaries, but I don’t care. I’m your friend and I care about 
you, I want to tell you how it is. (P3)  
 
There was some evidence of having high expectations of others; three male 
participants described when friends and partners have not met their 
expectations. A few of the participants reflected on finding it difficult to trust 
others. More than half of the sample had noticed a difference in relationships 
since the HIV diagnosis, with two participants giving the example of having 
isolated themselves. A third of the sample also reflected on worrying about 
interactions with others due to the HIV. 
 
If you meet somebody new it is like you are carrying a 100-weight 
baggage. (P8)  
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Dissatisfaction over the support received 
Perceived support from significant others 
There appeared to be evidence of dissatisfaction with the support they had 
received (or not received) from significant others. Five participants described 
situations where they had not felt supported.  
 
My sister is the one I told immediately […] she was in denial 
throughout. In fact, she is the one who could have given me support 
but for some reasons […] I didn’t get what I wanted from her when I 
told her. I regretted it afterwards. (P6) 
 
It was interesting to note that despite the dissatisfaction over the lack of 
support, the majority of participants reflected on not having asked significant 
others for support. This suggests that significant others may not have been 
aware of the support the individuals would have wanted to receive.  
 
I didn’t really ask much of my friends. (P9)  
 
Support for HIV 
The majority of participants reported finding HIV services very helpful. Three 
participants described depending on the support they receive from their HIV 
consultant, as they did not have anyone else to talk to about their HIV-related 
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or mental health difficulties. However, two participants reflected on not finding 
services supportive. 
 
People think I’m crazy, obviously when you have depression people 
think you are making these things up. (P6)  
 
What I struggled with was finding a role model. I didn’t find one single 
woman, heterosexual European woman with a job, I could relate to. 
Most of the groups are either African ladies with huge problems, but 
really nothing to do with HIV. (P9)  
 
All participants but one reflected on areas they would like to change in terms 
of support for their HIV. 
 
I don’t know what [support] I am entitled to or what I’m not entitled to. 
(P3)  
 
We used to have longer appointments and now they are shorter 
appointments. But I… I even write down things to say. (P8) 
 
Support for mental health 
Nearly half the sample reflected on times they have not felt supported around 
their mental health. Three male participants described feeling like services did 
not try to help them as they were deemed too complicated or too demanding, 
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whereas a female participant reported that the National Health Service was 
not able to meet her needs so she attended private therapy instead.  
 
My opinion is that, if it’s demanding and it requires too much 
headspace then you are considered as a patient as complicated, you 
are profiled as a result. (P2) 
 
I’ve been speaking to them [mental health services]. But every time 
they say ‘you’ve got a lot of baggage and I don’t think we can 
accommodate because we can only see you for a few times’ (P4)  
 
A third of the sample reflected on what support they would have wanted in 
terms of their mental health. Two male participants discussed issues of 
integration of care; they argued that more focus should be spent on 
relationship issues and other mental health difficulties within the HIV clinic. 
Two other participants discussed how current models of care don’t fit their and 
other peoples’ needs.  
 
It’s kind of contradictory you have an HIV diagnosis which… may or 
may not influence your relationship problems… and then the point of 
getting help would be building up another relationship with a health 
care professional outside of HIV to fix… or to guide you from having 
problems with relationships… (P1) 
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I think for me it was strict to only have been given 8 sessions of therapy 
[…] and at the start it was suppose to be Cognitive Behavioural 
Therapy but the therapist looked at me and said let’s put it aside, we 
need to do another thing with you […] It was one huge queue for 
people who wanted to do evenings. It wasn’t really fitting my need, and 
I think it would be the same for a lot of professionals. (P9)  
 
Reflecting on medication 
Nearly half of the sample reflected on difficulties with ART adherence. Three 
participants diagnosed in the 1980/90s reported strong levels of negative 
emotions around having to take medication and not feeling ‘normal’ while 
taking them. One female participant reported having refused to take the 
medication for eight years due to side effects. Another participant stated it 
was a big difference between taking ART and self-medicating with drugs. Both 
of these participants spoke about HIV clinicians not knowing about the side 
effects.  
 
2001 up to 2009 or 2010, I refused to take medication […] I refused to take 
medication completely because at that time they did not know about the 
side effect (P4)  
 
But what they don’t know is the changes that taken those drugs has in 
your life […] You never feel normal on them, those drugs, never […] I hate 
the thought I have to take drugs. I hate it. I absolutely detest it […] there is 
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a big difference between taking drugs for fun and then having to take them 
to live (P2)  
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Theoretical model of living with HIV in individuals with 
personality-related difficulties 
The main aim of this study was to develop a theoretical model describing the 
social and psychological processes associated with living with HIV in a 
sample of adults with personality-related difficulties. Figure 2 outlines how the 
eight theoretical codes relate to each other in an explanatory model 
highlighting the impact of personality-related difficulties in people living with 
HIV. The diagram presents the chronological phases of life before and after 
HIV diagnosis and the black arrows present suggested relationships between 
the theoretical codes.  
The model and previous research (e.g. Bateman & Fonagy, 2003) indicate 
that due to traumatic experiences prior to the HIV diagnosis (often in their 
childhood), participants present with challenges mentalizing self and others. 
The difficulty mentalizing self has led to challenges identifying and regulating 
emotions, which in turn lead to complicated feelings towards HIV and self 
following diagnosis, and as a result there is a significant impact of fear and 
shame on life with HIV. The difficulties mentalizing others has led to 
dysfunctional relationships and furthermore, dissatisfaction over the support 
they have received (or not) from significant others and services. Finally, it was 
evident in the current sample that negative feelings towards HIV and self 
following diagnosis, together with dysfunctional relationships, lead to anxieties 
over managing sex.  
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There was a particular strong link between difficulties identifying and 
regulating current emotions and feelings towards HIV and self before and 
after diagnosis, as well as to the impact of fear and shame on life with HIV. 
There was also a strong relationship between dysfunctional relationships and 
dissatisfaction over the support they had received.  
In summary, it can be assumed that personality-related difficulties may have 
an impact on life with HIV in regards to the feelings individuals have towards 
their HIV diagnosis as well as self. The model also suggests that individuals 
may have difficulties managing sex. Individuals may present with 
dissatisfaction over the support they have received from services (e.g. mental 
health care) and significant others. Finally, personality-related difficulties may 
also lead to fear and shame impacting on life with HIV. 
. 
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Figure 2. Theoretical model of living with HIV in individuals with personality-related difficulties
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Discussion  
This study explored the impact of personality-related difficulties in individuals 
living with HIV. Nine adults presenting with personality-related difficulties 
meeting criteria for Borderline or Narcissistic PD on the IPDE were 
interviewed about their life with HIV. The study aimed to answer the research 
question; how do personality-related difficulties impact individuals living with 
HIV? Eight theoretical codes were identified and a theoretical model indicating 
the diagrammatic representation of the relationship between the codes was 
generated.  
 
Overall Findings: Before HIV diagnosis  
Traumatic experiences prior to HIV  
In line with the risk factors for Borderline PD (e.g. Herman, Perry, & van der 
Kolk, 1989) the majority of the participants presented with traumatic 
experiences in their childhood. Two of the participants hypothesised that the 
early life experiences and trauma had lead them to have anger issues as well 
as difficulties trusting others. The diagnostic criteria for PD states that the 
difficulties must have an early onset (American Psychiatric Association, 2013), 
which indicates that the personality-related difficulties were present prior to 
the HIV diagnosis. This is also in line with research suggesting PD traits to be 
risk factors for HIV (Durvasula & Regan, 2015). 
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Mentalizing deficits 
It was evident that near half of the sample displayed difficulties understanding 
self and others. The interviews indicated that the participants found it difficult 
to imagine how others would describe them and they displayed 
inconsistencies in their suggested descriptions. The findings can be explained 
by a mentalization deficit often found in individuals with PD, and particularly in 
Borderline PD (Bateman & Fonagy, 2010). Mentalization is the ability to reflect 
upon, and to understand the state of mind of oneself and others. Mentalization 
allows us to have insight into what we are feeling and why, and it also gives 
us the ability to see behaviour as organised by mental states. Mentalization 
deficits can lead to difficulties understanding self and others (Bateman & 
Fonagy, 2010).  
 
Difficulties identifying and regulating emotions  
All participants presented with difficulties identifying and regulating emotions. 
This finding is supported by previous studies where Borderline PD patients 
have been found to exhibit high levels of alexithymia (i.e. inability to identify 
and describe emotions in the self) and have difficulty in describing their 
emotions in social situations (New et al., 2012). In the current sample, the 
participants described using negative coping strategies to manage their 
emotions, for example, substance use, self-harm and sex work. The 
substance use finding is unsurprising as research has highlighted a strong 
comorbidity between PD and substance use disorder (Trull et al., 2018). In 
fact, Hansen and colleagues (2009) found that PD indications had a 
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significant effect on both alcohol and cocaine use, but that the relationship 
was mediated by social support (Hansen et al., 2009). The use of self-harm to 
regulate emotions in PD is also well known (e.g. Turner, Jin, Anestis, Dixon-
Gordon, & Gratz, 2018). Previous studies have shown that the relationship 
between sex work and self-esteem is complex, where sex work can be 
perceived as having a positive short-term effect but in the end has a long-term 
negative effect on the individual’s self-esteem as well as their sense of self 
(Benoit et al., 2018). 
 
Dysfunctional relationships  
There appeared to be strong evidence for interpersonal difficulties throughout 
the interviews, with individuals describing finding it difficult to trust, which may 
have been associated with high expectations of others. There also appeared 
to be strong evidence for difficulties with romantic relationships, which was 
also evident by the fact that all participants but one were single. Difficulties 
with relationships are in line with the diagnostic criteria for Borderline PD. 
Research has also shown poor relationship quality and stability in couples 
when one partner suffers from Borderline PD (Bouchard, Sabourin, Lussier, & 
Villeneuve, 2009). It was interesting to note that some participants reported a 
change since the HIV diagnosis, as it can be hypothesised that participants 
due to their personality-related difficulties presented with dysfunctional 
relationships prior to the HIV as well. However, additional relationship 
stressors could be explained by mentalizing difficulties, as the capacity to 
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mentalize tend to be particularly absent at moments of high stress (i.e. around 
the HIV diagnosis) (Bateman & Fonagy, 2016).  
 
Overall Findings: After HIV diagnosis  
 
Feelings towards HIV and self before and after diagnosis  
There was evidence of difficulties with adjustment, including negative feelings 
towards self and HIV following diagnosis. It is hypothesised that neglect and 
abuse during childhood can disrupt mentalization and lead to maladaptive 
strategies to cope with trauma, leaving the capacity to mentalize vulnerable to 
being disrupted in moments of high stress (Fonagy & Luyten, 2009). Moss-
Morris (2013) proposes that early life experiences and personality will have an 
impact on adjustment, which could be seen in the current sample. According 
to Moss-Morris’ model, good psychological, physical and social adjustment 
involves less distress and interference with life roles and relationships, good 
illness management and high positive affect (Moss-Morris, 2013). Based on 
this together with the participants’ high HADS anxiety scores, suggest that 
there was poor adjustment in the sample. In fact, all participants but two 
described a high level of shame and reflected on negative emotions towards 
HIV or self. Two participants who reported a negative view of HIV prior to the 
diagnosis, described feeling like HIV had ruined them. This confirms Lazarus 
and Folkman’s model that the individual’s appraisal of the illness will have an 
impact on adjustment (Lazarus & Folkman, 1984). However, it is important to 
note that although Moss-Morris mentions personality traits in her model, there 
is no specific theory of adjustment for people with personality-related 
 131 
difficulties. The process of adjustment to HIV might be different to the 
adjustment to other health conditions.  
 
Fear and shame impacting on life with HIV 
There appeared to be strong evidence for a perceived negative impact of fear 
and shame on different aspects of the participants’ lives with HIV. The 
participants reflected on the negative impact on relationships. There appeared 
to be strong evidence for HIV disclosure being a difficult area for the 
participants, and three participants described having decided to not tell people 
about HIV due to high levels of fear and shame. Previous research has found 
that there is higher HIV disclosure anxiety in women (Holmes & Shea, 1997). 
In the current sample, both women reported very high disclosure anxiety.  
 
There appeared to be worries about how others would perceive them 
following disclosure. This is not surprising as anticipated HIV stigma is well 
documented (Earnshaw & Chaudoir, 2009). Three participants spoke about 
the negative cultural views held about HIV in the countries they were born in, 
including HIV being linked to ‘prostitution’ and immoral sexual behaviour. This 
is in line with research which has shown that HIV stigma was linked to 
culturally-held beliefs about HIV affecting people that were ‘bad’ or ‘sexually 
deviant’ (Manirankunda, Loos, Alou, Colebunders, & Nöstlinger, 2009).  
 
Evangeli and Wroe's (2017) model of HIV disclosure anxiety highlighted 
disclosure concerns some of the participants shared. The model outlines four 
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components: HIV core beliefs; a trigger event; a threat interpretation resulting 
in HIV-disclosure anxiety and processes (e.g. cognitive, affective, 
behavioural) maintaining this. It suggests that the participants’ internalised 
HIV-stigma and thoughts about the HIV diagnosis indicated in the current 
study, may predispose individuals to disclosure anxiety. The disclosure 
anxiety is heightened during specific ‘trigger events’, in the current study it 
appears that those were around sexual relationships and wanting close 
relationships with friends. As the model suggests, the high and persistent 
level of anxiety about disclosure displayed in the majority of participants in the 
current study, has an impact on the individuals’ quality of life and their social 
and occupational functioning. 
 
Difficulties managing sex following HIV diagnosis 
There appeared to be strong evidence for worries around managing safe sex 
in the sample. There appeared to be a high level of worrying about infecting 
others, where almost half of the sample reflected on having such worries 
despite being undetectable. This was particularly evident amongst females in 
the current sample which is interesting as a fear of infecting sexual partners 
despite being undetectable has been reported in a female sample (Keegan, 
Lambert, & Petrak, 2005). In the current sample, some participants indicated 
that the fear of disclosure and/or onward transmission had led to significantly 
reduced sexual activity and relationship avoidance (Hibbert et al., 2018; Peyre 
et al., 2019). On the contrary, one participant presenting with a high level of 
Narcissistic traits stated that he was not worried about managing safe sex as 
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‘you either have it [HIV] or you don’t’ (P1). This is not surprising as previous 
studies have shown that HIV-positive individuals scoring high in Narcissistic 
features had more HIV risk factors in terms of risky sexual behaviours (Martin, 
Benotsch, Perschbacher Lance, & Green, 2013). 
 
Dissatisfaction over the support received  
There appeared to be evidence for a high level of dissatisfaction over the 
support participants had received (or not received) from significant others. 
Five participants described situations where they had not felt supported. It 
was interesting to note that despite the dissatisfaction over the lack of 
support, the majority of participants had not asked significant others for 
support. This suggests that significant others may not have been aware of the 
support the participants would have wanted or needed. 
 
In terms of managing their HIV, the majority of participants reported finding 
HIV services very helpful. Three participants described depending on the 
support they receive from their HIV consultant, as they did not have anyone 
else to talk to about their difficulties. All participants but one, however, 
reflected on areas they would like to change in terms of support for their HIV, 
such as longer appointments, further information about what support they are 
entitled to, as well as more diversity in support groups.  
 
It is also worth noting the high level of ART adherence in the current sample, 
as all patients had an undetectable viral load. This may be surprising, as 
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research has indicated low levels of ART adherence in people with PD (e.g. 
Modrigan et al., 2017; Moore et al., 2012; Palmer et al., 2003). However, 
research has indicated that good patient provider relationship, which can be 
seen in the current sample, is associated with increased ART adherence (e.g. 
Beach, Keruly, & Moore, 2006). In addition, previous studies have indicated a 
strong relationship between depression and poor ART adherence (e.g. Sin & 
DiMatteo, 2014) and the current sample did not report symptoms of 
depression on the HADS.  
 
The participants did not describe themselves as having PD, despite their 
scores on self-report measures; instead the majority stated that they have 
difficulties with low mood or anxiety. This is in line with previous research 
which has suggested that individuals with PD have a poor insight into their 
difficulties (e.g. Fonagy & Bateman, 2006; Gabbard & Horowitz, 2009). It 
appeared that the participants felt less supported around their mental health 
compared to their HIV. Three participants described feeling like they had been 
deemed ‘too complex’ by services and not been offered enough therapy 
sessions or the correct treatment. Research has suggested that Borderline 
PD is often viewed negatively by mental health professionals and the general 
population, but also by individuals themselves. The negative view may lead to 
minimisation of symptoms and not receiving the best service (Aviram, 
Brodsky, & Stanley, 2006), for example by being diagnosed (or self-
diagnosed) with the wrong disorder (Richardson & Tracy, 2015).  
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The reasons behind the large discrepancy in satisfaction between HIV and 
mental health services are unknown. However, it can be hypothesised that the 
long-term, and often very boundaried, relationship with HIV services where 
clinicians take charge over treatments (e.g. ART) may be preferable to 
patients with PD. In particular perhaps when it is compared to short-term 
mental health treatments where individuals may be more encouraged to take 
responsibility for their treatment.  
 
The participants also highlighted that they would have found it beneficial to 
address their relationship and mental health issues within the HIV services 
they were seen in. This is line with previous research which has indicated that 
the intra-agency model in which all disorders are treated concurrently within a 
single treatment setting is the most effective for individuals diagnosed with co-
occurring disorders (Hendrickson, Schmal, & Ekleberry, 2004; Remien et al., 
2019). 
 
Strengths and Limitations of the Study  
Hannes’ (2011) quality assessment guide of qualitative studies helped to 
highlight the strengths and limitations of the current study. In terms of 
credibility, the internal supervisor provided feedback and regular supervision 
on the coding process and development on the model. Verbatim quotes have 
been used throughout the results section to support the coding, and negative 
cases have been highlighted. In regards of transferability, the characteristics 
of the reference population of people with HIV and personality-related 
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difficulties are unknown due to limited research. One limitation of the study 
was that it was not able to recruit participants with Antisocial PD, despite 
research indicating that it is one of the most common PDs in people living with 
HIV. However, the diverse nature of participants in the current study (e.g. 
variation in age, gender, sexuality, employment, ethnicity and time since 
diagnosis) suggests that the model could be applicable to a wide population, 
in particular in patients with Borderline PD and Narcissistic PD in high-income 
settings. All potential participants who agreed to be approached by the 
researcher after the initial conversations with HIV clinicians agreed to take 
part in the study. In terms of dependability and confirmability, regular 
debriefings with supervisor and peers as well as memo writing after the 
interviews helped the researcher to keep a self-critical reflexive stance 
throughout the research process. In addition, the research followed Elliot and 
colleagues’ proposed guidelines on good practice and quality in qualitative 
research (Elliott et al., 1999). The current study therefore appeared to meet 
the majority of the criteria according to the quality assessment guide (Hannes, 
2011).  
There is an ongoing debate regarding the numbers of interviews sufficient for 
Grounded Theory, some suggest that 12 interviews are enough and others 
believe more participants are needed for data saturation (Charmaz, 2014). It 
can therefore be assumed that the current study’s sample size is small and 
may limit the credibility of the findings. It is likely that not all categories 
reached theoretical saturation, however the majority of themes were 
consistently elicited across participants to form the Grounded Theory. 
 137 
However, due to specific inclusion criteria and research aims the study is 
more likely to have reached data saturation with a small sample.  
Due to the small size of the available population, theoretical sampling was 
restricted and all available participants were recruited. This is a limitation of 
the study as theoretical sampling is closely associated with Grounded Theory 
methodology. Theoretical sampling is thought to explore and expand the 
theory rather than validating without the risk of bias. It may therefore limit the 
credibility of the current findings.   
It is important to note that some theoretical sampling was possible. For 
example, in memo 1 (appendix H) it was reflected on the high level of anger 
displayed in the first three interviews. I queried whether this was due to the 
narcissistic traits found in the participants. Due to the limited sample, it was 
not possible to only approach specific participants, however, discussions were 
held with clinicians about traits that can be found in other personality 
disorders, e.g. Borderline PD, so they would be able to identify other PD traits 
and not only Narcissistic PD. I was subsequently able to interview participants 
who did not display Narcissistic traits but who presented with high levels of 
anger to further understand and satisfy the theme of anger.  It would have 
been useful to do this with other themes as well, such as the link between 
physical health difficulties and isolation (see memo, appendix H), however, 
due to the time restraint of a Doctoral thesis as well as the very limited sample 
this was not possible.  
 138 
A limitation of the study is that comorbidities were not assessed and excluded, 
however this is also a strength as it increased the external validity of the 
study. Another limitation was the use of self-reported questionnaire as a 
screening measure for the study. It would have been beneficial to use a 
diagnostic tool such as the SCID-5 (First, Williams, Benjamin, & Spitzer, 
2015), but due to time restrictions this was not possible. It is worth noting that 
the participants’ regular clinicians identified personality-related difficulties and 
therefore approached them about the study, suggesting that the IPDE 
screening measure was backed up by the assessment of clinicians.  
Another strength of the study was that service-user feedback was sought on 
the interview schedule prior to the interviews to ensure clarity and sensitivity 
of the questions. 
Research Implications  
The study has confirmed that personality-related difficulties impact on life with 
HIV. The study indicated several areas that appear to be affected (e.g. 
managing sex, relationship with care and substance use). Future research 
with larger samples would allow the examination of different areas of impact, 
both quantitatively and qualitatively. It would, for example, be interesting to 
explore the self-reported change in relationships in the current sample as it 
can be hypothesized that individuals presented with dysfunctional 
relationships already, prior to the HIV diagnosis. It would also be interesting to 
explore ART adherence and explore what factors contributed to this. There 
was a high level of alcohol and substance use in the current sample and two 
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participants described their substance use as a way to ‘self medicate’ their 
difficulties. However, research has indicated that there are many motivational 
processes underlying substance use and it would be useful to explore the 
function of substance use further in this population (Meyer, King, & Ferrario, 
2016). Furthermore, it would be interesting to explore the experience of 
prescription vs. non-prescription drugs quantitatively people living with PD and 
HIV.   
Larger samples would also allow comparison of different personality-related 
difficulties, such as Antisocial PD as previous research has suggested that it 
together with Borderline PD is the most common PD diagnosis in people living 
with HIV. It would allow comparisons of Cluster A and C PDs and the impact 
of these on life with HIV. In addition, very few qualitative studies with 
individuals with personality-related and health difficulties have been 
conducted and future research could examine the individuals’ relationship with 
care in other health conditions, such as cancer or diabetes.  
Clinical Implications  
The findings of the current research highlight that there are several areas 
Borderline and Narcissistic personality-related difficulties may impact on when 
living with HIV. It has been argued that the UNAIDS 90-90-90 target (90% 
people living with HIV diagnosed, 90% of these on treatment, and 90% of 
these virally suppressed) should be expanded by a fourth ‘90’ to include good 
health-related quality-of-life (BHIVA, 2018). For individuals with personality-
related difficulties, emphasis needs to be placed on the areas highlighted in 
the model to be able to ensure good health-related quality-of-life. Clinically, 
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this suggests that individuals with personality-related difficulties and HIV may 
need different support and treatment compared to individuals living with either 
HIV or PD traits.  
The participants stated that they felt supported in terms of the HIV but felt less 
supported around their mental health difficulties, which were often very 
specific to their HIV (e.g. adjustment, disclosure anxiety, worries around 
managing sex). In the British HIV Associations (BHIVA) standards of care 
(BHIVA, 2018), there is no specific guidance for people living with comorbid 
HIV and personality-related difficulties. Instead the guidance instead suggests 
that the mental health professional working with the individual should provide 
evidence-based care for the mental health problem identified, have up-to-date 
HIV-specific knowledge and an established communication channel with HIV 
services. However, this is often not the case. The participants in the current 
sample reported limits to the service offered at specialist HIV psychology 
services (e.g. short-term therapy, limited evening appointments). Instead they 
attended private clinics or secondary-care mental health difficulties. However, 
many of the difficulties experienced in the current sample were related to the 
HIV, which may not be addressed in a non-specialist service and goes against 
the suggestion of an intra-agency model (Hendrickson et al., 2004). 
Although the National Institute for Health and Care Excellence (NICE) 
guidelines for Borderline PD emphasis the need to also focus on the physical 
health of the individuals, there is no specific guidelines for treatment of 
comorbid PD and physical health difficulties (NICE, 2015). This is surprising 
as Dixon-Gordon et al. highlighted that personality-related difficulties were 
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associated with poorer short-term cognitive behavioural therapy outcomes in 
a randomized trial for patients with unexplained physical symptoms (Dixon-
Gordon et al., 2015), suggesting that PD may complicate the treatment of 
medical problems. The authors explored various mechanisms for why PD may 
result in poorer health outcomes and suggested that biological vulnerabilities 
(e.g. health difficulties), behavioural risk factors (e.g. overeating, smoking and 
substance use) and environmental factors (e.g. insufficient medical care, poor 
social and occupational functioning) that may influence the individual’s health 
outcomes (Dixon-Gordon et al., 2015). Further exploration of mechanisms 
underlying the negative impact of personality-related difficulties in HIV is 
needed.  
The NICE guideline for Borderline PD states that evidence base for 
psychological therapies in the treatment of Borderline PD is relatively poor 
(NICE, 2009). However, the guideline specifically suggests that Dialectical 
Behaviour Therapy (DBT) and Mentalization Based Therapy (MBT) are 
effective in reducing suicide attempts and self-harm, anger, aggression and 
depression. MBT also reduces anxiety and overall Borderline PD 
symptomatology and improves employment and general functioning, whereas 
DBT is effective in reducing self-harm in women. The guideline recommends 
that rather than outpatient therapy offered in isolation (which is the norm in 
HIV psychology services), individuals should be seen within a structured 
programme where the individuals with Borderline PD has other inputs and 
access to support between sessions (NICE, 2009). 
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On the contrary, the BHIVA guidelines highlights that there has been a shift 
towards more self-management and/or primary care low intensity treatment 
for people living with HIV. The current study suggests that there are many 
barriers for effective treatment that might not be able to be addressed in 
primary care services. Individuals with more severe and enduring difficulties, 
such as personality-related difficulties, may need a more specific pathway in 
place to ensure early detection and long-term support, as well as possible 
referral to appropriate services if HIV psychology services are unable to 
address their needs. It will also be important to keep in mind the interpersonal 
difficulties found in this client group, so an emphasis needs to be placed on 
the communications between services to ensure adequate support for the 
patients, but also to prevent splitting (i.e. the division or polarization of teams 
into good and bad by focusing selectively on their positive or negative 
attributes) between services. A preferable option, due to the high prevalence 
of PD in HIV, would be to introduce specific PD pathways in HIV services 
offering tailored support to individuals with this common comorbidity.  
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Integration, impact and dissemination 
 
Integration  
The systematic review provided a clear rationale for the empirical project and 
assisted this research. The literature within the review highlighted that there is 
a high prevalence of personality-related difficulties in HIV and this often leads 
to a high level of impairment and many additional issues. The existent 
literature provided a clear rationale for the systematic review, which focused 
on the prevalence and associations of personality disorders (PD) in HIV, but 
also the empirical piece, which focused on the impact of personality-related 
difficulties when living with HIV. The review informed the development of the 
empirical article.  
 
The systematic review provided an up to date summary of prevalence rates 
and associations of PD in people living with HIV. The high prevalence rate of 
PD in HIV across different samples and settings indicated that this common 
comorbidity needed to be explored further. To my awareness there had not 
been a review investigating the associations of PD in HIV. The findings 
highlighted that the associated variables assessed can be grouped into five 
categories: socio-demographic variables, substance use, mental health, high-
risk sexual behaviours, and health-related factors. The review findings were 
relevant to the empirical project as they informed areas to be further explored 
(e.g. symptoms of mental health, substance use and support)   
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The majority of the areas highlighted by the review were incorporated within 
the mood and demographics questionnaires used in the empirical study (e.g. 
substance use, mood, socio-demographic variables and physical health). The 
associated variables highlighted by the review also informed the interview 
guide as the findings indicated areas that may be impacted when living with 
PD and HIV. For example, the review highlighted that substance use and 
mental health difficulties are associations of PD in HIV. The empirical project 
therefore incorporated questions on substance use and mood in the 
demographic questionnaire as well as highlighted these areas to be explored 
in the qualitative interview.  
 
Reflections upon recruitment  
The review highlighted the need to explore personality-related difficulties in 
people living with HIV in a diverse sample to increase the transferability of 
findings. The empirical study planned to use theoretical sampling, however, 
challenges with recruitment for the empirical project presented themselves 
early on. The first challenge was securing recruitment sites.  Originally, the 
study had intended to recruit from both HIV clinics and PD services. Due to 
small number of HIV-positive patients, as well as reconstructions being under 
way and a described lack of capacity at many PD services, no PD service was 
able to act as a recruitment site. It was therefore decided to focus recruitment 
from HIV health clinics and HIV psychology services. Five HIV services were 
approached and four of these expressed interest in the study. In the end, one 
recruitment site failed due to lack of availability of rooms. The two HIV 
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psychology sites were very involved during the start-up phase of the project. 
However, when recruitment was due to commence they voiced concern about 
speaking to patients about the project, and especially around discussing 
potential PD traits. I responded to this by attending further meetings at the 
recruitment sites together with my academic supervisor. During the meetings 
we provided guidance on risk and background information on PD for the sites, 
as well as made it clear that participants were not going to be given a PD 
diagnosis. It was also agreed that I would change the title of the study from 
“personality-related difficulties in people living with HIV” to “longstanding 
emotional and relational issues in people with HIV” as clinicians stated that 
they would find it easier to talk to potential participants about emotional and 
relational issues instead of personality difficulties. During the meetings it was 
also agreed that the recruitment would focus on patients already diagnosed 
with PD at one of the sites. The other site would only approach potential 
participants where interpersonal difficulties had been spoken about in therapy 
(i.e. in more relational therapy modalities such as Cognitive Analytic Therapy) 
and only when it was deemed the right time during the therapy.  
 
In the end the recruitment failed at the latter site and only one participant was 
recruited from the first site. I responded to the challenges in recruitment by 
focusing and recruiting from one HIV clinic. This meant that most participants 
were sourced from one recruitment site. Recruitment was more successful 
here as clinicians were able to identify patients presenting with personality-
related difficulties and they felt able to approach the suitable candidates about 
the study. Recruitment from this one specific site limited the transferability of 
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the results but meant that I could recruit the number of participants needed for 
the study.  
 
The difficulties in securing recruitment sites and the extra meetings caused 
delays in starting recruitment, which had a knock-on effect throughout the 
project. Once recruitment could commence it became clear that it was difficult 
to recruit a sample. It was found helpful to be available on site during HIV 
clinics to answer questions from HIV consultants and nurse practitioners as 
well as to remind staff about the project. It was also helpful to be available for 
potential participants so they could ask any questions they may have prior to 
deciding whether they wanted to participate in the study.  
 
In the end, I found it useful to recruit the majority of participants from one site. 
I found the interviews very challenging, often involving high level of emotions 
(e.g. anger and sadness) and many of the participants presented with risk to 
self. It was therefore helpful to have a good working relationship with the 
service and an understanding of how the service worked with risk. There was 
always a clinician available for a quick debrief/check in after the appointment 
so they could be notified about any concerns. However, it may be worth 
noting that I was often not informed of risk issues prior to the interviews, which 
made the conversations challenging and I sometimes had to resort to risk 
management instead of focusing on the interview questions.  
 
In terms of my own experiences around recruitment, I found the interviews 
very interesting but challenging. I often reflected on the experiences I brought 
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to the study. I am female, Swedish, 30 years old, bisexual and born with a 
hand deformity. I think this helped me understand some of the issues facing 
those living with HIV such as stigma/discrimination, concerns around 
disclosure and adjustment of living with a condition. However, I also 
recognised how some of the participants may consider some of our 
differences (e.g. being female, young and of white ethnicity) and find it difficult 
to open up about some of their difficulties they faced (e.g. managing sex, 
racism).  
 
During the recruitment phase I was on placement in a PD service, which 
helped me manage the high level of distress, sadness and anger often 
displayed by the participants. However, it also made me more aware of the 
difference in seeing patients presenting with similar difficulties on placement 
and during my interviews. In a specialist PD service, we manage the high 
level of risk and challenging dynamics as a team. We often assess and 
interview patients in pairs and have regular debriefs and meetings to discuss 
the presenting difficulties but also the countertransference (i.e. the emotions 
raised in us). I found it difficult to not work as part of the treatment team while 
conducting the interviews, although it is important to note I felt supported in 
terms of risk issues. I also found it difficult to manage being both a researcher 
and a clinician, to not resort to only being a clinician and try to manage the 
patients’ difficulties and safeguarding concerns, but also to focus on the 
interview guide and conduct the research. In terms of the countertransference 
and the negative feelings I often was left with, I found it helpful writing memos 
following the interviews and engaging in regular debriefs with the academic 
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supervisor and peers. It often left me wondering how staff felt following their 
appointments with this patient group (discussed further below).  
 
Reflection upon service user involvement  
According to Arnstein’s (1969) ladder of participation, there are different levels 
of service-user involvement. These range from ‘no control’ (i.e. service users 
being passive consumers) to ‘full control’ (i.e. service users control decision 
making at the highest level). In the current research study, service users were 
not involved in the development of the systematic review and therefore were 
in the ‘no control’ area of the ladder of participation. For the empirical piece, 
service user feedback was used to assist development of the participant 
information sheet as well as the interview guide. According to Arnstein’s 
ladder of participation, this suggests that the current study sits at the 
‘participation’ levels, i.e. service users made suggestions and influenced 
outcomes (Arnstein, 1969). 
 
Service user feedback was sought from patients at HIV clinics and from 
university links at a recovery college. Two individuals, one with a HIV 
diagnosis and one with a PD diagnosis, were happy to give feedback on the 
participant information sheet and interview guide. They were asked to give 
feedback in terms of the clarity, relevance, comprehensiveness, as well as 
being asked for any other comments. Their feedback led to adaptations to the 
order of questions and language used. More attention was also paid to 
positive experiences with services and relationships. Service users were sent 
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the final questionnaire so they were informed of the influence their feedback 
had made. Due to time constraints and a small sample size, further feedback 
and opportunity for more service user involvement was limited. In addition, it 
would have been preferable to consult service users prior to the development 
of the draft versions so that the service user involvement would have driven 
the development of the information sheet and interview guide.  
 
According to the Department of Health’s (2005) research strategy, the 
empirical article met some of the aspects by involving service users in the 
design and reporting of research. Due to time constraints, service users were 
not involved in the analysis stage of the research. It would have been useful 
to consult service users about the theoretical themes and in the development 
of the model to add to my own understanding and interpretation of the data.   
 
Impact 
HIV remains a major public health concern with 1.8 million new diagnoses in 
2016 worldwide (WHO, 2017). It has been estimated that there are 36.7 
million people in the world (WHO, 2017) and 102 000 people in the United 
Kingdom living with HIV (Public Health England, 2017b). Although there has 
been an increasing amount of research exploring the mental health of people 
living with HIV, very limited research has explored the link between 
personality-related difficulties and HIV. The current review and empirical 
research have investigated the relationship between personality-related 
difficulties and HIV. This research contributes knowledge regarding the 
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prevalence and associations of PD in HIV, but also indicates areas affected 
by the diagnosis where individuals may need extra support.  
 
Potential Beneficiaries 
The potential beneficiaries of this work are a) individuals with personality-
related difficulties and HIV b) friends and family of these individuals c) HIV 
clinicians d) clinical psychologists and other mental health staff e) GP and 
A&E staff f) support organisations and peer groups g) policy makers h) 
researchers. 
 
Individuals with HIV and personality-related difficulties  
The findings of this research could potentially have an impact for individuals 
with personality-related difficulties and HIV. Only one participant reported they 
had a diagnosis of PD, whereas the majority described mixed anxiety and 
depression symptoms. This is in line with previous research suggesting that 
individuals with PD have poor insight into their difficulties (Gabbard & 
Horowitz, 2009). By increasing the individuals’ awareness, that is, either that 
the symptoms are line with a PD diagnosis or an explanation associated with 
that diagnosis (e.g. in schema/CBT/CAT model of Borderline PD) the service 
users may be able to have a greater understanding and acceptance of why 
they are feeling as they do (e.g. Fonagy & Bateman, 2006). In addition, it 
could lead to extra support being put in place.  
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The situated Information-Motivation-Behavioural skills (IMB) model suggests 
that information (i.e. clinician and client have knowledge about difficulties), 
motivation (i.e. clinician and client are motivated to seek/refer for treatment) 
and behavioural skills (i.e. treatment is available and clinician/client know how 
to access it) are needed to engage in a healthy behaviour such as engaging 
in treatments (Rivet Amico, 2011). By helping to ensure that relationships are 
discussed during their consultations in HIV services, there will be ‘information’ 
(and perhaps ‘motivation’) according to the IMB and the service users will be 
more likely to be referred to targeted treatments (e.g. mentalization based 
therapy; Bateman & Fonagy, 2010) if available. 
 
The study hopes to increase the participants’ and supporting staffs’ 
awareness of areas that may be impacted when living with personality-related 
difficulties and HIV. This would hopefully mean that service users would be 
able to access the right support. Borderline PD patients often have very poor 
insight into their difficulties (Fonagy & Bateman, 2006; Gabbard & Horowitz, 
2009).By increasing service users’ awareness that the use of alcohol and 
substances is a way to ‘self-medicate’ and manage negative emotions, or that 
mentalization deficits may lead to interpersonal difficulties, it may lead service 
users to being more willing to access support. Another area is the impact of 
personality-related difficulties on the adjustment to the HIV diagnosis. By 
increasing service users’ and health care staffs’ awareness of the impact of 
personality-related difficulties on adjustment and how the individual’s view 
themselves following the diagnosis, it may normalise the experience for 
service users as well as facilitating access to support from services.  
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A short summary of the key findings written in lay language will be provided 
for the participants in the study as well as for other attendees of the 
participating HIV-services. A poster of the key findings will also be placed in 
HIV clinic waiting rooms. In addition, the summary will be distributed to HIV 
websites such as the Terrence Higgins Trust and Body & Soul. The summary 
aims to inform participants and other non-professionals of the result of the 
study.  
 
Friends and family of individuals  
The significant others of people with HIV and personality-related difficulties 
may also benefit from the research, as it may increase their awareness of 
some of the challenges this population face. Findings will be distributed to 
family and friends of individuals through posters in HIV clinic waiting rooms 
and HIV websites.   
 
HIV clinicians  
The findings of this research could potentially have an impact for HIV 
clinicians working with this patient group. The result from the systematic 
review indicates that there is a higher prevalence of PD in people living with 
HIV compared to the healthy population. This suggests that clinicians at HIV 
services are very likely to see patients with PD. Although the empirical study 
showed that the participants often felt supported by HIV services, it is still 
important to think about HIV clinicians as beneficiaries of this study. By 
 153 
increasing services awareness of the high proportion of patients with PD that 
present to their services, it may motivate training initiatives. Training has been 
found to increase clinicians empathy, improve their attitudes toward patients 
with Borderline PD and their desire to work with them (Shanks, Pfohl, Blum, & 
Black, 2011).  
 
During the set up stage of the current project, clinicians voiced their anxieties 
over treating patients with a PD diagnosis. This is in line with previous studies 
that have highlighted that individuals with PD often are challenging to treat 
(e.g. Kaplan, 1986; Willinger, 2010). In line with this, I found the interviews 
challenging and was often left with negative feelings afterwards and it left me 
thinking about the impact on the treatment team and the HIV clinicians that 
see the individuals on a regular basis. 
 
In terms of countertransference, clinicians often feel strong negative feelings 
when treating individuals presenting with personality-related difficulties (Colli 
& Ferri, 2015). Clinicians might feel overwhelmed with patients’ behaviour or 
the responsibility they feel caring for the patient. In addition, they might feel 
expected to provide ideal care and be left feeling ‘not good enough’. It is also 
common to feel fearful and anxious about patients’ wellbeing. By summarising 
and disseminating the key findings across both review and empirical findings 
for HIV clinical staff, it could facilitate a discussion around the 
countertransference clinicians may feel treating this population. This would 
help normalise some of the negative feelings for clinicians and increase their 
awareness of the common difficulties often found in the relationship with this 
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client group. The project may also be able to highlight areas that staff may 
need extra support when treating this patient group. For example, it is 
important for staff involved with patients presenting difficulties to take care of 
themselves, which can be through recognising strong emotional reactions and 
ensuring that there is support available to discuss these reactions and share 
the load. It is also helpful to stick to agreed boundaries and treatment plans as 
much as possible, for example by setting limits, be clear of intentions and 
limits of service and keeping a consistent and non-judgmental approach (e.g. 
Saper & Lake, 2002).  
 
Increasing the HIV clinicians’ understanding of the difficulties individuals may 
face when living with personality-related difficulties and HIV will also help 
them discuss certain areas with patients during consultations. Disseminating 
findings through presentations at team meetings with the involved HIV 
services and to the wider HIV community (e.g. at BHIVA) would also allow 
feedback on what elements of study could potentially be most useful to other 
clinicians and services.  
 
Clinical psychologist and other mental health staff 
The findings from the empirical study could have an impact on clinical 
psychologists and other mental health staff. Prior to the current study, very 
limited research had explored the impact of personality-related difficulties 
when living with HIV. The results from the systematic review highlighted 
settings where personality-related difficulties are more common, indicating 
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settings where PD should be explored and assessed further. In addition, the 
review highlighted common associations of PD and HIV (for example 
substance use and other mental health difficulties), which will be important for 
mental health staff to further assess when working with individuals from this 
patient group. As mental health care for HIV patients move towards primary 
care and/or self-management (British HIV Association, 2011), summarising 
and disseminating the key findings across both review and empirical findings 
will increase non-HIV specialist psychologists’ and other mental health care 
staffs’ understanding of areas that might be affected when living with HIV and 
personality-related difficulties. In addition, the model developed in the 
empirical study could be used to further explore the areas identified in 
individuals living with personality-related difficulties and HIV. The model can 
also be used as basis for a formulation of the individual’s presenting 
difficulties to be able to further understand the relationship between 
personality-related difficulties and life with HIV.  
 
GP and A&E Staff 
GP and A&E staff are other potential beneficiaries of this research. It may be 
helpful for these healthcare professionals to be more aware of the 
experiences of individuals presenting with personality-related difficulties and 
HIV, as having more knowledge about the difficulties they may experience 
could help them support and work clinically with this population. Findings 
could be disseminated through factsheets highlighting the key findings. It may 
be that GP and A&E staff are not aware of some of the difficulties highlighted 
in the empirical study and by increasing their awareness it enables clinicians 
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to understand the individual’s difficulties further. In addition, it may help GP 
and A&E staff to manage interpersonal difficulties with this client group as well 
as crisis management. Helping to give clinicians a focus when having these 
conversations could help to ensure effectiveness and is crucial given current 
resource and time-limited service settings.  
 
Support organisations and peer groups  
Support organisations (e.g. the Terrance Higgins Trust) and peer groups 
organised by voluntary organisations offer information, support and guidance 
to individuals with HIV.  The current findings could be used for these 
organisations to help support individuals living with the diagnosis. For 
example, factsheets containing the key findings could be sent to group 
facilitators and counsellors working for these organisations to increase their 
awareness of areas affected. Overall, this would help these organisations to 
support service users during different phases of life with HIV.  
 
Policy makers 
The research may have a positive impact on policy makers, such as BHIVA, 
WHO and NICE. The British Psychological Society (BPS) and the British HIV 
Association (BHIVA) jointly suggested a stepped care model of psychological 
support for adults living with HIV. However, there are currently no guidelines 
for support and treatment for individuals living with HIV and personality-
related difficulties.  According to BPS and BHIVA model (2011), individuals 
with HIV and personality-related difficulties should be seen by ‘mental health 
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specialists’. The guidance also specifies that if the mental health professional 
is not based within the HIV service, they should have up-to-date HIV 
knowledge and established communication with a HIV service (BHIVA, 2011).  
 
The National Institute for Health and Care Excellence (NICE) guidelines 
states that evidence base for psychological therapies in the treatment of 
Borderline PD is relatively poor (NICE, 2009). The guideline recommends that 
rather than outpatient therapy offered in isolation (which is the norm in HIV 
psychology services), individuals should be seen within a structured 
programme where the individuals with Borderline PD has other inputs and 
access to support between sessions (NICE, 2009). The guidelines conclude 
that the state of knowledge about the treatments available for Borderline PD is 
in a development phase and further research needs to be undertaken before 
stronger recommendations can be made about specific treatments.  
 
The empirical piece highlighted that personality-related difficulties have a 
large impact on life with HIV and that individuals may need further support 
from services. Therefore, the current study’s findings could be outlined and 
summarised to provide helpful suggestions as to how guidelines can be 
written to support individuals living with HIV and personality-related difficulties. 
One example of this is to incorporate some of the principles of care for people 
with PD being seen as PD services, such as working closely as a team 
supporting the individual, setting limits, be clear of intentions and limits of 
service and keeping a consistent and non-judgmental approach (e.g. Kendall 
et al., 2009). 
 158 
Researchers  
Findings highlighted prevalence and associations that may be related to life 
with PD and HIV. It also highlighted the impact of personality-related 
difficulties in people living with HIV. This could inform researchers’ future 
investigation of the relationship between the two disorders. Future research 
with larger samples would allow the examination of different areas of impact, 
both quantitatively and qualitatively. It would also be interesting to explore 
ART adherence further as the findings of the current study contradicted 
previous studies suggesting poor adherence in individuals with PD. 
Furthermore, there was a high level of alcohol and substance use in the 
current sample and two participants described their substance use as a way 
to ‘self-medicate’ their difficulties. It would be interesting to explore the 
experience of prescription vs. non-prescription drugs quantitatively in this 
population. Larger samples would also allow comparison of different 
personality-related difficulties, such as Antisocial PD as well as Cluster A and 
C PDs, and the impact of these on life with HIV. 
 
Maximising Impact 
To maximise the impact of findings for clinicians, the results highlighted by the 
review and empirical article could be used to help prompt questions during 
assessments and consultations. For example, the review highlighted common 
associations that will be important for clinicians to assess further during 
consultations with this population. The empirical piece highlighted areas 
commonly affected by personality-related difficulties when living with HIV. 
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Clinicians could then focus conversations on these specific areas. Alongside 
the discussions, the areas could be highlighted when thinking about care 
plans and treatment for the individuals, supporting individuals to identify and 
cope with the difficult situations better (e.g. adjusting to diagnosis, managing 
safe sex, disclosure, relationships and support with significant others and 
health care staff).  
 
Dissemination 
It is planned that the current research will be made more broadly available by 
publishing results in a journal article. It is hoped that both the review and 
empirical study will be published in an academic journal (e.g. Clinical 
Psychology Review and AIDS & Behaviour). The aim of this is to disseminate 
the findings of the research to clinicians and academics specifically working 
within the HIV-field to increase awareness of the impact of personality-related 
difficulties when living with HIV. Alongside this, the empirical abstract will also 
be submitted to the 2019 AIDS Impact conference. By disseminating the 
research findings in this way, researchers working in the field of HIV research 
could become aware of the study’s findings.  
 
To facilitate dissemination to clinicians it is planned that I will attend team 
meetings to present key findings. It may be that clinicians are not aware of 
some of the challenges presented in the empirical article and by increasing 
their awareness it enables clinicians to have the necessary conversations with 
patients around how to manage the difficulties raised in the research before 
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they become a problem (e.g. how to manage safe sex). To help clinicians 
incorporate the information into their clinical practice, a summary will be made 
which outlines key findings. This could include a summary of areas for health 
care staff to assess further during consultations. A brief summary or checklist 
may make it easier to translate key findings into consultations and 
assessments with service users. To make sure the clinicians find the 
summary useful, feedback will be sought prior to delivering feedback about 
what they think would be helpful to their practice. Feedback from team 
members will be important as the impact of the study will be maximised if the 
clinicians find the summarised information useful and feel able to incorporate 
it during consultations.  
 
It is planned that I will disseminate the key findings written in lay language to 
the service users participating in the research. Disseminating findings with 
participants would allow feedback on what elements of the study could 
potentially be most useful to other service users. Once this has taken place, 
the feedback will be incorporated and findings will be disseminated at the 
participating services as well as relevant service user forums. Lastly, it is 
hoped that by developing and establishing relationships with multiple potential 
beneficiaries this will help to maximise the impact of the current study. For 
example, it is planned that I will present the findings to the PD service I am 
currently based in.  
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Evidencing Impact 
As previously discussed, effective disseminations will lead to increased 
awareness as well as changes in the clinician’s clinical practice. To be able to 
demonstrate that these activities have been achieved the impact will need to 
be evaluated. To explore the usefulness of my attendance at staff meetings 
and the information sheets given, it will be important for staff to be able to give 
anonymous feedback. The feedback could be given online through distribution 
of an online questionnaire, which could be circulated via email. The questions 
could include asking whether they felt the information had increased their 
awareness at the time of the meeting, but also whether the information had 
influenced their practice at a later date. It would also be useful to explore the 
staff’s experience of incorporating the key findings into practice qualitatively at 
a later time point.
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Appendices 
 
Appendix A: Interview Schedule  
 
IRAS Project ID: 243185 
Version: 3 
Date: 16/07/2018 
 
1. How would other people describe you?  
 How would you describe your relationships with others?  
 How would you describe how you cope with difficult 
situations/interactions with others? 
  
2. What was your life like prior to your HIV diagnosis?  
 Has your life changed since diagnosis? 
 E.g. relationships, education, employment, interests 
 Can you tell me what it was like when you received your HIV 
diagnosis?  
 How long do you think you were positive until diagnosis? 
 Optional: What factors do you think led you to receive a HIV 
diagnosis?  
 
3. How have you felt about being HIV positive since your diagnosis?  
 How does living with HIV affect your life now (e.g. anger/guilt/future 
thinking/hope/goals)?  
 How do you think the diagnosis has impacted on your relationships?  
 Has the HIV diagnosis changed the way you see yourself (e.g. 
stigma/shame)?  
 Do you have any concerns about your future? Relationships?   
 
4. How do you manage your emotions (e.g. sadness, anger)?  
 What strategies do you use to cope with your emotions? Helpful?  
 Have you noticed you experience different emotions since diagnosis?  
 How do you manage stress/difficulties around your HIV diagnosis?  
 
5. How were your relationships with partners, friends, family and sexual 
contacts before diagnosis?  
 How are they now after diagnosis?  
 Have your relationships changed since your HIV diagnosis?  
 How do you feel about how other people have reacted to your HIV 
diagnosis?  
 Have you had any positive or negative experiences of sharing your 
HIV status? How did you manage this?   
 How do you feel about your decisions to disclose or not disclose?   
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 Have you noticed a difference in how people react towards you since 
the diagnosis?  
 
6. How would you describe your part in relationships in your life now? 
 With partners, friends, family, sexual contacts? 
 Have you noticed any patterns in your relationships?  
 Would you like anything to be different in your relationships? 
 Optional: Manage sexual contacts/Grindr/other apps 
 
7. Tell me about your experiences with 
therapists/counsellors/psychologist/MH professionals? 
 How have you experienced care from HIV services?  
 How have your relationships been with health care staff?  
 How have you felt supported?  
 Are there times you have not felt supported?  
 Would you have liked anything to be different?  
 Have you noticed a difference in the healthcare you receive?  
 
8. How do you think your HIV affects your ability to have close 
relationships?  
 What difficulties have you had with keeping close relationships in your 
life?  
 What do you think makes it difficult to keep close relationships?  
 
In a minute we’ll be coming to an end but I’d just like to ask… 
 
9.  Do you have any suggestions for services working with clients with 
longstanding emotional and relational difficulties who are diagnosed with 
HIV?  
 Do you have any suggestions in how services could have better 
supported you with these difficulties? 
 Are there times when services have been able to support you well?  
 
10. I’ve come to the end of everything I want to ask, is there something else 
you feel is important? 
 
 
 
 
Debrief:  
 
We are now coming to an end of the interview. How have you found talking to me?  
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Appendix B: Demographic questionnaire  
 
What is your age?  
 
 
___________________________ 
  
Which gender do you identify as?  
 Female 
 Male 
 Other 
 Prefer not to say  
 
Which ethnic group best describes you?  
 Asian 
 Black 
 Mixed 
 White 
 Other: ____________________ 
 
What is your country of birth?  
 
 
___________________________ 
 
What is the highest degree or level of school you have completed? 
 CSE/O-levels or equivalence  
 GCSE or equivalent  
 A-levels or equivalent 
 Undergraduate degree 
 Masters degree 
 Doctorate or other postgraduate degree 
 Other: ____________________ 
 
How would you describe your current employment status? 
 Employed full time 
 Employed part time 
 Unemployed  
 Student 
 Other: ___________________ 
 
What is your relationship status?  
 Single 
 In a relationship and living together 
 In a relationship and not living together  
 
How would you describe your sexual orientation?  
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 Bisexual  
 Gay  
 Heterosexual  
 Lesbian 
 Other: ______________________ 
 Prefer not to say  
 
What is your living situation?  
 Living alone 
 Living with partner 
 Living with parents 
 Living with friends  
 Other: ____________________ 
 
Do you currently take any medication? 
 Yes, please specify: _______________ 
 No 
 Prefer not to say  
 
Do you have any other health conditions?  
 Yes, please specify: __________________ 
 No 
 Prefer not to say  
 
When did you receive your HIV diagnosis?  
 
 
____________________________ 
 
In which country did you receive your HIV diagnosis?  
 
 
____________________________ 
 
What was your CD4 count at diagnosis?  
 
 
____________________________ 
 
What is your current CD4 count? 
 
 
____________________________ 
 
What is your current viral load? 
 
 
____________________________  
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Do you have any (current or past) mental health difficulties?  
 
 
___________________________ 
 
 
Have you engaged in talking therapies?  
 
 
 
___________________________ 
 
 
How many units of alcohol do you consume per week?  
 
 
___________________________ 
 
 
In the past 12 months have you used any non-prescribed recreational drugs?  
 
 
___________________________ 
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Appendix C: HADS 
Directions 
 
Please read every sentence. Circle the answer that best describes how you have been 
feeling during the LAST WEEK.  
 
You do not have to think too much to answer. In this questionnaire, spontaneous 
answers are more important. 
 
1. I feel tense or ‘wound up’:        A 
Most of the time   3 
A lot of the time   2 
From time to time, occasionally 1   
Not at all     0 
 
2. I still enjoy the things I used to enjoy:       D 
Definitely as much   0 
Not quite as much   1 
Only a little    2 
Hardly at all     3
    
3. I get sort of frightened feeling as if something awful is about to happen:  A 
Very definitely and quite badly 3 
Yes, but not too badly  2 
A little, but it doesn’t worry me 1 
Not at all    0 
 
4. I can laugh and see the funny side of things:      D 
As much as I always could  0 
Not quite as much now  1 
Definitely not so much now  2 
Not at all    3 
    
5. Worrying thoughts go through my mind:      A 
A great deal of the time  3 
A lot of the time   2 
From time to time, but not often 1 
Only occasionally   0 
      
6. I feel cheerful:          D 
Not at all    3 
Not often    2 
Sometimes    1 
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Most of the time   0  
  
7. I can sit at ease and feel relaxed:       A 
Definitely    0 
Usually    1 
Not often    2 
Not at all    3
      
8. I feel as if I am slowed down:        D 
Nearly all the time    3 
Very often    2 
Sometimes    1 
Not at all    0 
   
9. I get a sort of frightened feeling like “butterflies” in the stomach:   A 
Not at all    0 
Occasionally    1 
Quite often    2 
Very often    3 
 
10.  I have lost interest in my appearance:       D 
Definitely    3 
I don’t take as much care as I should 2 
I may not take quite as much care 1 
I take just as much care  0 
 
11. I feel restless as I have to be on the move:       A 
Very much indeed   3 
Quite a lot    2 
Not very much  1 
Not at all    0 
 
12. I look forward with enjoyment to things:      D 
As much as I ever did  0 
Rather less than I used to  1 
Definitely less than I used to 2 
Hardly at all    3 
 
 
13. I get sudden feelings of panic:         A 
Very often indeed   3 
Quite often    2 
Not very often   1 
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Not at all    0 
 
 
14. I can enjoy a good book or radio/TV program:     D 
Often     0 
Sometimes    1 
Not often    2 
Very seldom    3 
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Appendix D: International Personality Disorder Examination 
 
 
Not included due to copyright restrictions 
 183 
Appendix E: Participant Information Sheet  
 
Patient information sheet 
 
Project title: Longstanding emotional and relational issues in people with HIV  
 
IRAS Project ID: 243185 
Version: 6 
Date: 26/11/2018 
 
You have been asked to participate in a study carried out by Emma Larsson, 
Trainee Clinical Psychologist at Royal Holloway, University of London, in 
collaboration with X (removed due to confidentiality) and X (removed due to 
confidentiality). 
 
Invitation: 
This research study is trying to understand how the challenge of managing 
emotions and difficulties with forming and maintaining relationships affect 
individuals living with HIV. Before you decide if you want to take part it’s 
important that you understand why this study is being carried out and what will 
happen if you take part. Please read this sheet carefully.  
 
If you want to discuss the study with a member of clinic staff or someone close to 
you before making a decision about taking part, please feel free to do so. You can 
also ask Emma any questions you might have about the study.  
 
Email:   emma.larsson1@nhs.net  
Telephone:   01784 414 012 (this is the university answer machine, you 
will be asked to say whom the message is for and to leave your name and contact 
details so that Emma can call you back). 
 
What is the study about?  
People’s early life experiences and personality traits influence how they cope 
with the demands of everyday life, which can include how they adapt to living 
with a life-long illness.  Some individuals may struggle with making and keeping 
close relationships by, for example, getting into very intense relationships that 
don’t last, or being very private, finding it hard to open up and trust people they 
don’t know very well.  This could happen with family, friends or people at 
work.  Some individuals may describe feeling ‘empty’ inside, or describe their 
feelings as always changing.  Others take chances, can be impulsive and find it 
hard to keep out of trouble.  Sometimes people find it hard to describe who they 
are or what is important to them, almost lacking a sense of identity.  
  
We would like to find out more about how these difficulties can have an impact 
on living with HIV. We believe our findings may help develop better support and 
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services for people living with HIV. The study forms part of a Royal Holloway 
University Doctoral thesis research project.  
Who can take part in the study?  
You have been invited to participate due to having been seen at X (removed due 
to confidentiality). Healthcare professionals in these services have been asked to 
invite people that they have met who they think would be suitable for this study.  
 
You have been approached to participate because you, together with your 
clinician, have discussed some of the difficulties mentioned in the above section. 
To participate in this study you must complete a questionnaire to see whether 
you are eligible. If you would like to meet with Emma to speak about the details 
of the study and see whether you are eligible please contact her on the contact 
details above or speak to your clinician at the clinic.  
 
Do I have to take part?  
This study is separate to any healthcare that you may be receiving from the clinic 
and taking part is entirely voluntary. You may withdraw from the study at any 
time, without giving a reason. If you withdraw from the study, however, the data 
collected will be kept in the study. If you decide to take part (or not) this will not 
affect the standard of your care in anyway. 
 
What will happen in the interview?  
Emma (who is a Trainee Clinical Psychologist) will meet you in a private room to 
answer any questions you may have about the study.  
 
If you decide to participate, you will firstly be asked to complete a brief 
questionnaire to see whether you are eligible to take part in the study. If you are 
eligible to take part, you will be given the option to be interviewed that day, or to 
attend at a more convenient date for you. The interview will take approximately 
60 minutes and will be in a private room either at the clinic you attend or at 
Royal Holloway University. 
 
At the start of the interview, Emma will ask you to complete a short 
questionnaire about your mood. The interview will then take place, beginning 
with some questions about your life with HIV as well as asking questions about 
relationships and other parts of your life. Emma will also ask some general 
questions about yourself (e.g. age, ethnicity and occupation). With your consent 
the interview will be audio recorded. This is to make sure that no important 
information is missed. To allow you to be able to speak freely, we ask that you 
attend the interview alone.  
 
The consent form also asks your permission for Emma to access your medical 
records to collect some basic information about your HIV (CD4 count, viral load 
and medication). The information is needed to further understand your health 
and well-being. 
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Will the interview be confidential?  
Yes the interview is confidential. In very rare cases, if you say something during 
the interview that suggests that you or someone else might be at risk of serious 
harm, Emma may need to speak to your clinical team so that they are able to 
provide you with support. This would be discussed with you first.  
 
The interview will be audio recorded so that it can be transcribed (written out) 
and analysed at a later date. The recording will be deleted once it has been 
transcribed. The transcribed data will be stored as a word document in a 
password protected folder on a computer that is also password protected. The 
consent form, which we will ask you to sign if you decide to take part in the 
study, will be kept in locked filing cabinets at the clinic and will be kept for two 
years after completion of the study and then destroyed.  
 
What are the risks of taking part?  
Some people might find talking about their relationships and diagnosis of HIV 
difficult, or in some cases upsetting. You will be given the opportunity to reflect 
on your experience of the interview immediately afterwards with Emma. If you 
feel that you need to speak to someone else after this meeting, suggestions will 
be made to help you with this. 
 
What are the benefits of taking part?  
You may find talking about your experiences helpful. The information you 
provide will help to increase knowledge about the impact of difficulties with 
relationships when living with HIV. This knowledge could help to develop better 
services and support for people like you in the future.  
 
Will I get anything personally for taking part? 
If you are eligible to take part in the study, we will reimburse your time for 
taking part in the interview with a £10 voucher. If you decide to attend an 
interview on a different day to your routine clinic appointment, you will also be 
reimbursed for travel expenses. 
 
What will happen to the results of the study?  
The research will be submitted in partial fulfilment of a doctorate degree in 
Clinical Psychology. For participants who opt-in to be informed of the results of 
the study, overall findings will be fed back via an email. We aim to publish the 
study’s result in a peer-reviewed journal. The published data will be anonymised 
and no participants will be identifiable.   
 
Who has reviewed the study?  
The research is being led by Emma Larsson under the supervision of Dr Michael 
Evangeli (Clinical Psychologist and Reader), Dr Caroline Coffey (Clinical 
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Psychologist) and Dr Naomi Adams (Clinical Psychologist). The study is being 
funded by Royal Holloway, University of London (RHUL), as part of the doctorate 
programme in Clinical Psychology.  This study has been reviewed and approved 
by an NHS ethics committee as well as the College Ethics Committee at RHUL. 
This means that these Committees are satisfied that your rights will be 
respected, that any risks have been reduced to a minimum, and that you have 
been given enough information to decide whether to take part or not. 
 
Who should you contact with questions?  
Emma Larsson (Trainee Clinical Psychologist) is the main researcher for the 
study. For more information, please contact her via the details above.  
 
Dr Michael Evangeli (Clinical Psychologist and Reader) at Royal Holloway 
University of London is supervising the study together with Dr Caroline Coffey 
(Clinical Psychologist) at X (removed due to confidentiality) and Dr Naomi 
Adams (Clinical Psychologist) at X (removed due to confidentiality). 
 
Who should you contact with a complaint?  
If you have any complaints about this research or how it is conducted please 
contact the Patient Advice and Liaison Service (PALS) who can offer confidential 
advice, support and information:   
 
Please contact the X (removed due to confidentiality) PALS on: 0300 XXX XXX 
(removed due to confidentiality) 
 
What happens next?  
If you are interested in taking part, you will be given the opportunity to meet 
with Emma on the same day as your clinic appointment (if she is available on 
site) to discuss whether you wish to take part and whether you are eligible to 
take part. If you do decide to participate, you will be given the option to be 
interviewed that day, or attend at a more convenient date for you. If Emma is not 
available on site on the day of your clinic appointment, you can contact her on 
the contact details above to arrange a time to meet. Alternatively, you can let 
your clinician know you are interested in taking part in the study and they will 
pass on your contact details so Emma can contact you to arrange a meeting.  
 
 
Thank you for taking the time to read this information sheet. 
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Appendix F: Consent Form  
Project Title: Longstanding emotional and relational issues in people with HIV  
Name of researcher: Emma Larsson (emma.larsson1@nhs.net) 
IRAS Project ID: 243185 
Version: 4 
Date: 23/08/2018 
 
You have been asked to participate in a study exploring how difficulties with 
managing emotions and forming and maintaining relationships affect individuals 
living with HIV.  
 
The study is being carried out by Emma Larsson (trainee clinical psychologist) at 
Royal Holloway University of London, in collaboration with X (removed due to 
confidentiality)              
            Please initial 
 Yes No 
1. I confirm that I have read and understood the information sheet 
for the above study and that I have had the opportunity to ask 
questions which have been answered satisfactorily 
  
2. I understand that participation is voluntary and I can withdraw 
from the study at any time, without giving reason and without it 
affecting my care. I understand that the data collected will be 
kept in the study if I withdraw from the study.  
  
3. I agree to have my interviews with Emma Larsson (Trainee 
Clinical Psychologist) audio recorded 
  
4. I understand that information will be stored confidential in 
password protected folders on a computer and in locked 
cabinets at the clinic 
  
5. I agree to have anonymised information and quotes from my 
research interview published in a peer-reviewed journal  
  
6. I agree to my clinical records (CD4 count, viral load and 
medication) being accessed by the researcher 
  
7. I agree to take part in the above study    
 
________________________ 
Name of participant 
Emma Larsson 
___________ 
Date 
________________________ 
Signature 
 
________________________ 
Name of researcher 
___________ 
Date 
________________________ 
Signature  
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Appendix G: Example of transcript with initial codes 
Pt7: Umm… I’m not saying I was ever 
perfect but this, if people strive for 100% 
this knocked a good 30% off. You know… 
and… so you only ever going to be 70% off 
what your ideal could be. Sometimes it 
knocks even more off because… I got into, 
when I moved down to London, I got into… 
umm… doing a lot of ketamine… and 
selling it as well to finance my habit. I did it 
for a long time. I don’t think my feet 
touched the ground for about 3 years. 
Umm… I became a prostitute because I 
needed in a weird, perverse kind of way, 
people paying me… because I had a lot of… 
I had a gym body and I was also… I got self-
esteem from people paying me for sex… in 
a weird kind of way. Umm… gosh I wasn’t 
planning on telling you about that. Umm… 
it’s not like I needed the money 
particularly, it was some warped way of 
validation. Umm… and yes I used to go and 
party and have a long list of sexual 
partners… because of all… I was careful 
but I just thought… the world changes 
when you… because you are either positive 
or your not positive… and once you are, 
you can’t get positive again. So, that… even 
that fulcrum of left or right. Umm… yes you 
can get all sort of other nasty things… but, 
that big… either the lights are on or off for 
HIV, the big scary one. And if the lights are 
on, then… 
Feeling like the HIV knocked 
at least 30% of his potentials  
 
Reflecting on getting into 
drugs when moving down to 
London 
 
Reflecting on financing his 
drug habits by selling drugs  
Reflecting on not touching the 
grounds due to drugs  
 
Reflecting on becoming a 
prostitute  
 
Reflecting on getting self-
esteem from people paying 
him for sex 
 
Reflecting on not needing the 
money from selling sex but 
needed validation  
 
Reflecting on having a long list 
of sexual partners  
 
Feeling like the world changed 
when became positive  
 
Reflecting on not being able to 
get positive again 
 
Reflecting on not needing to 
worry about HIV anymore  
Do you think you kind of stopped caring 
for other things then? To catch another 
STD?  
 
Pt7: Yeah… Umm… and there was a time 
when, you know, if people… if you meet 
somebody and they go ‘are you positive’, I 
would say ‘yes I am,’ and somebody would 
go ‘oh good’ and then walk away and so… 
you think ok, well suck it up… but you… 
Reflecting on not caring about 
other STDs 
 
Reflecting on being rejected 
due to HIV  
How was that for you? To hear that or to 
see someone else’s reaction?  
 
Pt7: You learned to brush it off. It hurts in Having to learn to brush of 
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the beginning because that’s what 
reinforces the damaged goods kind of 
feeling… but then, then I learnt… sort of… 
cover those… if people were pushing those 
buttons that would hurt you, I learnt to 
cover those buttons… I, saying ‘I’m not 
going to answer your question, but I’m 
guessing your negative but you should 
treat everyone as they are positive… 
because gay men with a hard on, on drugs, 
they are going to lie through their teeth if 
they want to sleep with you. So, you need 
instead of asking the question, you need to 
protect yourself against all the liars that 
are out there, you are just lucky that I’m 
being honest. So it’s up to you if you want 
to protect your status…’  
others negative reactions to 
HIV  
Feeling like others negative 
reactions to HIV reinforced his 
view of damaged goods 
 
Learning to protect himself in 
the way he disclosed HIV to 
sexual partners   
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Appendix H: Example memo 
 
11/01/2019:  
 
All three participants so far have displayed high levels of anger throughout the 
interviews. They have also all currently single and report a longstanding 
difficulties with relationships. I noticed that they often wanted to be in charge of 
the interview and talk about areas they wanted instead of following the 
questions. All participants reported narcissism traits on the IPDE screening 
measure. I wonder if this can be linked?  
 
 
07/02/2019:  
 
There was a high level of risk in the interview yesterday. I found it difficult to 
manage being a researcher as well as clinician as I ended up having to manage 
the risk. I have been finding this balance difficult throughout the interviews. I 
wonder if this specific patients group stirs up more worries in me than others? 
This is in line with previous research indicating a large amount of 
countertransference issues in PD populations.  
 
 
11/03/2019:  
 
The three last participants reported poor physical health due to the HIV. They 
were all diagnosed late and were therefore very poorly. They have also all 
isolated themselves. I wonder if this is due to the physical health difficulties or 
the personality-related difficulties as other patients without physical health 
difficulties have also isolated themselves.  
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Appendix I: NHS ethics approval  
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 193 
 194 
Appendix J: Royal Holloway University Ethics approval  
Memorandum 
 
To:   Emma Larsson 
 
From:  Lyn Ellett (on behalf of the Research Sub- 
Committee and Course Executive) 
Date:  12th January 2018 
Copy To: Michael Evangeli 
Re:   Main Research Project Proposal 
 
 
The Research Sub-Committee has considered your Main Research Project 
Proposal response and has decided to give you Approval.  Your research costs 
have also been approved.  Please note that if these costs change and you do not 
re-submit an amended form for approval prior to incurring any additional costs, 
these additional costs will not be reimbursed. 
 
Feedback for Systematic Review: 
 
 The proposed question for your systematic review fits nicely with the 
focus of your empirical study.  You may want to consider including ‘peer 
reviewed studies’ only as an eligibility criteria, to avoid unpublished 
studies, dissertations etc, unless you want to include these. 
 
"In addition, as your proposed study is qualitative, please keep the following 
points in mind throughout your major project: 
 
1. Justification for choosing a qualitative approach instead of a quantitative 
approach  for the research questions you wish to address. 
 
2. Providing a rationale for the particular method you chose as opposed to 
other  methods, including the stated philosophy behind the method. 
 
3. Reflecting on your own contribution to the research process. 
 
4. Stating and adhering to published quality standards. 
 
5. Stating what potential contribution to knowledge your study can make.  
Whereas  many qualitative approaches discourage predicting specific 
outcomes, this does  not preclude anticipating in general terms how outcomes 
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you foresee will be  useful to future steps in research and practice.  These 
should be stated in specific  enough terms that the reader of your eventual thesis 
can judge whether or not you  achieved the goals you set out to achieve." 
 
 
 
Now that you have received approval it is time to apply 
for ethics.   Please keep Annette informed and where 
possible provide copies of all applications, letters and 
approvals.  Also, please ensure that if RHUL is your 
sponsor, Annette is sent all participant signed consent 
forms. 
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Appendix K: NHS ethics amendment 
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Appendix L: PRISMA checklist 
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